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Cholera toxin catalyses the ADP-ribosylation of N_, a regulatory
component of adenylate cyclase causing the cyclase to be permanently
activated. To study this reaction a model system was used in which
low molecular weight arginine derivatives were substituted for the
acceptor protein. Michaelis constants calculated using this method
were 4mM for NAD"" in the absence of the arginine derivatives but
45 - 51mM in their presence while the values for the arginine
derivatives themselves were 0.40 - 0.41mM. A number of inhibitors
of the enzyme competitive with NAD"" were examined, the best of these
being thio-NAD"" and acetyl pyridine adenine dinucleotide. Other
alternative ADP-ribose acceptors including transducin and
p-nitrobenzylidine aminoguanide were studied but found to be poor
substitutes for N. under the conditions used.
The binding of NAD"" and the arginine model substrates to the
cholera toxin's enzymatically active Aa chain was studied using
equilibrium dialysis and indirect methods based on changes in the
absorbance or fluorescence of toxin or fluorescently-labelled toxin
upon binding but results were inconclusive. It was noted that
saturating concentrations of NAD"" could protect the Ax chain from
digestion with trypsin and this relationship was eventually used to
calculate a K* of 4mM for NAD"" and to demonstrate the ability to
bind to the Ax chain of one of the arginine model substrates.
Heat labile toxin (LT) was purified from E.coli 2107E (which
carries the plasmid EWD299 (LTA""B^"Ap*")) using gel filtration on
agarose and elution of pure LT wih galactose. The LT, which
catalyses the same reaction as cholera toxin, was compared with
2
cholera toxin and found to have lower activity in an ADP-
ribosylation assay.
The active site of the cholera toxin's Aa chain was studied by
photoaffinity labelling with underivatised NAD*". The NAD*" became
covalently linked to the Ai chain in a saturable manner. A peptide
containing tritiated NAD*" was purified from a tryptic digest of
radiolabelled Ai chain and its amino acid content determined by
amino acid analysis. The amino acid sequence of the peptide could
not be determined using a gas-phase sequencer based on reaction of
the amino acids with phenylisothiocyanate neither could its amino
terminal residue be detected using dansyl chloride. Fast-atom-
bombardment mass spectrometry suggested a possible molecular weight
of 1147 which together with the amino acid analysis allowed a
tentative identification of the peptide as Asn•Asp•Asp•Lys
corresponding to the first four residues of the Aj chain with [4_3H]
NAD*" attached to one or more of its residues.
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Chapter 1 Introduction
Vibrio cholerae can produce one of the most profound
physiological responses known to occur in any human infection.
Without invading the body and without bringing about significant
structural changes in any tissue, these bacteria can cause the host
to become depleted of extracellular fluid to the point of collapse
and death within a few hours. Fluid and electrolyte deficits result
from a massive loss of diarrhoeal fluid (Sack, 1980). Clinically,
this is manifest by vomiting, poor skin turgor, sunken eyes, deep
breathing and intense peripheral vaso-constriction. This latter
symptom is one of the most common causes of death (De, 1961). In
untreated patients with clinical cholera the mortality rate may
approach 70%, making this one of the most lethal of all bacterial
diseases.
As is now known, these dramatic effects are due to a protein
exo-enterotoxin called cholera toxin. Following ingestion of Vibrio
cholerae in contaminated drinking water, the small intestine becomes
infected and colonised with the bacteria which bind tightly to the
mucosa. The bacteria then secrete cholera toxin into the lumen. At
least a part of the toxin then enters the epithelial cells where it
causes increases in cyclic AMP concentrations. This in turn alters
the normal secretory processes of the small intestine by inhibiting
uptake of sodium and chloride by the villus cells as well as by
stimulating active anion secretion by the crypt cells (Field, 1980).
Vibrio cholerae was identified as the causative agent of
cholera as long ago as 1854 by Pacini (see Pollitzer, 1965) but it
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was not until 1959 that De, (1959) and Dutta et al ., (1959)
convincingly demonstrated the existence of a cholera toxin. They
observed that fluid accumulation in rabbit small intestine could be
produced by cell-free culture filtrates of V.cholerae. Finkelstein
and LoSpalluto, (1969) and later Richardson et al., (1970) purified
the protein and showed it to be composed of several subunits. Field
(1971) showed that cholera toxin greatly stimulated the flow of
electrolytes across ileal mucosa, an event mimicked by cyclic AMP or
substances such as theophylline that increases cyclic AMP
concentrations (Field, 1980). It was proposed that cholera toxin
activated adenylate cyclase and that the subsequent rise in cyclic
AMP levels led to the change in flow of electrolytes. This idea was
soon supported by a number of workers (Schafer et al., 1970; Kimberg
et al., 1971; Sharp and Hynie, 1971). The observation that cholera
toxin could induce lipolysis in fat cells in a cyclic AMP-dependant
manner (Vaughan et al., 1970) suggested that the activation of
adenylate cyclase was the primary action of cholera toxin and that it
could be demonstrated not only in intestines but also in other cells
and tissues.
The currently accepted view of the molecular mechanism of
cholera toxin can be summarised as follows. The toxin consists of
one A subunit and five B subunits. The B subunits can bind to
ganglioside Gx, a natural toxin receptor on the cell surface. This
causes a conformational change leading to the entry of all or part
of the A subunit into the cell. During or after entry the A subunit
is split into two chains, Ax and Aa. The Ax chain then catalyses
the ADP-ribosylation of N„, the stimulatory regulatory component of
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the adenylate cyclase complex. ADP-ribosylation inhibits the
GTP'ase activity of N„, leaving it in a permanently activated state.
The over-production of cyclic AMP generates a variety of
physiological responses that vary with cell type (Gill and Meven,
1978; Cassel and Pfeuffer, 1978; Johnson et al., 1978; Cassel and
Selinger, 1977; Field, 1980). The biochemical aspects of cholera
toxin have been extensively reviewed (see for instance van Heyningen
1977a, 1982b; Gill, 1982; Holmgren and Lonnroth, 1980; Gill and
Enomoto, 1980, Moss and Vaughan, 1979; Lai, 1986).
1.1 The structure of cholera toxin
The complete toxin molecule is a protein of molecular weight
82,000 - 84,000 (van Heyningen, 1976; Lospalluto and Finkelstein,
1972; Lai et al., 1976; Sattler et al., 1975) and the purified
toxin contains no detectable quantities of lipid or carbohydrate
(Lospalluto and Finkelstein, 1972). Analysis of cholera toxin by
SDS-PAGE (polyacrylamide gel electrophoresis in the presence of SDS)
showed that the toxin contains two kinds of non-covalently associated
subunits, called A and B (Finkelstein et al., 1972; Cuatrecasas,
1973; Lonnroth and Holmgren, 1973). The toxin contains one A
subunit (28,000) and several identical B subunits (8,000 - 14,000)
(Finkelstein et al., 1974; van Heyningen, 1974; Kurosky et al.,
1977; Gill 1976a). The B subunits exist as an aggregate even in the
presence of SDS owing to very strong non-covalent interactions
between them and can only be separated by boiling in SDS. The A
subunit consists of two polypeptide chains called Ai (22,000) and Aa
(6,000) connected by one disulphide bond. The Ax and Aa chains have
been shown to be formed by post-translational modification by
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nicking of a precursor polypeptide with bacterial proteases (Gill
and Rappaport, 1979; Mekalonos et al., 1979b). The protease
responsible in V.cholerae is thought to be a soluble hemagglut<iiv>\
protease (Booth et al, 1983). The "un-nicked" form of the toxin,
produced by a protease-deficient strain of V.cholerae had greatly
reduced enzyme activity (Mekalonos et al., 1979b). The nicking of
the A subunit does not produce any significant decrease in the
molecular weight suggesting that few amino acids, if any, are lost.
The precursor is believed to have the sequence NH2-Aa-A2-COOH (Duffy
et al., 1981).
1♦2 Subunit arrangement
A molar ratio of five B subunits to every A subunit was proposed
by Lai (1977) from calculatios of molar ratios using the molecular
weights of each subunit and of whole toxin. This ratio has been
verified (van Heyningen, 1977b; Gill, 1977). Some electron
micrographs support this model (Ohtomo et al., 1976) as do cross-
linking experiments with bifunctional reagents (Gill, 1976b). X-ray
diffraction analysis of crystalline toxin was consistent with five B
subunits per molecule (Sigler et al., 1977). Intact cholera toxin
therefore consists of subunit A, comprising Ax and A2 chains, joined
non-covalently to five B subunits, all associated non-covalently
with each other. A heterologous ring of B subunits with subunit-" A
in the centre is the proposed structure and is shown in fig. 1-1.
The A2 chain is thought to serve as a direct link between the Ax
chain and the B ring (Gill 1976a; van Heyningen, 1976; 1977b).
Plan Elevation
fig. 1-1 Proposed structural relationship of the cholera
toxin subunits.
Taken from van Heyningen, 1977a
*
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1,3 Primary structure of the subunits and the organisation of their
structural genes
The primary ab'^cture of both subunits is known (Lai, 1977; Duffy
et al., 1981; Lai et al., 1979), The B subunit contains 103 amino
acid residues and shows significant similarity to the B chains of
glycoprotein hormones such as thyrotropin, luteinizing hormone and
follicle stimulating hormone (Ledley et al., 1976; Kurosky et al.,
1977). The A subunit is unusually rich in charged residues (Duffy
et al., 1981). Before 1981 it was prohibited by the Guidelines for
Recombinant DNA research to clone the genes encoding cholera toxin.
Recognition of the structural and functional homology between E.coli
heat labile toxin (LT, see Chapter 4) and cholera toxin was one of
several reasons why the Recombinant DNA Advisory Committee voted to
allow the cloning of cholera toxin genes at a suitable level of
containment.
The toxin structural genes ctx A and ctx B have been cloned and
their complete nucleotide sequence determined (Mekalonos et al.,
1983; Pearson and Mekalonos, 1982). The two genes are cotranscribed
from a polycistronic operon (Mekalonos et al., 1983) which in turn
is part of a larger 7- to 12- kilobase genetic element (Mekalonos,
1983). Analysis of the nucleotide sequence of the ctx genes
suggests that they are cotranscribed from a single promoter
preceding the ctx A gene (Rosenberg and Court, 1979) and that ctx
mRNA contains two Shine-Dalgarno sequences (Steitz, 1979) preceding
the AUG translation starts for ctx A and ctx B. The Shine-Dalgarno
sequence preceding B can potentially pair with the complementary
sequence at the 3'- end of 16s-rRNA with greater efficiency than
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that for the A cistron (Yamamoto et al. , 1984; Gennaro and
Greenaway, 1983). Greater trcvn^VatvoocxL efficiency would then
explain the production of five B subunits for each A subunit.
It appears that several genetic factors influence the level of
cholera toxin production. The first is the copy number of the toxin
genetic element; amplification of this element increases the
production of toxin (Mekalonos, 1983), Secondly, the number of
tandem repeats of a sequence T-T-T-T-G-A-T upstream of the ctx
promoter affects toxin expression (Miller and Mekalonos, 1984).
Lastly, there are at least two regulatory genes, one whose product
stimulates transcription of ctx AB and one which may encode a
negative regulatory factor (Miller and Mekalonos, 1984). Studying
the factors involved in the control of cholera toxin production
including nutritional and physiological factors may help to define
the precise role that the toxin plays in pathogenesis because the
intestine apparently provides a selective environment for bacterial
cells which have the capacity to produce cholera toxin (Dutta and
Habbu, 1955; Dutta et al., 1963; Finkelstein, 1973).
1.4 Binding cells and ganglioside
The evidence that ganglioside GMi is the receptor for cholera
toxin is impressive (e.g. van Heyningen, 1974; Pierce, 1973; Moss et
al, 1976a, 1977; Fishman, 1980). More than two million toxin
molecules may bind to ganglioside GMi located on the plasma membrane
of each mucosal cell (Holmgren et al., 1973). Binding is tight and
irreversible (van Heyningen, 1977a). The pentavalent interaction
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between subunit B and GM1 may lead to patching and capping of the
toxin-ganglioside complex and induces changes in conformation in
both B and A subunits (Mullin et al., 1976; van Heyningen, 1982b).
The binding of cholera toxin to cells is followed by a lag of from 15
to 90 mins. (Cuatrecasas, 1973; Gill and King, 1975; Bennet and
Cuatrecasas, 1975; Fishman, 1980), depending on the type of cell,
before the levels of adenylate cyclase inside the cell begin to
rise. There was no lag when toxin was incubated with lysed or
broken cells (van Heyningen and King, 1975) which suggested that the
lag may have something to do with transport across the membrane or
with release of ki from intact toxin. A general theory of the
mechanism of entry of the toxin is summarised in fig. 1-2.
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fig. 1-2 Model for the movement of the Ax chain across the
membrane.
The A.i chain may remain associated with the rest of the
toxin or may become completely dissociated. From
van Heyningen, (1982b)
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1.5 Entry of the A^ chain
Adenylate cyclase is located on the inner surface of plasma
membranes. To activate the cyclase, all or part of subunit A must
be transported at least to the cytoplasmic surface of the cell
membrane. This entry process is incompletely understood and several
theories offer explanations. Gill (1976b) proposed that the B
subunits form a channel through which the A subunit can pass
although this theory is now not thought to be true. Wisnieski and
Bramhall (1981) used photolabelling to show that only the Aa subunit
enters the membrane. The simplest theory originally suggested by
van Heyningen and King in 1975 was based on their observation that
subunit A was active alone even with intact cells, although at low
specific activity. There may be no specific mechanism of entry, but
the high local concentration of toxin following the binding to GmZ
could increase the chance of a few molecules entering by some random
process. As little as one molecule per cell may be all that is
needed for activation of adenylate cyclase.
It is not clear whether the whole of the Ax chain has to penetrate
the membrane as quite small proteolytic fragments are claimed to
show activity (Matuo et ai., 1976; van Heyningen and Tait, 1980).
Van Heyningen (1977b) reported that cross-linked cholera toxin as
well as native toxin could activate adenylate cyclase in intact
cells. This suggests that the Ax chain does not necessarily
dissociate from the rest of the toxin as is passes through the
membrane. Although some cells take up the whole toxin (such as
neuronal cells (Joseph et al., 1978)) most people assume that it
remains outside the cell (Wisnieski and Bramhall, 1981).
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1.6 Activation of adenylate cyclase
Cuatrecasas and co-workers proposed a model in which cholera toxin
directly interacted with adenylate cyclase to activate it
stoichiometrically (Bennet et al., 1975; Sahyoun and Cuatrecasas,
1975). However, kinetic data suggested that the toxin acted
enzymically and Gill (1975) proposed that cholera toxin caused an
enzymic modification to adenylate cyclase or a regulatory component.
NAD"*" had been found essential for cholera toxin's action in all
cell-free systems examined (e.g. Bitensky et al., 1975; Martin et
al., 1977). Moss et al., (1976b) then discovered that cholera toxin
catalysed the hydrolysis of NAD"" to ADP-ribose and nicotinamide
(NAD"" Glycohydrolase activity, EC 3,2,2,5). Moss and Vaughan (1977)
further demonstrated that the release of nicotinamide from NAD"" was
greatly stimulated by arginine. ADP-ribosyl arginine was
formed as a product.
Although much of the NAD"" Glycohydrolase activity of crude toxin
may be due to another enzyme (Tait and van Heyningen, 1978) it is
clear that both NAD"" Glycohydrolase and ADP-ribosyl transferase
activities are true properties of the toxin, specifically of its Ai
chain. Reported K„ values for NAD"" were 3.6mM (Mekalonos et al.,
1979a) and 5mM (Moss et al., 1979b).
1.7 ADP-ribosylation catalysed by the Ai chain
The hormone-sensitive adenylate cyclase system is complicated,
consisting of at least three types of protein embedded in the plasma
membrane. Receptors communicate with a pair of homologous GTP-
binding regulatory proteins, N. and NA, which in turn stimulate (N.)
or inhibit (NA) the activity of a catalytic subunit, C.
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The role of GTP in the regulation of adenylate cyclase was first
recognised by Rodbell et al., (1971) who used it to restore hormone
sensitivity to adenylate cyclase in isolated membranes. Levinson
and Blume (1977) observed that cholera toxin activation of adenylate
cyclase was dependant on GTP, as well as NAD"1". The magnitude of
activation was quantitatively similar to that obtained with
5'-guanylyl-imidodiphosphate (Gpp(NH)p) alone, a non-hydrolysable
analogue of GTP. It was suggested that cholera toxin was
interfering with hydrolysis of GTP at some regulatory site and that
this resulted in permanent activation of adenylate cyclase (Levinson
and Blume, 1977; Schramm and Rodbell, 1975). Direct evidence for
this model came from Cassel and Selinger (1977) using turkey
erythrocyte membranes. A catecholamine-sensitive GTP'ase activity
was observed in these membranes with properties suggesting it was
associated with a GTP regulatory site of adenylate cyclase.
Treatment of the membrane with cholera toxin, NAD"1", ATP and cytosol
resulted in a decrease in hormone stimulated GTP'ase activity which
paralleled the elevation of adenylate cyclase activity in these
membranes. Thus toxin activation of adenylate cyclase was
associated with an inhibition of GTP'ase activity. The guanyl
nucleotide regulatory site of adenylate cyclase was presumably the
site of both GTP dependant activation of cyclase and the inhibition
of GTP'ase activity by cholera toxin, although separate sites for
these activities have more recently been proposed (Gill and
Woolkalis, 1985).
Pfeuffer (1977) first reported the purification of a GTP-binding
protein from pigeon erythrocyte membranes which could be ADP-
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ribosylated by cholera toxin and which could restore activation of
adenylate cyclase to membranes depleted of their intrinsic GTP-
binding proteins. The protein, of molecular weight 42,000 now seems
to be a subunit of N. (Katada and Ui, 1982). The homologous
protein, N±, has been shown to have intrinsic GTP'ase activity. A
similar activity for N, has not been purified but may be lost during
purification (Enomoto and Asakawa, 1984). The two guanine-
nucleotide-binding regulatory components, N. and N±, have been
purified to apparent homogeneity (Bokoch et al., 1983, 1984; Codina
et al., 1983, 1984; Sternweis et al., 1981) and they appear to be
structurally and functionally very similar. Both are <X88
heterotrimers (Hildebrant et al., 1984a) of molecular weight 80,000-
90,000 (Bokoch et al., 1984; Codina et al., 1984). Although their (X
subunits are unique, their 8 subunits (molecular weight 35,000)
appear to be indistinguishable although apparent size heterogeneity
has been reported (Sternweis and Robishaw, 1984; Codina et al.,
1984; Manning and Gilman, 1982). They can sequester and inactivate
the a subunits. The role of the recently discovered 8 subunit
(molecular weight 5,000) is unknown. The a subunits of both
proteins bind GTP (Northup et al., 1982). Activation of either
protein is guanine nucleotide- and Mg2r-dependant (Northup et al.,
1982; Hildebrandt and Birnbaumer, 1983), is also brought about by
NaF in the presence of Mg2*" (Sternweis et al., 1981) and appears to
result in the dissociation of the proteins into separate a and 88
components (Hildebrant et al., 1983; Bokoch et al., 1983; Northup et
al., 1983). N. and N* are substrates for NAD""-dependant ADP-
ribosylation by bacterial toxins. The (X subunit of N, (molecular
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weight 45,000) is ADP-ribosylated by cholera toxin; inhibiting its
GTP'ase activity and prolonging its active state (Cassell and
Selinger, 1977). The a subunit of N± (molecular weight 41,000) is
ADP-ribosylated by pertussis toxin. This inhibits GTP'ase activity
presumably by stabilising the OtfSH complex (Murayama and Ui, 1984;
Katada et al., 1984).
One theory of the sequence of events surrounding hormonal
stimulation of adenylate cyclase is as follows (Gilman, 1984). The
binding of an external signal to the receptors R. and R* (see fig.
1-3) induces a conformational change in the receptors which is
transmitted to N. and to Nit making them susceptible to GTP.
When the GTP binds it forces them into a different conformation and
leads to dissociation of the subunits. No, can then activate the
catalytic subunit while NA inhibits it. When the GTP'ase activity
of these subunits has hydrolysed the bound GTP to GDP they
re-associate into oligomers and return to the inactive state. The
role of Ni in inhibiting the catalytic subunit is uncertain. No, may
simply release N±» which binds to N-0» and antagonises stimulation
(Gilman, 1984) or it may act directly on the catalytic subunit
without affecting the activity of N_ (Hildebrand et al., 1984b;
Enomoto and Asakawa, 1984). The effects of cholera toxin are then
simply explained by its ability to prolong the life of the activated
N_o.-GTP complex to that the cell produces cyclic AMP continually







1-3 Schematic diagram of the interaction of the components of
the adenylate cyclase complex.
C^is the catalytic component of adenylate cyclase,







fig. 1-4 Simplified scheme showing the mechanism of activation of
adenylate cyclase by cholera toxin.
R„ represents the stimulatory hormone receptor and H a
stimulatory hormone (such as ACTH).
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1.8 Other effects of the toxin
Although the ADP-ribosylation of N„ is thought to be responsible
for the physiological effects of cholera toxin, it is not the only
effect seen. In many tissues a protein of molecular weight 54,000
is also modified (Cooper et al., 1981). Although peptide analysis
of this protein indicates that it is closely related to the N»o»
subunit (Manning and Gilman, 1983) and reconstitution studies
implicate it in N.c activity (Sternweis et al., 1981; Hanski et al.,
1981) its role in the transmembrane signalling process is unclear.
Owens et al., (1985) report that cholera toxin may ADP-ribosylate
the N±<x subunit under certain conditions causing similar functional
consequences as ADP-ribosylation by pertussis toxin. It is not
clear whether this reaction is significant in vivo. The toxin can
certainly ADP-ribosylate several membrane-bound 'minor' substrates
not all of which are likely to be larger precursors or proteolytic
derivatives of N.. Some have been identified, such as a major
erythocyte membrane protein (Gill and Woolkalis, 1985). Soluble
proteins, even globin, are ADP-ribosylated. Almost every abundant
protein can be seen to be modified provided the detection is
sensitive enough although some of these modifications may be non-
enzymic, perhaps through the formation of Schiff's bases (Run et
al., 1976). Whether these modifications cause any effects is
uncertain, although cholera toxin has been reported to inhibit
chemotaxis in a cyclic-AMP independant manner (Aksamit et al., 1985)
in human and rabbit neutrophils (Hill et al., 1975; Bergman et al.,
1978), to block phosphate incorporation into pyruvate kinase
(Tsuchoja, 1985) and decrease phosphate transport in canine renal
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brush border membranes (Hammerman et al., 1982). Again, the
significance of these effects in the pathogenesis of V.cholerae is
unclear. Recently, clinical trials have been undertaken in humans
using an attenuated strain of V.cholerae as a live oral vaccine
(Levine et al., 1984). The strain used was Texas Star, an A~B*'
mutant derived by nitrosoguanidine treatment from V.cholerae El Tor
Ogawa strain 3083. Although the strain produced no A subunit it
still caused some diarrhoea in 25% of cases. It is conceivable that
the mere act of colonization of the small intestine may elicit some
response (Smith and Linggood (1971)). It has also been claimed that
V.cholerae can elaborate cytotoxins and other "toxic materials"
distinct from cholera toxin that have the ability to induce
secretion when tested in animal models (Nishibuchi and Seidler,
1983; Nishibuchi et al., 1983; Sanyal et al., 1983). These factors
may become important when considering the production of oral
vaccines based on attenuated strains of V.cholerae and indicate that
the actual disease-state of cholera may be caused by a number of
factors working together, of which the ADP-ribosylation of N_ is the
most significant.
1.9 N. as a model for other GTP-binding proteins
It is now apparent that N. and N± are not the only GTP-binding
proteins which transduce and integrate information flow across the
plasma membrane. A whole family of similar GTP-binding proteins, or
G proteins has been proposed (Hughes, 1983; Berridge, 1985).
Receptor molecules at the surface of the cell are thought to
transmit information through the plasma membrane and into the cell
through these G proteins; membrane proteins which apparently cannot
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be active unless they bind GTP. In an analagous way to N„ and N±,
the G proteins are then proposed to act on enzymes which regulate
the concentration of highly phosphorylated intracellular messengers
such as cyclic GMP ana inositol triphosphate. The functional
homologies have been backed up in many cases by close structural
homologies. Both cholera toxin and pertussis toxin (produced by
Bordetella Pertussis) have been instrumental in the elucidation of
some of these processes as they show the ability to ADP-ribosylate
proteins homologous to their respective substrates, N, and N±. (see
fig. 1-5).
The most striking structural and functional homology is that
seen between N„, N± and transducin, a protein responsible for
mediating rhodopsin-catalysed photoactivation of a cyclic GMP-
phosphodiesterase (Yamazaki et al., 1983; Fung, 1983; van Dop et
al., 1984). In a similar way to activation of N„ or N±,
photoactivation of rhodopsin (c.f. hormone-receptor interaction)
leads to a conformational change in transducin which in turn leads
to activation, GTP-binding and dissociation of its <X$#
subunits (Fung and Stryer, 1980; Kuhn, 1980). The striking
homologies between transducin, N. and NA are covered in more detail
in section 3.2.9. Transducin is a substrate of both cholera toxin
and pertussis toxin.
A number of other G-proteins have been reported, about which
less is known, a GTP-binding protein was identified in brain tissue
in 1984 (Stemweis and Robishaw, 1984; Neer et al., 1984). The
protein, designated N0 was present in high concentrations and was a
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Hi. IM 25 unknown cholera toxin
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P21 «? 21 unknown -
fig. 1-5 Proposed G-protein family
to N, and N± with subunits of similar sizes (Milligan and Klee,
1985; Malbon et al., 1984). N0 has not been found in other tissues
and its function is unknown.
Another novel G protein may be involved in coupling hormone
receptors to phospholipase an enzyme which converts phospholipids in
the plasma membrane into the intracellular messengers inositol
triphosphate and 1,2 diacylglycerol (for recent reviews see
Williamson et al., 1985 and Majerus et al., 1985). The protein has
been tentatively named Np by Cockroft and Gompert (1985) and is a
substrate for pertussis toxin (Nakamura and Ui, 1985; Brandt et al.,
1986). Nj, perhaps represent a particular permutation of the
subunits of N± in which phosphorylation of the B subunit (stimulated
by epidermal growth factor) has altered its function to allow it to
interact with phospholipase C (Joseph, 1985).
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It has also been proposed (Heyworth et al., 1983) that a specific
G-protein might mediate the effect of insulin on plasma membrane
kinases and phosphodiesterases. The proposed Nin is suggested
(Heyworth et al., 1985) to have a protein component of molecular
weight 25,000 which has a GTP-binding site, a site for cholera
toxin-mediated ADP-ribosylation and a site for interaction with the
insulin receptor. Insulin could inhibit ADP-ribosylation of NA„ by
cholera toxin.
An analogy can also be drawn between the G-protein family and
p21 proteins. These are a highly related group of proteins of 189
amino acids (and hence molecular weights around 21,000) encoded by
the multigene family of mammalian ras oncogenes (Change et al.,
1982; McGrath et al., 1983; Taparowsky et al., 1983). The proteins
have reported amino acid homology to both transducin and GTP-binding
elongation factors (Lochrie et al., 1985). It is of note that the
homologies to transducin are confined to regions implicated in the
binding and hydrolysis of GTP. In vitro, p21 proteins bind GTP and
are membrane bound although their function is unknown (Scolnick et
al., 1979; Papageorge et al., 1982; Finkel et al., 1984). Normal
and mutant transforming ras proteins show no alteration in
localisation or GTP-binding but the intrinsic GTP'ase activity of
normal ras proteins is tenfold lower in transforming mutants (Sweet
et al., 1984). It is tempting to speculate on the functional
analogy between oncogenic ras proteins and N, and N±. In the
latter, ADP-ribosylation inhibits GTP'ase activity and leaves N. and
Ni permanently switched on. Perhaps the transforming mutations
which destroy the ras protein's GTP'ase activities leaves them in a
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'switched-on' form, which leads in some unknown way to the over-
proliferation characteristic of tumour cells. If the analogy were
to hold then suitable effectors and receptors for p21 would have to
be found. A candidate for the receptor might be a peptide growth
factor, despite the lack of evidence (Bourne, 1985). Phospholipase
C has been mentioned as a possible effector (Smith, 1985). However,
despite the presumed similarities, Gill and Woolkalis (1985) could
not detect any ADP-ribosylation of p21 by cholera toxin. Further
biochemical and genetic analysis of this and other systems may yet
identify other proteins involved in the transduction of information.
The ease of purification of transducin (Kuhn, 1980) and N0
(Stemweis and Robishaw, 1984) and the use of cholera toxin as a
tool in highlighting similar protein structures and functions and in
labelling proteins using (32P)-NAD~ may allow a greater
understanding of how these systems function.
1.10 Other ADP-ribosylation reactions
ADP-ribosylation is not a reaction unique to cholera toxin. As
shown in fig. 1-6, it is shared by other bacterial toxins, by
bacteriophages and even by certain eukaryotic enzymes.
E.coli heat-labile toxin
Of the ADP-ribosylating bacterial toxins, E.coli heat-labile toxin
(LT) shows the most striking similarities to cholera toxin. LT is
produced by certain entero-pathogenic strains of E.coli and induces
diarrhoea in exactly the same way as cholera toxin, namely by
catalysing the ADP-ribosylation of a susceptible arginine on N,
(Evans et al., 1972; Gill et ai., 1981; Moss and Vaughan, 1981).
The two proteins are highly homologous (Spicer and Noble, 1982;
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Dykes et al., 1985) and there seems little doubt that they are
evolutionarily related.
Diphtheria toxin
Diphtheria toxin shares with the A exotoxin from P.aeruginosa
the ability to catalyse the ADP-ribosylation of elongation factor 2
(EF-2), a protein essential for ribosomal protein synthesis (Honjo
et al., 1968; Iglewski and Kabort, 1975; van Ness et al., 1980).
Like N„, EF-2 is a GTP'ase and ADP-ribosylation destroys this
activity, preventing protein synthesis and leading to cell death
(Honjo et al., 1968). However, these two proteins differ from
cholera toxin in that they catalyse the ADP-ribosylation not of
arginine but of diphthamide, a modified histidine so far found only
in EF-2 (van Ness et al., 1980) (see fig. 1-7).
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Enzyie Protein Aiino acid Reference
Prokaryotes
Diphtheria toxin Ef-2 diphthaiide
F.iengiaosi exotoxin A Ef-2 diphthaiide






Rohrer et il., (1975)
cholera toxin 1. and other proteins arginine?
E.coli LT 1. and other proteins arginine? Tait et il., (1980)
Pertussis toxin lt and other proteins asparagine,
aspartate
or cysteine
P.acruginosa exotoxins if-1 and associated
proteins
unknown Iglewski et il., (1978)
1* phage E.coli proteins unknown Pesce et il,, (1976)
Eukaryotes
aanaiian cytosolic enzyie Ef-2 dipthaiide
avian erythrocyte enzyie 1. (?), soluble proteins arginine?
nanalian cytoplasiic enzyie soluble proteins arginine? Moss and Stanley, (1981)
nanalian neibrane enzyie 1., leibrane proteins arginine? Reckner and Blecher., (1981)
De Rolf et il,, (1981)
nanalian litochondrial enzyie litochondrial inner
■eibrane protein
argiiine? Adaiietz et il., (1981)
avian nuclear enzyie nuclear proteins arginine? Tanigasa et il., (1984)




















fig. 1-7 Acceptor amino acids for ADP-ribosylation
Diphthamide (2-{3-carboxyamido-3(trimethyl am' n o<
propyl] histidine is formed by post-translattonal
modification of a histidine residue.
The acceptor amino acid for pertussis toxin may be
asparagine (shown above), aspartate or cysteine
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Pertussis toxin
Much less is known about pertussis toxin, also known as islet
activating protein (Katada and Ui, 1982), It is a protein of
complex structure (Manning et al., 1984) which catalyses the ADP-
ribosylation of N±. The reaction has been studied using transducin
which can also act as a substrate. The amino acid which is modified
has been variously reported to be aspartate (Hurley et al., 1984),
asparagine (Abood et al., 1982; Manning et al., 1984) or cysteine
(West et al., 1985).
Mono (ADP-ribosyl) transferases in eukaryotic cells
Poly (ADP-ribosyl) transferases in the nucleus have been
extensively studied (see Hayaishi and Ueda, (1985) for a recent
review) and have been implicated in such processes as DNA strand
repair, sister chromatid exchange and other processes involving DNA
strand cleavage (Gaal and Pearson, 1985; Hayaishi and Ueda, 1982).
In addition, a number of mono (ADP-ribosyl) transferases have been
identified. Their function is, however, less clear. For instance
an avian erythrocyte protein has been identified (Moss and Vaughan,
1978) which can apparently ADP-ribosylate N», resulting in
stimulation of adenylate cyclase (Beckner and Blecher, 1981; De Wolf
et al., 1981; Vitti et al., 1982). The protein is partially
homologous to cholera toxin (Ledley et al., 1976), is specific for
arginine and appears to share aspects of the kinetic mechanism of
cholera toxin (Osborne et al., 1985). Another mono (ADP-ribosyl)
transferase has been reported which catalyses the ADP-ribosylation
of EF-2 at its diphthamide residue (Lee and Iglewski, 1984).
The existence of these supports the view that the eukaryotic
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enzymes might be functioning as physiological counterparts of
cholera toxin and diphtheria toxin. The former might presumably
have a role in signal transduction and the latter in the control of
protein synthesis (although it would have to be under very tight
control to avoid cell death). It seems that ADP-ribosylation must
play some important role in the eukaryotic cell judging from the
large number of ADP-ribosyl transferases identified, although what
that role is, is as yet unknown.
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Chapter 2 Materials and Methods
2.1 Materials
Cholera toxin
Cholera toxin was obtained from either Sigma Chemical Co. or from
List Biochemicals, Richmond, California. Samples of isolated
cholera toxin chain were provided by the Institut Merieux,
France. »'
Radioactive chemicals
[nicotinamide-4-3H] -NAD"" (1 .0 ICi/mMol) and [ U-14C ] NAD"*"
(l.OCi/mMol) were from Amersham International. [Adenine-2,8-3H]NAD""
(27.ICi/mMol) was from New England Nuclear.
Other materials and reagents
NAD"" was Grade 1 from Boehringer Mannheim. Bovine serum
albumen (BSA), alkaline phosphatase, trypsin, chymotrypsin,
benzyol-8-arginine ethyl ester (BAEE), 4-chloro-7-nitrobenzofuran
(Nbf), thio-NAD"", nicotinic acid adenine dinucleotide, deamide-NAD"",
3-aminopyridine adenine dinucleotide (APAD), adenine, adenosine,
ADPR, FAD, NADP"", NADH, NMN, AMP, ADP and ATP were all from Sigma
Chemical Co.
Bio-Gel P10 agarose (100-200mesh) and Bio-Gel A5M agarose were
from Bio-Rad. Sephadex G75, Sephadex QAE-25 and Sephadex G25 were
from Pharmacia Fine Chemicals.
Pre-coated aluminium backed sheets of silica gel (60F254, 5cm x
7.5cm) were from Merck. Polyamide sheets (15cm x 15cm) and dansyl-
amino acid derivatives were from BDH.
Aminoguanidine bicarbonate and p-nitrobenzaldehyde were from
Aldrich Chemical Co.
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Spectrapor dialysis membrane was from Spectrum Medical
Industries.
t12—[(phenylmethyl) amino] dodecanyl] guanidine, [10—[(phenyl
methyl) amino] decanyl] guanidine and [10-(acetyl amino) decanyl]
guanidine were made available as intermediates from synthetic
programmes within Glaxo Group Research Ltd.
All other reagents were analytical grade.
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General methods
2.2 Preparation of Cholera Toxin
Freeze-dried cholera toxin or E.coli heat labile toxin (LT) were
rehydrated to give a 1-10 mg/ml solution in 50mM tris-HCl, lOOmM
sodium chloride, 3mM sodium azide, ImM EDTA, pH7.5 (TEAN buffer).
Isolated Ai chain was stored frozen. Aliquots were thawed as
required and dialysed against 0.1M Glycine/HCl, 6.5M urea, 5mM DTT
pH3.2. The dialysed solution was then applied to a column of
Sephadex G75 (1cm x 110cm) and run at lOml/hour (Moss et al., 1976).
Fractions of 1ml were collected and monitored by absorbance at
280nm. (A lOmg/ml solution of Aa chain was assumed to have an
absorbance of 7.6 at 280nm (Holmgren and Lonnroth, 1980)). The
purity of the At chain was checked by 12% SDS-PAGE. Urea was
removed by gradual dialysis against solutions of TEAN buffer, pH7.5
containing stepwise urea concentrations decreasing from 6M to zero.
2.3 Separation and reconstitution of subunits
2.3.1 Isolation and assay of subunits
Subunits of cholera toxin and LT were separated by gel filtration
on Sephadex G75 as described in section 2.2 except that DTT was
omitted from the buffer. Alternatively the same G75 column was used
but with 5% formic acid in place of urea buffer (Lai et al., 1979).
A typical elution profile is shown for cholera toxin in fig. 2-1.
However, when LT was treated in this way, the subunits were
incompletely separated and the process had to be repeated to allow
complete separation, (fig. 2-1).
fig. 2-1. Separation of cholera toxin and LT subunits
by gel filtration chromatography
The toxins, 5mg/n>l in 6.5M urea, 0.1M Glycine pH3.2 were
chromatographed on Sephadex G75 (1cm x 110cm) at lOml/h.
Fractions of 1.5ml were collected and monitored by
absorbance at 280mm
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The activity of subunit A was measured using an ADP-ribosylation
assay described in section 2.9. Binding of subunit B to ganglioside
was measured quantitatively by diffusion in agar (Holmgren et al.t
1973). Wells containing 6/1 of solution and about 5mm apart were
cut in a 1.5% agar gel made up in 50mM sodium phosphate, 150mM
sodium chloride pH7.0. One well was filled with a solution of toxin
or subunit (about 5yg/ml) and the others with ganglioside Gmi
solution (about lyg/ml). The plates were incubated at 4°C for 20
hours.
2.3.2 Reconstitution of separated subunits
Native toxin was reconstituted from subunits A and B by mixing
solutions together in the presence of 8M urea and then dialysing the
urea away as described. The two solutions were mixed so that the
ratio (A2so of B)/(A2So of A) was 1.45. This ratio was calculated
from the observed yield of columns used to separate the two subunits
from native toxin, assuming that the yield of each subunit from the
column was the same.
2.4 Purification of E.coli Heat Labile toxin
The method followed was essentially that of Hofstra et al.,
(1984). The work described in this section was performed in the
Department of Microbiological Biochemistry, Glaxo Group Research
Ltd., Greenford, Middlesex. E.coli 2107E, a strain carrying the
plasmid EWD299 (Amp*, porcine LT"") was grown in casamino acid growth
medium containing Ampicillin for 8 hours at 37*C with vigorous
shaking. This culture was then used to inocculate ten one litre
flasks each containing 500ml growth medium. The flasks were
incubated overnight at 37*C with vigorous shaking and the cells
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harvested by centrifugation at 5000xg for 10 min. The cells were
suspended in 50ml TEAN buffer, pH7.5 and were lysed by sonication
(three one minute blasts). Cell debris was removed by
centrifugation for one hour at 5000xg and the resulting supernatant
subjected to ammonium sulphate precipitation at 60%. The
precipitate was centrifuged at 2000xg for 10 min. and the pellet
resuspended in TEAN buffer, pH7.5 before dialysis overnight against
TEAN.
The protein was further purified on a column of Bio-Gel agarose
A5m (2.5 x 90cm) pre-equilibrated with TEAN, pH7.5. The column was
run at 20ml/hour and fractions of 5ml were collected. An initial
wash with about 100ml TEAN buffer pH7.5 was continued until no more
protein was eluted. The LT was then specifically eluted with 0.2M
galactose. Throughout the purification procedure, samples were
assayed for total protein, for the presence of LT using a GMX-ELISA
procedure described in section 2.5 and for ADP-ribosyl transferase
activity using the assay described in section 2.9. LT purified in
this way was analysed on 12% SDS=PAGE. Typically 20-25mg LT was
recovered per ten litre culture.
2.5 Identification of E.coli heat labile toxin using a ganglioside
immunosorbent assay (Gmi~ELISA) procedure
The method used was essentially that of Svennerholm and Holmgren,
(1978). 96-well microtitre plates (Nunc) were coated with 50yl per
*
well of a solution of phosphate-buffered saline (PBS). After 16
hours at 37*C, free ganglioside was removed by washing three times
with PBS. Free binding sites were blocked with lOOyl/well 2% (v/v)




with PBS. Standard LT solutions, or test samples, were added (50yl
in PBS), incubated for one hour at 37*C and washed with PBS
containing 0.05% (v/v) Tween 20. The presence of bound LT was
determined by the sequential addition of 50yl rabbit anti-LT serum,
50yl goat anti-rabbit immunoglobulin alkaline phosphatase conjugate
and 50yl p-nitro phenyl phosphate with incubation at 37*C for one
hour and washing with PBS containing 0.05% Tween 20 between each
step. The absorbance of each well was read at 405nm and the
concentration of toxin determined from a standard curve shown in
fig. 2-2. The optimum dilution for each batch of serum was
determined from a dilution curve such as the one shown in fig. 2-3.
In this case the optimum dilution was taken to be 1/200.
37
yg/ml LT
fig. 2-2 Standard curves of LT with anti-cholera toxin
(anti-CT) and anti-LT antisera
LT purified as described in section 2.4 was diluted to
cover the range 10 - 0.005 yg/ml. The antibody dilutions
used were 1/50 for the anti-CT and 1/200 for the anti-LT
(see fig. 2-3). The absorbance at 405nm of each toxin
sample was determined following the Gm-ELISA procedure
described
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2-3 Antibody dilution curve
To determine the optimum dilution factor for each batch
of antiserum, dilutions were made of up to 1/10,000 and
tested using either lyg/ml or 5yg/ml LT. The results are
presented of absorbance of each sample at 405nm following
the Gmi ELISA procedure described.
39
2.6 Purification of Transducin from Bovine Retinal Rod Outer
Segments (ROS)
2.(3.1 Bovine ROS membrane preparation
Transducin is one of several peripherally bound membrane proteins
in the rod outer segments (ROS) of the eye. It is soluble in the
dark in hypotonic buffer but becomes membrane bound upon
illumination (Kuhn, 1980). This property has been exploited in the
purification of transducin which can be specifically eluted from
purified ROS membranes with GTP.
Fresh cattle eyes were obtained from a local slaughter house
(Gorgie Abbatoir). Bovine ROS membranes were isolated in buffer
solution containing 60mM KC1, 30mM NaCl, 2mM MgCla, ImM DTT, O.lmM
PMSF and lOmM MOPS pH7.5 at 4'C. One hundred retinas were stirred
gently in a beaker containing 30ml of 45% (w/v) sucrose in buffer
for 3 min. The suspension was then diluted with an additional 100ml
of 45% sucrose and centrifuged at 2445xg for 15 min. The
supernatant was collected and diluted with an equal volume of buffer
and recentrifuged at 43500xg for 15 min. The resulting crude ROS
membranes were further purified by flotation centrifugation in 35%
sucrose in buffer (Hong and Hubbell, 1973). Purified ROS membranes
were washed twice with buffer, freeze-dried, and stored frozen at
-20®C. When analysed by 10% SDS-PAGE the major protein band present
in the purified ROS corresponded to a molecular weight of 38,000
representing rhodopsin, which makes up 80% of the total protein
present in ROS. The rhodopsin concentration was determined in the
presence of 0.1M tridecyl trimethyl ammonium bromide using a molar
absorptivity of 42600M_lcm_1 at 500nm (Hong and Hubbell, 1973).
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2.6.2 Purification of Transducin from Bovine ROS membranes
Transducin was isolated from ROS membranes by the method of Kuhn,
(1980). Purified ROS from 500 retinas containing approximately 150
- 200mg rhodopsin were suspended in 80ml 5mM tris-HCl, 2mM DTT,
0.5mM MgCl2, 0.05mM PMSF pH7.5 at 4*C and exposed to room light for
10 min. This bleaching causes certain polypeptides, among them
transducin, to remain membrane bound. The membranes were then
sedimented at 45000xg for 30 min. The pellet was washed twice more
with buffer to remove phosphodiesterase. Transducin was then eluted
by suspending the pellet in 50ml buffer containing lOOyM GTP and
centrifuging at 45000xg for 30 min. This extraction was repeated
twice. The resulting solution containing 15 - 20mg transducin was
freeze-dried and stored at -20°C. Transducin purified in this way
was analysed by 10% SDS-PAGE.
2.6.3 Reconstitution of Transducin into ROS membranes
The method used was essentially that of Roof et al.y (1982).
Membranes stripped of peripheral proteins were prepared by
resuspending ROS membranes from 50 retinas in 5ml of lOmM NaCl,
0.25mM KC1, ImM CaCl2, 2mM MgCl2, 5mM HEPES pH7.5 at 4*C. After two
hours in the dark, the stripped ROS membranes were pelleted by
centrifugation at 40000xg for 20 min. For reconstitution, freshly
prepared stripped membranes were incubated with 300 - 400yl
transducin (2.5mg/ml) in lOOmM NaCl, 2mM CaCl2, 5mM MgCl2 and lOmM
HEPES pH7.5 at 4*C and gently stirred overnight. The reconstituted
membranes were diluted ten fold with 5mM HEPES solution and pelleted
by centrifugation at 45000xg for 30 min., resuspended in 5mM tris-
HCl, 2mM DTT, 0.5mM MgCl2, 0.05mM PMSF and used at once.
41
2.7 Polyacrylamide Gel Elecrophoresis (PAGE)
2.7.1 General Method
Polyacrylamide gel electrophoresis was routinely conducted under
denaturing conditions, i.e. in the presence of 0.1% (w/v) SDS
(SDS-PAGE). The gel and buffer system was based upon that of
Laemmli, (1970) with the addition of 2mM EDTA to chelate metal ions
which may interfere with the polymerisation of acrylamide and cause
aggregation of proteins (Douglas and Butow, 1976). Polyacrylamide
of molecular weight up to 5 x 106 was added to 0.5% (w/v) in the
separating gel to increase the mechanical strength. Protein samples
(20 - lOOyl) were mixed with 5yl 50% 2-mercaptoethanol in water, 5yl
10% SDS, 5yl 0.1% bromophenol blue and a drop of glycerol and
incubated in a boiling water bath for one minute. Samples were
applied to gels and electrophoresed at lOOmV for about five hours.
Gels were fixed in 20% methanol (v/v), 10% acetic acid (v/v) for 15
min., stained in 55% methanol (v/v), 10% acetic acid (v/v), 0.25%
coomassie brilliant blue R (w/v), then destained until the gel
background was clear in 5% methanol (v/v), 7.5% acetic acid (v/v).
The staining procedure was carried out at 55°C.
For determination of molecular weights, gels were calibrated
with the following standard proteins: alactalbumin, soybean
trypsin-inhibitor, trypsinogen, bovine erythrocyte carbonic
anhydrase, glyceraldehyde-3-phosphate dehydrogenase, egg albumin and
bovine serum albumin. Using these proteins, the standard curve
shown in fig. 2-4 of electrophoretic mobility on 10% SDS-PAGE
against the log of the molecular weight was obtained. This curve
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2-4 Electrophoretic mobility versus log molecular weight on
101 SDS-PAGE
The calibration curve was obtained using proteins from
the Dalton Mark VII-L™ molecular weight marker kit
(supplied by Sigma Chemical Co.)
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2.7.2 Autoradiography
Exposure times for films exposed to low energy 3 emitters like
tritium can be weeks or even months. To reduce the time required
for exposure gels were treated with an enhancer (New England Nuclear
EN3HANCE) which contains a fluor. As decay particles from the gel
hit the enhancer, it starts to fluoresce, producing many photons in
response to each decay particle. This enhancement significantly
reduces exposure times.
Gels containing tritium-labelled protein were stained as
described in section 2.7.1 except that the temperature was kept
below 45"C, then immersed in the fluorographic enhancer for 30 min.
with shaking. Gels were dried using a Hoeffer slab gel dryer onto
Whatman 3mm paper under vacuum with heating to 60#C. The dried gels
were then exposed to X-ray film at -70*C for times between seven and
fourteen days and developed.
2.7.3 Densitometric analysis
cvnc\
Gels were scanned for Esso^then the amount of protein was
estimated from the areas under the peaks, assuming a local
background level to be the bottom of the peak.
extinction
at 550nM





2.8 Synthesis and assay of p-nitrobenzylidine amino guanidine
(pNAG)
Guanyl hydrazones of p-nitro benzylidine and methyl glyoxal serve
as acceptors of ADP-ribose groups for the reaction catalysed by
cholera toxin. ADP-ribosylation lowers the pKa of pNAG by 0.7 - 0.8
*
pH unit/\at 370nm. This change in absorbance can be used as a
continuous spectrophotometric assay of cholera toxin activity (Soman
et al.y 1983).
structure of pNAG
2.8.1 Synthesis of pNAG
The procedure followed for the synthesis of pNAG was that
described by Baiocchi et al, (1963) for the synthesis of
guanylhydrazones. Two molar aminoguanidine bicarbonate was
acidified with HC1 to pH5 and heated to 60#C. Two motes.1 dry weight
of p-nitrobenzaldehyde was added with constant stirring and with the
addition of ethanol to keep the mixture in solution. Following
continuous stirring for 16 hours the mixture was filtered and rotary
evaporated. The dry product was recrystallised twice from alcohol,
washed with acetone and weighed. Total yield was 21.9g which was a
38% yield from the starting weight. The product had a melting point
of 247*C (lit.248*C) and absorbance maxima as described in fig. 2-5.








fig.2-5 Absorbance of pNAG
The absorbance of pNAG was recorded in 0.1M HC1 and
0.1M NaOH. The absorbance maxima were at 31Snm
<€ = 2.1 x 10* mol/l/cm)and 375nir <€ = 1.8 x 10* mol/l/cm)
respectively.
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2.8.2 Spectrophotometric assay of ADP-ribosylation
Assays were performed using a PYE Unicam SP8-100 ultraviolet/
visible wavelength spectrophotometer. Temperature equilibration at
37*C was attained by pumping liquid from a thermostated bath to the
reaction chamber. The absorbance increase at 370nm was monitored
continuously. Assays in a total volume of 1ml contained 0.6pM
(500yg/ml) cholera toxin, 20mM tris-acetate pH7.5, 40mM DTT and lOmM
NAD"". The reaction was started by adding pNAG to a final
concentration of 0.4 - 4mM. The reference cuvette contained
everything except cholera toxin. After a few minutes of
unsteadiness, a steady linear phase was achieved.
2.9 Assay of ADP-ribosylation
ADP-ribosylation of low molecular weight arginine derivatives was
estimated indirectly by measuring the rate of [3H]-nicotinamide
release from [4-3H]-NAD"" (Tait and Nassau, 1984). Assays^contained
200mM potassium phosphate buffer pH6.5, 20mM DTT, various
concentrations of NAD"" containing 20nCi of [4-3H]-NAD""
(approximately 2 x 10s cpm), 1.2uM(lOOyg/ml) cholera toxin, E.coli
heat labile toxin (LT) or cholera Ax chain and concentrations of
arginine derivatives from 0.01 - 8mM. All samples were assayed in
triplicate. Incubations were conducted for up to 30 min. at 37*C
and reactions terminated by dilution with 1ml water. [3H]~
nicotinamide was separated from the reaction mixture by ion-exchange
chromatography on a 0.5 x 1cm column of QAE-Sephadex A25. Samples
were loaded onto columns and washed with a further 3ml of water, the
effluent being collected directly into scintillation vials. After
the addition of 15ml of scintillation fluid, samples were counted
"\<\ cv. -tertol s^oLvA.fYie_ oj \QOmA
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for one minute. Under these conditions NAD"" is retained by the
Sephadex columns while nicotinamide is completely eluted by the
water. Columns were regenerated by washing with 5ml of lMHCl, which
removes the NAD"", followed by 12ml of H20.
An alternative method of separating the nicotinamide and NAD"' was
as follows. Reactions were terminated at the appropriate time by the
addition of 300yl butan-l-ol and mixing. Following centrifugation
at 15000xg for 5 min., [3H]-nicotinamide in the upper phase was
determined by scintillation counting.
2.10 Thin layer chromatography (tic)
The efficiency of the separation procedure in the ADP
-ribosylation assay, and the breakdown of NAD"" into nicotinamide
during other procedures was routinely checked using tic. Samples
from the acid or water washes from ion exchange columns, or from the
organic solvent or aqueous phase of the butanol treated samples
described in 2.9 were centrifuged to remove protein. Samples of 5 -
lOyl were spotted onto silica gel-coated aluminium backed plates
(7.5cm x 5cm) and were developed in propan-2-ol: ethyl acetate:
ammonia (9:4:3) or alternative solvents as indicated. Solutions of
NAD"" and of nicotinamide (lOOmg/ml) were used as markers. Plates
were dried, visualised under short wave ultraviolet light anc&the
spots scraped and counted (fig. 2-6). Typically, more than 98% of the
nicotinamide and 2% of the NAD"" were extracted into the organic
phase in the butanol separation procedure, about 96% of the









2-6 Separation of MAD"" and nicotinamide by tic
Samples and solvents were as described in the text
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2«11 Spectophotometric detection of NAD- with Cyanide
The method used was derived from that of Colowick et al., (1951)
who first developed an assay for NAD"" from the observation that NAD""
reacts with cyanide to form complexes having absorption spectra
resembling those obtained by enzymatic reduction of NAD"".
Q-CONHj CN" Q-C0fJH,
R R
Samples of between 25 and lOOyl containing approximately 25 - lOOyM
NAD"" or unknown derivative were diluted with either 0.9ml H20 or
0.9ml 225mM KCN in H20, and the final volume made up to 1ml with
H20. After mixing by inversion the samples were transferred to a
quartz 1ml cuvette and the absorbance recorded between wavelenghts
240 - 400nm using a Carey Model^spectrophotometer. The reference
cuvette contained the same reagents as the sample cell but with
water added in place of the nucleotide solution. The absorb iice




These studies were carried out in Teflon cells (Dianorm "R"
Fisons Ltd.). Each cell consisted of two Teflon half-cells (volume
0.25ml, membrane surface area 2.0cm2) separated by a membrane
(Spectrapor) of molecular weight cut-off 6000 - 8000. Five such
cells were arranged in an assembly that rotated gently (10 turns/
min.) in a water bath at 37#C. For binding experiments, 200mM
potassium phosphate pH6.5, or buffer as indicated, containing 20mM,
[43H] NAD*" (20nCi) and concentrations of unlabelled NAD"' from 0.1 -
lOOmM in a total volume of 200yl was injected into one half-cell and
the same volume of buffer containing 10 - 80yM cholera toxin or its
Ai chain injected into the other half-cell. During dialysis samples
were taken through ports from both sides of the membrane and the
radioactivity was determined. At the end of each experiment (up to
180 min.) samples were taken from both sides of the dialysis
membrane and the breakdown of NAD"*" into nicotinamide was noted using
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the tic method described in section 2.10. Typically, breakdown was
negligible. The activity of dialysed protein Reparations was
assayed using the ADP-ribosylation assay in section 2.9.
2.13 Fluorescent labelling of cholera toxin with 4-chloro-
7-nitro benzofuran (Nbf)
The fluorescent molecule 4-chloro-7-nitro benzofuran (Nbf, also
known as NBD) has been shown to be a useful probe of protein
structure (Ghosh and Whitehouse, 1968) (Birkett et a!., 1971). Nbf
derivatives become highly fluorescent at low dilutions when their
amino group is derived from an aliphatic amine e.g. an amino acid.
no2^cl n02f>nhch9c00"/r* ' / a




A solution of cholera toxin or E.coli heat labile toxin (5mg/ml) was
dialysed at 4°C against 50mM triethanolamineHCl, ImM EDTA pH8.5. A
3.9mM solution of Nbf-Cl in H20 was prepared by stirring the Nbf-Cl in
H20 for six h. at 25#C then filtering. Its concentration was
estimated from the absorbance at 345nm. Equal volumes of the toxin
and Nbf-Cl solutions were mixed and incubated for 48 hours at 4*C.
The solution was then exhaustively dialysed against TEAN buffer
pH7.5 until no more free Nbf-Cl was detected in the dialysate. The
protein concentration of the product was estimated from the
absorbance at 280nm (assuming an absorption of 11.4 for a lOmg/ml
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solution of toxin, (LoSpalluto and Finkelstein, 1972)) and the
concentration of the amino acid-Nbf derivative was estimated from
the absorption at 480nm (assuming an absorption coefficient of
26000M~1cm~1, (Aboderin et al., 1973)).
2.14 Fluorescent measurements
Titrations were carried out in a Perkin-elmer MPF-3000
spectrofluorometer containing a thermostatically controlled cuvette
holder. The excitation and emission slits were set at 15nm and 5nm
respectively. Titrations were performed by adding 5 - lOyl
increments of NAD"*" in TEAN buffer pH7.5 to a 1ml solution of cholera
toxin, Ai chain or Nbf-labelled cholera toxin or subunits in TEAN
buffer. Samples were stirred after each addition and the decline in
protein fluorescence was measured at 333nm (excitation 285nm) or at
533nm (excitation 468nm) respectively. Samples were kept at 37"C
and shielded from incident light when readings were not being taken.
The fluorescence of samples was compared with that of either a
solution of tryptophan or of Nbf-myoglobin of comparable initial
fluorescence intensity to the sample. To correct for attenuation of
the excitation beam by added ligand, , the control solutions were
similarly titrated and appropriate corrections were made. All data
were corrected for dilution.
2.15 Photochemical labelling of cholera toxin with NAD""
This section of work was performed in the Department of Microbial
Biochemistry, Glaxo Group Research Ltd., Greenford, Middlesex and
was financed entirely by Glaxo Group Research Ltd. The technique
used is derived from that of Carroll and Collier (1984).
Samples of cholera toxin, 50 - 75yM (5 - 6.5mg/ml) in TEAN buffer
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pH7.5 containing 20mM DTT and 5mM NAD"" with either [nic-43H]NAD"" or
[adenine-2,8~3H]NAD"" were allowed to stand for 10 min. at 4'C. The
samples were then placed as droplets of 100 - 150yl on a
parafilm-coated microtitre plate (Nunc) floating in an ice-bath.
The droplets were irradiated at a distance of 5cm using a CAMAG 8w
dual wavelength lamp set at 254nm. At appropriate time intervals
20yl aliquots were removed and diluted into 6M urea containing 2.5%
BSA. This was designed to dissociate any non-covalently bound NAD""
from the toxin. Protein was then precipitated by adding 300yl 12%
trichloroacetic acid (TCA) in 0.1M phosphoric acid and the pellet
spun down, washed three times in 12% TCA and finally dissolved in
600yl Ha0. Emulsifying scintillant (10ml) was added and the samples
counted for one minute.
2.16 Digestion of the Ai chain by Trypsin in the presence of NAD""
When cholera toxin Ai chain was digested by trypsin in the
presence of saturating concentrations of NAD^", it was found that the
NAD1" could protect the Ai chain from digestion. This observation
was exploited in the calculation of the dissociation constant, Kd,
for the binding of NAD"" to cholera toxin as described in section
5.2.5.
Samples containing 50yM Ai chain in TEAN buffer pH7.5 and
various concentrations of NAD"" were allowed to stand for 10 min. at
room temperature. Trypsin was added to a final concentration of
5yg/ml and digestion allowed to proceed at 37#C for the appropriae
time before being stopped by the addition of ImM PMSF in
propan-l-ol. Control samples contained ovalbumin instead of the
chain. The digested peptide was run on 15% SDS-PAGE and stained
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with coomassie blue as described in section 2.7. A <^ilford
densitometric scanner was used to measure the appearance of the
largest digestion band of molecular weight 20000 by its absorbance
at 550nm.
To determine whether or not NAD"*" had any direct effect on
trypsin activity, a pH stat meter was used which records the amount
of titrant used to maintain a pre-selected pH value as a function of
time. This is then correlated to the activity of trypsin via the
appearance of ions which are produced during the reaction. Each
sample contained 250yM N-benzyl-<X arginine ethyl ester (BAEE), a
synthetic substrate of trypsin, in a total volume of 5ml ImM sodium
phosphate pH7.0 in the presence or absence of 40mM NAD"". After an
initial equilibration at 30#C the reaction was started by the
addition of 20yl ImM HC1 containing 150yg trypsin. The reaction
rate was identical in the presence and absence of NAD"".
2.17 Amino acid analysis and sequencing
Hydrolysis was performed in evacuated tubes with 0.5ml 5.7M HC1 at
110*C for 20h. Amino acid analysis was performed using one of two
methods.
Quantitative analysis was carried out with a Waters amino acid
analysis hplc system incorporating a Waters ion-exchange column and
fluorescent detection of amino acids after reaction with
hypochlorite (to convert proline to a primary amine) and
o-phthalaldehyde. This analysis was kindly performed by
Mr. Bryan Dunbar, University of Aberdeen, Department of
Biochemistry.
Alternatively, amino acid analysis was performed with an LKB
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4400 analyser in the Department of Biochemistry, University of
Edinburgh with the help of Mr. Andy Cronshaw using the ion exchange
method of Moore, Spackman and Stein (1958). Conditions were as
outlined in the Analysis Data sheet shown in fig. 2-7.
Amino acid sequencing was done automatically with an Applied
Biosystems gas phase sequencer by Bryan Dunbar. The sequencer was
operated with a double cleavage, double extraction programme without
a vacuum as recommended by the manufacturers. The phenyl thio
hydtmtoin derivatives were identified by hplc on Apex Cyano columns
(0.4 x 25cm) with an acetate buffer pH.5.0/acetonitrile gradient
system and detection at 254n:*i.
2.18 Dansyl chloride end group analysis
The method used was derived from that of Gray (1967). A solution
of peptide (lOnMol ) in 50yl was transferred to a small glass test
tube with a fine-tipped micro-pipette. Ethanol (450yl) was added
and the sample allowed to stand for two hours at room temperature.
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fig. 2-7 Analyis Data sheet for LKB analyser showing details of
the citrate buffer programme
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The precipitate was spun down, redissolved in lOyl sodium
bicarbonate (ImM) and dried down under vacuum with 1M H2SOA present
to absorb ammonia. The sample was redissolved in lOyl H20 and to
this was added lOyl dansyl chloride, 2.5mg/ml in acetone. Addition
of the acetone causes the pH to rise to pH 8.5 - 9.8. The final
concentration of dansyl chloride was 5mM. The tubes were incubated
for two hours at 37°C. During this time most of the excess reagent
is hydrolysed to the sulphonic acid and the solution, previously
yellow, becomes colourless. Any dansyl chloride remaining is
subsequently broken down during acid hydrolysis.
When the reaction was complete the solutions were dried under
vacuum. Hydrolysis was performed in evacuated tubes with 50yl 6M
HC1 at 110'C for 20h. When hydrolysis was complete the tubes were
opened and HC1 removed under vacuum over NaOH pellets.
Thin layer chromatography using poly amide plates (BDH) 7.5cm
x 7.5cm was used to analyse the hydrolysed samples. Standard
solutions contained approximately 10,^M each of the dansyl
derivatives of alanine, valine, isoleucine, proline, phenylalinine,
threonine, tyrosine, aspartate, lysine and arginine. Sample or
standard (2yl) was spotted onto the bottom right-hand corner of each
plate 1cm from each edge, and the top left corner marked for
identification. Plates were developed in one direction in 3% formic
acid and then at 90* to this first in toluene: acetic acid (9:1)
and then in n-butyl acetate: methanol: acetic acid (20:1:1).
Plates, when dry were visualised under ultraviolet light at 365nm.
Using this method, as little as 10~^ .oi fluorescent dansyl derivative
can be detected although 10~AyM per spot is the practical lower
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limit. The results for a set of standard dansyl-amino acids





fig. 2-8 Dansyl amino acids separated by tic
Conditions were as described in the text. Typically,
sample and standards were run on opposite faces of the
same sheet to allow a more accurate identification of
any dansyl-amino acid in the sample.
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2.19 Determination of protein
Unless otherwise stated, protein was measured using the technique
of Lowry et al., (1951).
2.20 Liquid scintillation counting techniques
All radioactive samples were counted in "Optiphase Safe"
emulsifying scintillant from LKB. All samples were identical with
respect to volume of scintillant, volume of sample, etc., and for
each experiment background and standard vials were also counted.
The background vial was identical to all other samples except that
it contained no radioactive material. The standard vial consisted
of a known amount of assay medium containing radioactive substrate.
Counts arising from this vial served as an estimate of the cpm of
radioactive substrate added to each assay.
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Chapter 3 Kinetic analysis of cholera toxin
3.1 Introduction
Cassell and Pfeuffer (1978) first demonstrated that activation of
adenylate cyclase by cholera toxin resulted from ADP-ribosylation of
N., a regulatory subunit of adenylate cyclase. This modification
leaves N. incapable of hydrolysing its bound GTP and so induces the
permanent activation of the catalytic subunit of the cyclase (Cassel
and Selinger, 1977). Why ADP-ribosylation should have such an
effect and why a bacterial toxin should be causing it is unclear
unless the toxin is subverting a cellular regulatory mechanism.
Although a number of eukaryotic ADP-ribosyl transferases have been
identified (see fig. 1-6), a distinct function for mono ADP-
ribosylation in the cell has not been proven.
To understand more about the catalytic activity of cholera
toxin, a more detailed understanding of the kinetic mechanism would
be helpful. The kinetic parameters K™ (Michaelis constant) and K^t
Vm_
Kct = . . , the maximum catalytic activity when substrate is
1 J saturating
give an estimate of the kinetics of that reaction under the
conditions likely to be found in vivo. Also, kinetic mechanisms and
parameters can be compared between enzymes. Cholera toxin could be
compared with other ADP-ribosylating toxins such as diphtheria
toxin, exotoxin A and pertussis toxin, the kinetic mechanisms of
which are known at least in part (Chung and Collier, 1977a; Ui,
1984; Moss et al., 1983). It would be especially interesting to
compare cholera toxin with eukaryotic mono (ADP-ribosyl)
transferases such as the turkey erythrocyte transferase reported by
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Moss and Vaughan (1978). Osborne et al., (1985) recently presented
estimates of the kinetic parameters and mechanism of action of this
transferase.
The physiological substrate of cholera toxin, N», has been
purified to apparent homogeneity (Northup et al., 1980; Bokoch et
al., 1983, 1984; Codina et al., 1983, 1984). However it makes up on
average only one part in 105 of total cellular protein, is extremely
labile and hydrophobic, and requires to be in a certain orientation
in an appropriate membrane for activity (Gilman, 1984). It is also
not the only protein in the cell membrane to be ADP-ribosylated by
cholera toxin. Additional cofactors required for the reaction
include NAD"*" (Gill, 1975; Moss et al., 1976a; Gill and Meren, 1978),
GTP (Moss and Vaughan, 1977; Enomoto and Gill, 1980), an
unidentified membrane-bound protein of molecular weight 21000 (Kahn
and Gilman, 1984) and possibly additional cytosolic factors (Enomoto
and Gill, 1979). Obviously, a simpler system employing a more
readily available analogue of N, would make kinetic analysis easier.
Moss and Vaughan (1977) first demonstrated that cholera toxin
catalyses the ADP-ribosylation of arginine, guanidine and other
related compounds. This suggested that it might be an arginine side
chain on N„ that was the site of modification by ADP-ribose. Indeed
cholera toxin can catalyse ADP-ribosylation of other GTP-binding
proteins including tubulin (Hawkins and Browning, 1982) and retinal
transducin (van Dop et al., 1984) which is ADP-ribosylated at the
in
guanidjium group of an arginine residue. Other structurally
unrelated proteins including follicle stimulating hormone,
luteinising hormone and adrenal corticotrophic hormone will accept
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ADP-ribose (Trepel et al., 1981). At high concentrations the toxin
can even ADP-ribosylate its own Ai chain at an arginine residue (Lai
et al., 1983). An available arginine may be all that is required to
allow certain proteins to be ADP-ribosylated although as the total
percent of arginine in the acceptor is not directly proportional to
its ability to incorporate ADP-ribose, other factors must be
important too.
Tait and Nassau (1984) developed a model assay system for
cholera toxin using low molecular weight arginine derivatives in
place of N». The assay measures toxin activity indirectly by
measuring the rate of toxin-catalysed splitting of NAD'' into
nicotinamide in the presence of an arginine derivative which acts as
an acceptor for the ADP-ribose group. They examined a large number
of potential substrates and found that the side chain of the
arginine derivative was important in determining whether or not the
compound would be ADP-ribosylated. They proposed that cholera toxin
preferentially ADP-ribosylates guanidine groups when they are
associated with a hydrophobic domain devoid of charge centres near
the guanidine. This agreed with findings by Mekalonos et al.,
(1979a) who reported that 125I-guanyl tyramine was a more efficient
substrate than guanyl tyramine alone. Presumably the halogenation
of the aromatic group causes a decrease in the dipole moment of the
phenolic hydroxyl resulting in increased hydrophobicity.
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The kinetic mechanism of cholera toxin has been studied previously
using arginine derivatives (Mekalonos et al., 1979a; Osborne et al.,
1985 ) with differing results. Here two of the compounds
characterised by Tait and Nassau (1984), [ 10—[(phenyl methyl) amino]
decanyl] guanidine (4406) and [ 12—[(phenyl methyl) amino] dodecanyl]
guanidine (A599) are used in a study of the kinetic parameters of
cholera toxin, using the indirect assay described in the same paper.
Various competitive inhibitors of NAD"" and alternative substrates
for N„ are also considered in an attempt to gain further information
about the nature of the toxin's activity.
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3.2 Results
3.2.1 ADP-ribosylation catalysed by the A! chain
As gram quantities of the isolated Aj chain of cholera toxin were
available, preliminary experiments were performed to check its
suitability for kinetic measurements. It is well established that
the At chain is responsible for the catalytic activity of cholera
toxin, and that the catalytic activity is enhanced when the toxin is
treated with high concentrations of sulphydryl-containing compounds
(such as DTT) and chaotropic agents such as SDS at low
concentration (Bitensky, 1975; Gill and Meren, 1978; Gill, 1975;
Wheeler et al,, 1976). These treatments are known to promote
dissociation of the A and B subunits and to reduce the disulphide
link between the Ai and A2 chains. This suggested that isolated,
reduced Ax chain itself might be suitable for studying the enzyme
activity of the toxin.
Using 2mM A599 (one of the arginine derivatives shown in fig.
3-1) as a substrate, the activity of preparations of isolated Aa
chain or of whole toxin were tested using the ADP-ribosylation assay
described in section 2.9. As shown in fig. 3-2, the release of
nicotinamide from NAD"" catalysed by the At chain was linear over
30 min. but when whole toxin was used there was a slight lag of about
5 min. When the whole toxin was preincubated with 20mM DTT at room
temperature for 15 min., the lag was no longer seen (fig. 3-2).
This suggests that the lag is presumably the time taken for
activation of the toxin whereby the catalytically active Ax chain is
released by reduction of the disulphide bond that attaches it to the















fig. 3-1 Arginine derivatives used as substrates for
ADP-ribosylation
1. (lO-(acetylamino) decyl] guanidine = A603
2. p-nitrobenzylidine amino guanidine = pNAG
3. arginine methyl ester
4. arginine
5. [12-{(phenylmethyl) amino] dodecanyl] guanidine = A399


















fig. 3-2 Rate of ADP-ribosylation reaction
using different toxin preparations
Cholera toxin (lOOyg/ml) was either untreated or
preincubated with 20mM DTT for 15 min. at room
temperature. The Aa chain was 25ug/ml. Assays were as
described in section 2.9 with 2mM A599 and 2mM NAD"
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As shown in fig. 3-2, the preparation of Ax chain consistently
showed much lower specific activity than did whole toxin. It seemed
to lose activity on standing, even when kept frozen. Contamination
with proteases was suggested by the gradual degradation of the
sample over a period of weeks, (this degradation was not seen for
the sample of whole cholera toxin, which came from a different
supplier). At concentrations above lmg/ml (40yM) the At chain
became increasingly insoluble (see section 5.2.1.4). When in
solution at low concentrations it would gradually dissappear,
presumably through sticking to glassware. This phenomenon has been
reported by others (Gill, 1976a; van Heyningen, 1980). In attempts
to increase the activity of the Aj, chain, the assay was repeated
using different arginine substrates (fig. 3-1) and using buffers of
differing concentration and/or pH, but no increase in the level of
activity was achieved. The Aa chain itself was dissolved and stored
in TEAN buffer, pH7.5^ 0.1M borate, pH8.5* 0.1M sodium phosphate,
pH7.5 containing 2.5M urea, or 0.4M potassium phosphate, pH6.5, but
none of these buffers increased the activity of the Ax chain or
prevented its gradual degradation, precipitation and/or
disappearance.
The practice of including SDS in the preincubation of cholera
toxin suggests that the toxin must have a fairly stable
conformation. However, the primary sequence of the Ai chain
contains a high proportion of hydrophobic residues in its centre and
secondary structure predictions suggest that it may exist mostly in
a random coil configuration, a structure which might enable it to
pass easily through the plasma membrane (Yamamoto et al., 1984;
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Duffy and Lai, 1986). This could mean that without the stabilising
influences of the A2 chain and B subunit (both of which contain much
more a helix and f5 sheet and are therefore more rigid (Yamamoto et
al, 1984)), and with no membrane present, the Ax subunit cannot
maintain an active conformation.
In order to test this theory, a sample of whole toxin (5mg) was
separated into its constituent subunits, and portions of each
subunit were reconstituted as described in Materials and Methods.
The original toxin, separated subunits and reconstituted toxin were
all tested for activity using the ADP-ribosylation assay with A599
as a substrate. The results, shown in table 3-1 show that while the
separated A subunit had lower activity compared to the original
toxin, the activity compared to the original toxin, the activity of
the reconstituted toxin was higher than that of the A subunit alone,
(although not as high as the original). This suggests that the A
subunit, if stored on its own, does lose something of its active








whole toxin 12 0.33
A subunit 12 0.20
B subunit 15 0.04
Ai chain 12 0.13
reconstituted 12 0.23
toxin
Table 3-1 ADP-ribosylation activity catalysed by
different toxin preparations
Assays contained 20mM DTT, 2mM NAD"*" with 20nCi [4_3H]
NAD"", 2mM A599 and toxin preparations as above in a
total volume of lOOyl KHaPO*, pH6.5. Samples were
incubated at 37°C for 30 min. then treated as
described in section 2.9
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An alternative explanation of the low activity of the Ax chain
preparation is that the protein could have lost a few residues from
one end or other, affecting its active site. However Lai et al.,
(1981) showed that 50% of the activity of the Ai chain is retained
by a fragment which lacks almost 50 residues. The loss of only a
few residues would be unlikely, then, to alter the activity of the
A! chain so drastically. To check the integrity of the sample, a
portion was subjected to dansyl chloride end group analysis as
described in Materials and Methods. Only one dansyl-amino acid
derivative was evident, corresponding to dansyl-aspartate/
asparagine. This agrees with published primary sequence data (Duffy
et al., 1985) which give asparagine to be the amino terminal residue
of the A.1 chain. At least this end of the A! chain appears to be
intact.
In view of all these problems, the isolated Ai chain was not used
for kinetic analysis and whole toxin, prereduced to eliminate the
lag in the time course in fig. 3-2, was used instead.
3.2.2 Characterisation of the ADP-ribosylation assay
Preliminary experiments were conducted to check the suitability of
the assay for kinetic measurements. Using 2mM A599 as a substrate,
enzyme activity was found to be proportional to enzyme concentration
over a ten fold concentration range of 10 - 100yg/ml. The activity
was also dependent on temperature and increased between 25"C and
3 7*C above which it started to decrease again (fig. 3-3). The
reaction could be reversed by the addition of lOOmM nicotinamide and
a lowering of the pH to pH 6.0 (fig. 3-4). These observations are
consistent with the notion that this is an enzyme-catalysed
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reaction. The linear progress curve indicates that the initial
conditions of the assay apply throughout the assay time, i.e. there
has been no depletion of substrate, inactivation of enzyme or
product inhibition.
3.2.3 Identification of a putative ADP-ribose - A599 complex
The assumption made in this assay system is that the arginine
to
derivatives usedyenhance the rate of nicotinamide release from NAD1"
by serving as substrates for ADP-ribosylation by cholera toxin.
This assumption has been verified for arginine methyl ester (Moss
and Vaughan, 1977). In fig. 3-5 the results are presented of an
experiment to isolate the putative ADP-ribose product. A standard
assay was run as described in Materials and Methods except that
[4~3H]-NAD"" was replaced by [carbonyl-U~1AC]-NAD"'' and the products
of the reaction were analysed by tic. With the solvent used, NAD1"
and free ADP-ribose, which both carry a net negative charge remain
at the origin^ while the positively charged nicotinamide migrates
with the solvent front. In the absence of A599 all the
radioactivity remained at the origin but, with A599 present, a new
peak of radioactivity appeared with Rf = 4cm. Although a detailed
structural analysis of this species was not attempted, its mobility
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fis. 3-3 Characterisation of the ADP-ribosylation assay
The effect of temperature was studied using 2wM NAD"",
2mM A599 and lOOyg/al cholera toxin. All other
conditions were as described in section 2.9.
ADP-ribosylation activity as a function of cholera toxin
concentration was measured at 37*C with conditions as
described in the text.
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fig. 3-4 Reversal of the ADP-ribosylation assay
Assays contained 20mM DTT, 2mM NAD", 2mM A60 3 .
20nCi [U-1AC]-NAD and lOOyg/ml cholera toxin in a
total volume of 200ul KH3PCU. pH6.5 The control
sample contained buffer in place of toxin. At the times
indicated, lOyl samples were removed and analysed on tic
plates as described in section 2.10. Spots corresponding
to NAD" were cut out and counted.
The arrow marks the point where lOOmM nicotinamide was
added and the pH adjusted to pH6.1 with HC1
76
I I l i I
2 U 6 8
distance fronn origin (cm)
fig. 3-5 Identification of a putative ADP-ribose A599 complex
Assays in the absence (-•-) or presence (-o-) of 2mM
A599 were conducted as described in Materials and Methods
except that [4_3H] NAD" was replaced by [U-1,*C] NAD"
and incubations were conducted for 60 min. Assay
mixtures were immediately applied to an aluminium-backed
silica coated plate (5cm x 7.5cm) and chromatographed in
a sealed tank with n-butanol/acetic acid/water (2:1:1) as
, solvent. The plate was dried and cut into 0.5cs long
segments, then counted for radioactivity
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3.2,4 Controls for NAD* breakdown
As well as transferring ADP-ribose to N_, other proteins or to
arginine and its derivatives, cholera toxin can also catalyse the
transfer of ADP-ribose to water, in which case the activity is
called NAD* Glycohydrolase (or more commonly, NAD'ase) activity.
This activity occurs at a low level both in the presence and absence
of alternative acceptors such as A599 (Moss et al., 1976b, 1983;
Ueda et al., 1975; Katada et al., 1983). As this assay measures the
release of nicotinamide catalysed by cholera toxin and not the
direct formation of an ADP-ribose-acceptor, it was important to
include controls to take account both of nicotinamide formed due to
the toxin's NAD'ase activity, to possible contaminating NAD'ase
activity and to non-enzymic breakdown of NAD*. This latter can
occur at pH values of 7.0 or above, especially in the presence of
phosphate (Colowick et al., 1951). However phosphate has been shown
to be optimum for activity in this assay (Tait and Nassau, 1984;
Moss et al., 1976a). The assays were therefore performed using
phosphate buffer but at a slightly acid pH of pH 6.5 to minimise
degradation of NAD*.
Controls were included for each assay sample. These contained
identical concentrations of each reagent except that they had no
A599. Values for these controls were typically under 5% of sample
values and were a measure of NAD'ase activity. The control value was
subtracted from the blank value in each case. Additional controls
were included at each concentration of NAD* to measure non-enzymic
breakdown of NAD*. These controls contained everything except
enzyme. Non-enzymic breakdown of NAD* was typically negligible
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under the conditions of the assay for up to 30 min. at 37#C.
3.2.5 Kinetics of the NAD'ase reaction
The rate of [4-3H]nicotinamide release from [4-3H]-NAD"" catalysed
by cholera toxin was measured at various concentrations of NAD"" in
the absence of any artificial acceptor. This was therefore a
measure of the toxin's NAD'ase activity. Results are presented as a
direct linear plot of substrate concentration versus velocity
(Cornish-Bowden and Eisenthal, 1978) in fig. 3-6. The Km for NAD""
calculated from this data was 3mM with a kcat value of 0.1 sec-1.
The kCBlt value assumes that all protein present is enzyme and that
all the enzyme is active.
3.2.6 Kinetics of the ADP-ribosylation reaction
The initial velocity of [4-3H] nicotinamide release was then
measured at various concentrations of NAD"^ and of either A599 or
4406. The concentrations of each substrate were originally designed
to span estimated Km values of 4mM for the NAD"" and O.lmM for the
A599, but had later to be extended when computer analysis of the
data obtained showed both substrates to be sub-saturating. Direct
linear plots of the results are shown in figs. 3-7 and 3-8. The
estimated values were = 45 - 51mM for NAD"*" and Km = 0.40 -
0.41mM for A599 and 440. This indicates that in the presence of the
artificial acceptors, the affinity of the toxin for NAD"' appears to
have fallen, k^.* was estimated to be 4.9 sec-1.
79
figs. 3-6 - 3-8 Kinetic parameters illustrated by the Direct
Linear Method
In figs. 3-6, 3-7, 3-8, kinetic parameters were calculated using
computer programmes described in Appendix A. The data are
illustrated here using the Direct Linear Plot as described by
Eisenthal and Cornish-Bowden (1974). In this method, each
experimental observation of substrate concentration and velocity (s
and v) is marked off on the -x or -y axis and a line is drawn
through the two points and extended into the first quadrant. For a
theoretically ideal experiment, all lines will intersect at a common
point in the first quadrant whose co-ordinates provide values for
and Km.
In real situations which are subject to error, lines will not
intersect at a common point and in these cases VmMC and K„ values
are taken as the median of all points of intersection. When there
are an even number of observations the median is taken as the mean
of the middle two estimates, and where more than two lines intersect
at a common point, the total number of intersections taken into
account in calculating the median value is 2n(n-l) where n = the
number of intersecting lines.
The theory behind this method is discussed in detail by







fig. 3-6 Kinetic analysis of the NAD'ase reaction catalysed
by cholera toxin
Assays were conducted in a total volume of lOOul
containing 200mM KH2P0*, 20mM DTT, 20nCi [4~3H] NAD*,
lOOyg/ml cholera toxin and concentrations of
NAD* as indicated at pH6.5. Samples were treated as
described in Materials and Methods. A K„ of 3mM for NAD*






-8 -6 •4 -2 0
A599 (mM)
fig. 3-7(a) Kinetic Analysis of ADP-ribosylation activity catalysd
by cholera toxin
Assays contained 20mM DTT, 20nCi [4~3H] NAD", 5n*l NAD",
lOOyg/ml cholera toxin and the indicated concentrations
of A599 in a total volume of lOOyl 200mM KHaPO*, pH6.5.
In fig. 3-7(b), the A599 concentration was 2mM and the
NAD" concentrations were as indicated. Samples were
treated as described in Materials and Methods.
The 14. values calculated from these data were 45mM for

























fig. 3-8(a) Kinetic analysis of ADP-ribosylation activity
catalysed by cholera toxin
Assays contained 20mM DTT, 20nCi [4~3H] NAD", 5mM NAD",
100vig/ml cholera toxin and the indicated concentrations
of 4406 in a total volume of lOOpl 200mM KHaPO.», pH6.5.
In fig. 3-8(b) the 4406 concentration was 2mM and the
NAD" concentrations were as indicated. Samples were
treated as described in materials and methods.
The values calculated from these data were 51mM for




Numerous attempts were made to obtain sufficient data for a more
detailed analysis of the two substrate kinetics of the reaction.
However when the concentrations of each substrate were increased,
the linearity of the reaction rate was disrupted in a way which
suggested product inhibition, substrate inhibition, or both, i.e.
the rate fell sharply towards the end of the incubation time. At
high concentrations of NAD"", the NAD'ase activity controls increased
substantially. In some cases they were close in value to the sample
measurements themselves. At high concentrations of A599 or 4406 the
controls for non-enzymic NAD"" degradation were elevated although not
to the same extent as the NAD'ase controls. As well as having
adverse effects on enzyme activity and NAD"" stability, the increased
ionic strength caused by the concentrations of each substrate could
have been affecting the separation procedure on QA-25 that is the
basis of the assay. QA-25 Sephadex is a strongly basic anion
exchange resin. At high ionic strength, samples that are normally
retained may in some cases pass through the column because of
competition from other ions in solution. If NAD"" were leaking from
the columns, this could account for high blank readings (although
routine analysis of column effluent on tic did not reveal large
concentrations of NAD""). In addition to all these problems, another
one was presented by the possibility that the arginine derivatives
might have been forming micelles. The critical micellar
concentration of the derivatives used is not known. In fact nothing
is known about their behaviour in solution. The presence or absence
of micelles at different concentrations of A599 of 4406 may or may
not have affected the assay results.
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3.2,7 Competitive inhibition of NAD" in the ADP-ribosylation assay
Initial rates of ADP-ribosylation were measured in the presence of
fixed levels of a number of partial structural analogues and
synthetic derivatives of NAD"" that contained minor alterations to
the adenine or nicotinamide rings. Results obtained using one of
these inhibitors, the thionicotinamide derivative of NAD""
(thio-NAD"") were analysed using a computer program (Appendix A) and
are presented in fig. 3-9 in the form of a double-reciprocal plot.
This shows the effect of thio-NAD"" on the initial rate of ADP-
ribosylation at various concentrations of NAD"". A secondary plot of
this data, in fig. 3-10 shows the K* value for thio-NAD"" calculated
from the results. Similar results were obtained using other NAD""
derivatives some of which are illustrated in fig. 3-11. Table 3-3
lists the compounds tested and the results obtained. All the
compounds tested were competitive with NAD"". Inhibition was linear
which is consistent with the interpretation that competitive binding
of these analogues to a single binding site is the cause of the
competitive inhibition. The effectiveness of these analogues in
inhibiting the reaction should therefore depend primarily on their
affinity for cholera toxin, i.e. on the dissociation constant, Kd.
This point is explored further in section 5.2.5.3.
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N/^7mM )
fig. 3-9 Double reciprocal plot of velocity-1 versus
substrate concentration-1 in the presence of
the competitive inhibitor thio-NAD"
Assays contained 20mM DTT, 2mM A599, lOOyg/ml cholera
toxin, 20nCi [4-3H] NAD" and concentrations of NAD" and
thio-NAD" as indicated in a total volume of lOOyl 200mM
KHaPOA, pH6.5. Samples were treated as described in
Materials and Methods
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fig. 3-10 Secondary plot of inhibition data
A value of K± for thio-NAD* was calculated using a
computer programme described in Appendix A. The results
from fig. 3-9 are presented here as a secondary plot of
slope (from fig. 3-9) versus inhibitor concentration.




































table 3-3 Competitive inhibitors of NAD"*"
Ka. values were calculated using a computer programme
described in Appendix A. Assays were conducted as
described for thio-NAD" in fig. 3-9.
N/D = not detectable under these conditions
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3,2.8 Continuous spectrophotometric assay of ADP-ribosylation
As the indirect assay used had not enabled the two substrate
kinetics of cholera toxin's catalytic activity to be studied, a
direct assay of ADP-ribosylation activity was sought which might
eliminate some of the problems previously encountered. Foremost of
these was the fact that in a direct assay of ADP-ribosylation, there
is no longer any need to run each and every sample in the presence
of a control for NAD'ase activity. One such assay has been recently
reported by Soman et al., (1983) who used the guanyl hydrazone
p-nitro benzylidine aminoguanidine (pNAG) as a substrate for cholera
toxin and other guanidine-specific ADP-ribosyl transferased. This
assay has the added advantage of providing a continuous trace of
ADP-ribosylation activity. In addition it uses no isotopes. The
pNAG is highly coloured with an absorbance maximum at 370nm at
pH7.5. After ADP-ribosylation, there is a change in the pKm value
of pNAG which leads to a increase in absorbance at this wavelength.
The increase in absorbance may be followed continuously by
spectrophotometric means.
Firstly, samples of pNAG were prepared as described in Materials
and Methods, which also contains details of the assay procedure.
Assay samples contained 40mM DTT, 1 - lOmM NAD", 0.4 - 4mM pNAG and
500yg cholera toxin or E.coli LT in a total volume of 1ml 20mM tris
acetate pH7.5. When LT was used it was incubated with 5yg/ml
trypsin for 30 min. at 37*C immediately prior to use and the
reaction stopped with ImM PMSF in propan-l-ol. A time course of the
spectral increase at 370nM accompanying the ADP-ribosylation of pNAG
is presented in fig. 3-12. This represented a specific activity of
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150pmol product/min./mg. The activity seen with LT was too low to
be detected. No activity was seen using the isolated Aa chain. No
activity was seen at concentrations of NAD"*" below lOmM. At
concentrations of pNAG above 0.4mM, the considerable absorbance of
pNAG itself made the assay difficult to follow without the use of a
spectrometer sensitive enough to detect accurately a change in
absorbance of .05 - 0.1 units per hour against a background of >2.0
units. The pNAG was also increasingly insoluble at concentrations
above 0.4mM. It therefore appeared that under the experimental
conditions described, there was only a narrow range of NAD"" and pNAG
concentrations which would allow any measurement of ADP-ribosylation
activity. No further experiments were performed using this assay
system, which even if the problems of solubility were overcome, used
huge amounts (500yg) of cholera toxin in each assay. The assay's
main advantage, of avoiding expensive radio label led NAD"", was










fig. 3-12 Continuous spectrophotometric assay
of ADP-ribosylation
Assays were conducted as described in the text. A change
in absorbance of 0.1 unit at 3 70nm was equal to the
formation of 5 x 10-ayMol product (Soman et al., 1983)
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3,2,9 Retinal transducin as a substrate for cholera toxin
3,2,9,1 Introduction
As mentioned, cholera toxin catalyses the ADP-ribosylation of many
proteins in addition to N.. One of these is transducin, a membrane-
bound protein found in the rod outer segments of the vertebrate
retina. It couples photolysis of rhodopsin to the activation of a
cyclic GMP specific phospho-diesterase (Stryer et al., 1981; Fung et
al., 1981) which in turn leads eventually to a nerve impulse in the
optic nerve (Miller and Nicol, 1978).
Transducin and N„ and N± are remarkably similar both in terms of
structure and function (Fung, 1983). Transducin is an OcBb
heterotrimer (Manning and Gilman, 1983; Hildebrandt et al., 1984).
The subunits of N», N4 and transducin cross-react immunologically
and the 8-subunits at least have largely homologous sequences
(Manning and Gilman, 1983). The a subunit of transducin has GTP'ase
activity and its ability to activate cyclic GMP phosphodiesterase is
controlled by GTP/GDP exchange in a way analogues to the control of
N, and NA (see Chapter One and fig. 3-13) (Fung and Stryer, 1980,
1980; Fung et al., 1981; Wheeler and Bitensky, 1977). The tt subunit
can be ADP-ribosylated not just by cholera toxin (Abood et al.,
1982) but also by pertussis toxin (Hurley et al., 1984; West et al.,
1985). The most striking evidence of the similarity between these
G-proteins is the demonstration of functional exchange between
components of the two systems such as rhodopsin for hormone-receptor
or Nao» for transducin-<* (Bitensky et al., 1982; Kanaho et al.,
1984). Indeed bovine rhodopsin and the mammalian B-adrenergic




fig. 3-13 A possible aechanisa for the interaction of transducin
with rhodopsin and the light dependant activation of
phosphodiesterase
JL
R represents rhodopsin and R an active, mobile
configuration of rhodopsin formed on exposure to
ultraviolet (U.V.) light. Transducin (0tfJ8, in the
presence of photolysed rhodopsin and GTP becomes soluble
and may interact with the cyclic GMP phosphodiesterase
(PDE) in the cytosol. Hydrolysis of GTP to GDP may
return transducin to an inactive conformation.
After Yamazaki et al., (1983)
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(Dixon et al., 1986). This demonstrates a remarkable functional
compatibility between subunits and implies that specialised peptide
domains responsible for protein: protein-interactions have been
conserved (Lochrie et al., 1985).
All of this suggests that transducin may be a more readily
available alternative to N„ for studying ADP-ribosylation by cholera
toxin. Although both proteins are labile and hydrophobic,
transducin can be obtained in milligram quantities (Kuhn, 1980).
This is because the rod outer segments of the retina are enriched in
proteins of the visual transduction pathway and may contain up to 5%
transducin compared to the estimate of 0.001% that N. typically
contributes to total cellular protein (Gilman, 1984). Here
transducin has been purified and its use as a possible model
substrate for N. investigated.
3.2.9.2 Purification of transducin
The light-induced binding of transducin to rod outer segment (ROS)
membranes and its subsequent elution with GTP were used to purify
the protein (Kuhn, 1980). Bovine ROS were purified from freshly
dissected retinas by flotation and subsequent centrifugation on
stepwise sucrose density gradients as described in section 2-6. The
ratio A2ao*A50o of the purified ROS was 2.0 - 2.6 indicating good
purity with rhodopsin the only protein present (Daeroan, 1973). When
the purified ROS were analysed on 10% SDS-PAGE, rhodopsin was the
major protein present with a band corresponding to molecular weight
34,000 (Godchaux and Zimmerman, 1979). The ROS membranes were
exposed to daylight thoroughly and then washed several times to
remove soluble proteins. The three polypeptides representing
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transducin remained membrane bound and sedimented with the membrane
pellet. Transducin was then eluted from the pellet with 40yM GTP in
5mM tris-HCl. The only bands present on 10% SDS-PAGE of this
extract corresponded to molecular weights of 39,000 and 36,000 with
the 6,000 subunit presumably running with the dye front (fig. 3-14).
The yield of purified transducin was approximately 60 - 70yg of each
large subunit per mg rhodopsin. Together the two bands made up
about 90% of the protein on densitometric analysis of the gel. On
average 8mg transducin was purified per 500 bulls eyes.
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3-14 Purification of transducin from ROS membranes
Transducin, purified as described in the text, was
analysed on 10% SDS-PAGE. The two bands correspond to
molecular weights of approximately 39,000 and 36,000
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3.2.9.3 Transducin as a substrate for ADP-ribosylaticm
Van Dop et al., (1984) showed that transducin could be ADP-
ribosylated by cholera toxin when still located within ROS
membranes. It may only be an efficient substrate however in the
presence of photolysed rhodopsin and GTP or Gpp(NH)p (Navon and
Fung, 1984). With these points in mind, a portion of the transducin
was reconstituted with 'stripped' ROS membranes as described in
Materials and Methods.
ROS membranes containing approximately 5mg/ml rhodopsin (lOOyM)
and 0.5mg/ml reconstituted transducin (6yM) were incubated with
50yg/ml cholera toxin, 20mM DTT, lOOyM Gpp(NH)p and either
[4-3H]NAD"* or [U-1*C]NAIT" (5nCi, or 5 x 105cpm) in a total volume
of 50yl. Some samples contained ROS membranes alone, 2mM A599 or
transducin in place of the reconstituted transducin. In some
samples cholera toxin was replaced by E.coli LT. Samples were
incubated for 3 hours at 37#C after which time the samples
containing [U_1AC]NAD"" were subjected to 10% SDS-PAGE. The gel was
stained and protein bands cut out and counted. No detectable
radioactivity had been incorporated indicating either that no ADP-
ribosylation had occurred or that the levels were too low to be
detected by this method.
The samples containing [4~3H]-NAIT were treated as follows. An
aliquot of each sample (5yl) was analysed using tic (section 2-10).
The remaining 45yl was diluted with 1ml water and separated on QA-25
sephadex as described (section 2.9). Results are presented in
table 3-2 as fold stimulation of activity compared to a blank
control with no ADP-ribose acceptor. Only the reconstituted
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transducin was shown to have stimulated the release of nicotinamide
catalysed by cholera toxin, and to a lesser extent by LT.
Difficulties arose in quantifying the exact concentration of
transducin present in the reconstituted system. The considerable
effect of the membranes themselves on the assay in the absence of
transducin suggested contamination with unidentified proteins,
perhaps NAD'ases. The stability of the transducin preparation was
limited possibly due to protease contamination, and the level of
activity seen in table 3-2 shows that transducin is only a poor
substrate under these conditions.
toxin preparation A599 fold stimulation
acceptor versus blank






Ai chain A599 1.8
transducin 1.2
reconstituted transducin 1.5
table 3-2 ADP-ribosylation activity using transducin as a
substrate
Samples were treated as described in the text. When
reconstituted transducin was used, the effect of ROS
membranes alone was subtracted from the sample value.
Results are presented as fold stimulation compared to a
blank control identical to the sample but with buffer
instead of ADP-ribose acceptor ."The. b^o-neduACvo /





These studies provide some additional information about the ADP-
ribosylation reaction catalysed by cholera toxin.
The indirect assay using arginine derivatives as ADP-ribose
acceptors measured the release of [3H]nicotinamide from
[ 4~3H]-NAD"". Adequate controls were required to distinguish ADP-
ribosylation activity from NAD'ase activity for which water acts as
an ADP-ribose acceptor. When the release of [3H] nicotinamide as a
function of time was followed under the original conditions
described, (2mM A599, 2mM NAD""), a linear progress curve was
obtained. This contrasts with the finding for certain eukaryotic
ADP-ribosyl transferases of biphasic kinetics for NAD"" (Furneaux and
Pearson, 1980). For the eukaryotic enzymes, this was taken as an
indication either of substrate activation by NAD"" or of multiple
binding sites for NAD"" on the toxin.
A calculated value of 3mM for NAD"" was observed for cholera
toxin's NAD'ase activity (i.e. with no A599 or 4406 present). This
value agrees well with published results (Mekalonos et al., 1979a;
Moss et al., 1979b). When the arginine derivatives A599 or 4406
were included in the assay, the value for NAD"" rose almost
tenfold to 45 - 51mM. A similar result was reported by Osborne et
al., (1985) when they studied the toxin using agmatine as an
acceptor for ADP-ribose. They showed that binding of either NAD"" or
the arginine substrate had a negative effect on the subsequent
binding of the other substrate. They proposed a random order rapid
equilibrium model for cholera toxin and accounted for the reduced
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affinities as a possible control mechanism to allow certain arginine
residues to be more readily ADP-ribosylated than others.
These high Km values for NAD" contrast markedly with the
micromolar values for NAD" reported for most other ADP-ribosyl
transferases such as diphtheria toxin (Kandel et al., 1974)
pertussis toxin, (Moss et al., 1983). P.aeruginosa exotoxin A
(Chung and Collier, 1977b) and at least one mammalian ADP-ribosyl
transferase (Burtscher et aJ., 1986). The cellular concentration of
NAD" is about 70yM in pigeon erythrocytes (Gill, 1975) and is
unlikely to exceed 100yM in any cell type. This makes the
millimolar K™ of cholera toxin seem inexplicably high. However,
Tait (1981) showed that for optimal activation of adenylate cyclase
in rat liver membranes, cholera toxin required the addition of ImM
exogenous NAD". In this case high NAD" concentrations were required
in an assay system which was more closely analogous to the in vivo
situation than the one used here. Membrane-bound N. was the
substrate for ADP-ribosylation and the various factors reported to
be necessary for cholera toxin's activity in vivo would have been
present. These include an unidentified cytosolic factor of
molecular weight 16000 (Enomoto and Gill, 1979) and an intrinsic
membrane protein of molecular weight 21000 called ARF, which has
been purified by Kahn and Gilman (1984). Their results imply that
the substrates for cholera toxin in rat liver membranes are NAD" and
a GTP-N.-ARF complex and the reaction proceeds in a lipid
environment. Their assay system required the addition of only lOOyM
exogenous NAD" in order to demonstrate a significant level of ADP-
ribosylation. Gill and Woolkalis (1985), compared various
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substrates for ADP-ribosylation by cholera toxin and showed that N.
was by far the preferred substrate when compared to a number of
proteins and arginine derivatives. There must be a rather special
environment of the relevant arginine in N„ that makes it so
susceptible to ADP-ribosylation, an environment which none of the
alternative substrates considered in this Chapter; A599, 4406, pNAG
or transducin is providing. In conclusion then, cholera toxin has
an extremely high Km for NAD"". This is reflected in the value
calculated in Chapter 5, indicating a low affinity binding of NAD"*"
to the toxin. Explanations for this high Km include the possibility
that NAD"" is not the true substrate in vivo, but as most derivatives
and breakdown products of NAD"" have been examined, an alternative to
NAD"" would have to be an as yet unidentified derivative.
Alternatively, there could be an intracellular pool of NAD""
providing high localised concentrations although there are no
results to suggest that this is the case.
It could be that cholera toxin's possible membrane location when
it catalyses its ADP-ribosylation reaction has some bearing on the
availability of its substrates in vivo.
3.3.2 A599, 4406 and the indirect assay
The presence of A599 or 4406 seemed to have a negative effect on
the binding of NAD"" to the toxin. The in vivo substrate N„ is a
large intrinsic membrane protein (Kaslow et al., 1980). Its high
frictional ratio and the small amount of detergent it binds after
solubilisation suggest it to be elongated and anchored into the
membrane by a hydrophobic stalk (Brunner et al., 1979). As
mentioned, the actual substrate for ADP-ribosylation by cholera
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toxin in vivo may consist of N» with a number of interacting
cofactors, with ADP-ribosylation sites within the membrane
environment (Johnson, 1981). In contrast to this complex situation,
A599 is a small guanidine derivative with a polar head group
separated from a charged end group by an unbroken length of hydo-
carbon chain. This hydrophobic chain seems to be an important
structural prerequisite in making A599 a better substrate for
cholera toxin than arginine alone (Tait and Nassau, 1984) and may
mimic the susceptible arginine(s) on N». Assuming that either A599
or NAD"' can bind to toxin first, it could be that A599 can bind and
can act as a substrate, but cannot induce a conformational change
(whch N„ presumably can). This change in conformation may be needed
to form a high affinity binding site for NAD"*". A599 would then be
an unproductive substitute for N». Alternatively, a small molecule
like A599 could have access to inappropriate sites on cholera toxin
which are blocked to a large protein like N.. These sites may then
interfere with the subsequent binding of NAD"'.
Whatever the reasons, the indirect measurement of nicotinamide
release did not seem to be an adequate method for studying the
kinetic mechanism. When concentrations of NAD"' and more especially
of A599 were varied, the linearity of the reaction was disrupted in
a way that suggested substrate inhibition. The high levels of
apparent NAD" hydrolysis seen in the blank controls were in some
cases similar to the actual samples. The NAD'ase activity of
cholera toxin has been reported to be greater relative to ADP-
ribosy lation activity at high NAD" concentrations and could be due
in some cases to contamination (van Heyningen, 1977a; Tait and
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van Heyningen, 1980). A direct assay such as the one described by
Mekalonos et al., (1979a) using 125I-guanyl tyramine seems more
appropriate for these kinds of measurements.
3.3.3 Transducin as a substrate
In neither of the forms studied; pure or reconstituted, was
transducin an efficient substrate for cholera toxin. The activity
of the reconstituted transducin in a GTP'ase assay was not checked,
and its correct orientation within the membrane was therefore not
established. Even so, it seems that transducin, despite its
striking similarities to N., is not as good a substrate for cholera
toxin (see table 3-2). In fact transducin appears to be a better
model for N4. Peptide mapping has shown that transducin's a subunit
is more closely homologous to N±ol than to (Manning and Gilman,
1983). The homology between N±<x and transducin-a is accentuated by
the fact that both are substrates for ADP-ribosylation by both
pertussis toxin and cholera toxin whereas N.c, is a substrate only of
cholera toxin (Owens et al., 1985). If transducin were to be used
as a model for N„, a direct assay, perhaps using [ 32-P]-NAD"" would
be more suitable than the indirect assay here. Again, problems with
high control values designed to detect NAD'ase activity were found.
The membrane preparations could very well have had intrinsic NAD'ase
activity due to contaminating proteins.
3.3.4 Cholera toxin's kinetic mechanism
The results from the indirect assay did not provide sufficient
information to say what the kinetic mechanism of cholera toxin is
likely to be. However, the results obtained, together with binding
results from Chapter 5 can be compared to previously published
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results. There is evidence from both Osborne et al., (1985) and
Mekalonos et al., (1979a) that the reaction proceeds through a
ternary complex. Assuming that this is so, there are then two
possible mechanisms, either ordered or random sequential binding of
substrates. Both have been proposed. As outlined previously,
Osborne's model was of a random order rapid equilibrium mechanism,
with binding of the first substrate having an effect on the
subsequent binding of the next substrate which for agmatine was
negative but which for the in vivo situation may even be positive.
Alternatively, Mekalanos proposed an ordered sequential model, with
NAD'*' binding first.
A key point in comparing these models is whether or not the
ADP-ribose acceptor, be it 12SI-guanyl tyramine, A599 or N„, can
bind to cholera toxin in the absence of NAD"". Results from binding
studies in Chapter 5 show that although no binding of A599 to
cholera toxin was detected using a number of methods (including
changes in absorbance or fluorescence) an effect on the toxin's
conformation caused by A603 was seen in section 5.2.5. It was shown
that saturating concentrations of A603 (another arginine derivative,
illustrated in fig. 3-1) could protect the Aa chain of the toxin
from digestion with trypsin. This was interpreted as evidence that
A603 was binding to the Aa chain and protecting it from digestion
through a change in conformation. Taken together with the results
from this Chapter which suggest that the affinity of the toxin for
NAD"" is reduced in the presence of A599, Osborne's proposed random
order rapid equilibrium model seems the most likely mechanism for
cholera toxin. This model is illustrated in fig. 3-15.
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IS A possible kinetic mechanism for cholera toxin
In this mechanism, the binding of one substrate alters
the binding of the other substrate by a factor a. If
OKI, the affinity for the second substrate is increased,
whereas if 0t> 1 it is decreased. The apparent maximal
velocity changes when either A or B serves as the
variable substrate. A and B correspond to SAD' and A599
respectively and the equilibrium dissociation constants
are given by kA and KB. The factor B is equal to the
ratio of maximal velocities of NAD' Glycohydrolase and
transferase reactions.
From Osborne et al., (1985)
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It would be interesting to see whether this mechanism is also seen
for E.coli LT, which seems to be similar to cholera toxin in so many
ways (Chapter 4). Osborne's work shows that a turkey erythrocyte
ADP-ribosyl transferase studied at the same time as cholera toxin
had an identical mechanism, although its Km for NAD"" was only 7yM.
It appears that cholera toxin differs from other toxins such as
diphtheria toxin and exotoxin A, not only in its high Km of
approximately 4mM (elevated to around 50mM under certain assay
conditions), and the non-specific nature of its ADP-ribosylation,
but also in having a random order mechanism. Diphtheria toxin and
exotoxin A have compulsory order mechanisms (Chung and Collier,
1977b). They are both entirely specific for EF2, possibly because
the site of modification, a 'diphthamide' residue, has not been
found elsewhere. Cholera toxin could turn out to be more closely
related to other arginine-specific ADP-ribosyl transferases, both
bacterial and eukaryotic (see fig. 1-6) than to the diphthamide-
specific bacterial toxins.
3.3.5 Inhibitor Studies
The only competitive inhibitors of NAD"" of any significance were
those that contained all of the NAD"" molecule with minor alterations
to the nicotinamide ring. Some, such as thio-NAD"" can substitute
for NAD"" in most NAD""-requiring reactions, while others such as
acetyl pyridine adenine dinucleotide (APAD) are replacements for
NAD"" for many dehydrogenases. The other molecules tested, which
included NADP, FAD, NADH, purine nucloeotides, nucleosides or bases
were not significant inhibitors. Gill (1976a) reported that only
thio-NAD"" could replace NAD"" for the activation of erythrocyte
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adenylate cyclase by cholera toxin.
As shown in table 3-3, the most efficient inhibitors were thio-
NAD"" with a sulphur group at carbon 3 of the nicotinamide ring and
acid and 3-amino NAD"*" with a C3 amino group were poor inhibitors.
There appears to be some correlation between the C3 substituent of
the nicotinamide and that molecule's efficiency as an inhibitor.
Presumably the C3 substituent is involved in some specific
interaction at the binding site, perhaps a hydrogen bond, which
cannot be achieved, e.g. by the carboxylic acid derivative, deamido-
NAD"". The nicotinamide ring as a whole plays an important role in
binding as shown by the inhibitory effects of nicotinamide itself
and of analogues such as benzamide. Although compounds lacking the
nicotinamide ring were in general poor inhibitors, e.g. AMP,
adenine, the adenine moiety does have some importance in binding.
Deamino-NAD"^, in which the amino group of adenine is replaced by a
hydroxyl group was a poor inhibitor. Presumably the hydroxyl group
caused electrostatic repulsion.
Benzamide and 3-amino benzamide had some inhibitory activity.
These compounds are potent inhibitors of eukaryotic ADP-ribosyl
transferases (Pumell et al., 1980) and have even been used in the
preparation of affinity chromatography media for their purification
(Burtscher et al., 1986). Although this might point to homologies
between eukaryotic enzymes and cholera toxin, benzamide is most
probably recognising a general NAD"*"-binding region, as other enzymes
involved in NAD^-metabolism are also inhibited by benzamide
(Johnson, 1981). Diphtheria toxin and exotoxin A have similar
APAD with a C3 Both deamido-NAD^ with a C3 carboxylic
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sensitivities to inhibition (Chung and Collier, 1977) and indeed
have almost identical enzyme activities but are not particularly
homologous in their amino acid sequences. Although cholera toxin's
active site may share some features with these two enzymes, any
similarities are likely to be confined to the NAD""-binding portion
of the active site. The other part is more likely to resemble
arginine-specific enzymes. Certainly the phenomenon reported for
both diphtheria toxin and exotoxin A in which adenine was a more
potent inhibitor than adenosine which in turn was better than ADP-
ribose (Chung and Collier, 1977) was not apparent for cholera toxin
(although the inhibition was so slight as to be difficult to
quantify at all). Presumably, entropy factors were responsible for
this decrease in affinity.
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Chapter 4 Purification of E.coli heat labile toxin (LT)
4.1 Introduction
Certain strains of E.coli associated with enteropathogenic
disease in man and other animals are known to produce a diarrhoea-
inducing exo enterotoxin similar in many respects to cholera toxin
(Finkelstein, 1973). E.coli heat labile toxin (or LT as it is
commonly called) has the same subunit structure as cholera toxin
with one toxin-active A subunit and five receptor binding B
subunits. The B subunits are arranged in a ring and held together
by tight non-covalent bonds. The A subunit is linked to and
partially inserted in the B ring through weaker non-covalent
interactions (Clements and Finkelstein, 1979; Gill et al., 1981).
Unlike cholera toxin, the A subunit of LT is normally purified
un-nicked. Subsequent treatment with trypsin nicks the LT A subunit
and increases the biological activity of the LT molecule (Rappaport
et al., 1976) probably by cleavage and removal of two amino acid
residues after arginine 188 (Spicer and Noble, 1982).
The two toxins are functionally almost identical. The receptors
for both cholera toxin and LT in the gut mucosa are GM1 gangliosides
although the receptor for LT may also contain a structurally related
glyco-protein (Holmgren et al., 1982). The Ai chain of LT can
catalyse the same enzyme reactions (Moss et al., 1979a) and ADP-
ribosylations (Gill and Richardson, 1980) as those of cholera toxin,
»
resulting in vivo in a similar activation of adenylate cyclase.
Both subunits cross-react immunologically (Moseley and Falkow, 1980)
although each has unique determinants. Both cholera toxin and LT
are encoded by polycistronic operons but whereas cholera toxin's ctx
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operon is chromosomally encoded, the elt operon for LT is located on
a variety of plasmids (Gyles et al., 1974; So et al., 1978) and even
bacteriophages (Takeda and Murphy, 1978) harboured by entero
pathogenic strains of E.coli. Analysis of the nucleotide sequence
of the elt genes suggests that they are cotranscribed from a typical
E.coli promoter preceding the elt A gene (Rosenberg and Court, 1979)
and that elt mRNA contains two Shine-Dalgarno sequences (Steitz,
1979) preceding the AUG translation starts for LT A and LT B. The
Shine-Dalgamo sequence of LT B resembles that of cholera toxin B in
that it is more closely homologous to 16SrRNA than that of the A
subunit. Greater trans Io tional efficiency would then explain the
production of five B subunits for every A subunit.
Comparison of the amino acid sequences of the two toxins shows that
they are homologous to varying degrees throughout their primary
structures. Of the 103 residues of the LT B subunit only 22 differ
from the corresponding residues in cholera toxin and in 20 of these
a single base-pair change in the elt B codon could account for the
differences (Dallas and Falkow, 1980). The LT A subunit contains
236 amino acids and shows a high degree of homology to cholera toxin
A, particularly the Al chain (Spicer and Noble, 1982). A more
recent sequence analysis (Dykes et al., 1985) reports even greater
homology between LT and cholera toxin of 80% overall. Yamamoto et
al., (1984) have compared the available nucleotide sequences of
cholera toxin and of porcine and human LT strains. They showed that
in addition to their homologous sequences, both codon usage and G+C
content of the nucleotide sequences were the same. Amino acid
homology was most apparent in the Ax chains which contained four
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stretches of identical sequence. A short stretch of high divergence
near the end of the LT Ai chain had a unique base change pattern.
Divergence in this region may be the result of adaptation to the
different proteases of V.Cholerae and E.coli. Secondary structure
predictions place this sequence on a hydrophilic region of random
coil, which may be looped out on the surface of the toxin (Yamamoto
et al.. 1984). The porcine LT showed greater divergence from
cholera toxin than did human LT. Much of this divergence was
compressed within a short stretch of the A! chain. The reason for
this is unclear but could represent a species-specific alteration.
These observations raise interesting questions regarding the
similarity of the two enterotoxins. For instance, if specific
regions are strongly conserved, are they associated with special
functions such as NAD"* binding, ADP-ribosylation of adenylate
cyclase, the formation of bonds between A and B subunits and the
movement of the A subunit across the cell membrane into the target
cell?
In this Chapter, the purification and characterisation of
porcine LT is described. The purification relies on the ability of
LT to adhere to columns of agarose from which it can be eluted by
galactose (a monomer component of agarose), in practically
homogenous form. The specific binding affinity of LT B for plastic
adsorbed GM1 ganglioside is used in an ELISA procedure to detect LT
during the purification. This work was done in the Department of
Microbial Biochemistry, Glaxo Group Research Ltd.
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4.2 Results
4.2.1 Purification and characterisation of LT
In this study fractions were screened not for biological activity
but ^t>r antigenic activity. The strain of E.coli was E.coli 2107E
(containing plasmid EDW299 (porcine LT A"" B~* apr)) and was provided
by Glaxo Group Research Ltd. It is a genetically engineered strain
which produces 50 - 100 fold more toxin than do normal strains
(Evans et al., 1974). About 1% of its total cellular protein or up
to 20% of its periplasmic protein is enterotoxin. Cells were
harvested and lysed by sonication. After precipitation with 60%
(NHA)2S0« preparations were applied to a column of Bio-Gel agarose
A5 m. A typical elution profile from the agarose column is shown in
fig. 4-1. The GM1 ELISA revealed that little or no LT eluted from
the column with TEAN buffer (50mM tris-HCl, 200mM NaCl, 3mM NaN3,
ImM EDTA, pH7.5. After 0.2M galactose was applied, a single ELISA
positive peak eluted with the leading edge of the applied galactose.
This peak, when pooled, concentrated by ultrafiltration on Amicon
P10 filters and analysed by 15% SDS-PAGE, consisted of two non-
covalently associated subunits (fig. 4-2). Of these, the
migrating component corresponded to a protein of molecular weight
28,000, the same as cholera toxin A subunit.
Treatment with thiol (which separates cholera toxin A subunit into
its Ax and A2 peptides) had no effect upon the apparent molecular
weight of this band, indicating that the LT A is in a completely
un-nicked form. Treatment of the purified LT with trypsin before
thiol reduction an^electrophoresis resulted in complete dissociation
of LT A into its Ax peptide of molecular weight 21,000 and its A2
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peptide of molecular weight 6,000 (and not visible on the gel in
fig. 4-3) The biological activity of LT samples treated with
concentrations of trypsin from 1-20 yg/ml using the ADP-
ribosylation assay described in section 2.9 reveals that there is an
optimum concentration of trypsin for enhancing the ADP-ribosylation
activity of the toxin (fig. 4-3).
4.2.2 ADP-ribosylation activity of LT and of cholera toxin
The activities of cholera toxin and of the purified LT were
compared using the ADP-ribosylation assay (section 2.9). The LT was
treated with 5yg/ml trypsin for 30 min. at 37°C immediately prior to
use. The digestion was stopped with ImM PMSF in propan-l-ol.
Samples of cholera toxin and nicked or unnicked LT at concentrations
in the range 50-500pg/ml (6-60yM) were compared. Controls were
included to check that PMSF, propan-l-ol and trypsin did not affect
the assay system. The nicked LT consistently showed less than half
the activity of cholera toxin in this concentration range; the
un-nicked LT showing no activity at all (fig. 4-4). Both toxins
are able to use A599 as a substrate as reported previously (Tait,
personal communication).
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fig. 4-1 Gel filtration chromatography of crude LT on Bio-Gel A5m
(2.5 by 80 cm)
The flow rate 20ml/h and fractions of 10ml -up to
fraction 15) then 5ml were collected. The arrow marks the
start of the galactose (0.2M) wash
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fig. 4-2 15% SDS—PAGE showing the purification of LT by gel
filtration on Bio Gel A5m agarose
Lane (a) shows the crude (NHA)2SOA precipitate which was
loaded onto the Bio Gel A5m column. Lane (b) shows the









fig. 4-3 Activation of LT with trypsin
10 20
>ig/ml trypsin
Samples of LT (400yg) were incubated with 0-20 yg/ml
trypsin. 20mM DTT in a total volume of 150yl KH3POA,
pHb.5. After 30 min. at 37*C. reactions were stopped with
PMSF. lOOyl of each sample was analysed by 15% SDS-PAGE.
The remaining 50yl was assayed using the ADP-ribosylation
assay described, protas vep^e-^enY-iVve prefer "scunapte ok3cxv->e<i
exv gcxcvv txv|p^vn cj^r-vccrvwodxcso .
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fig. 4-4 ADP-ribosylation activity of cholera toxin and of LT
Purified LT ( 4 m g / a» 1 ) was treated with 5 y g / m 1
trypsin as described. A similar sample of cholera toxin
was treated in an identical way but without adding
trypsin. Both toxins were diluted to give a range of 5 -
500yg/ml by the addition of a cocktail of 2mM NAD*. 20nCi
(4-3H]NAD* and 2mM A603 in a total volume of lOOyl KHaPO*,
pH6.5. Samples were treated as described in Materials and
Methods
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4.2.3 Fluorescent labelling of LT with Nbf-Cl
The interaction of LT with NAD"" was studied using LT which had been
fluorescently labelled with Nbf-Cl (4-chloro-7 nitrobenzofuran). A
solution of LT was pretreated with 5yg/ml trypsin for 30 min. at
37aC in the presence of 5mM DTT, the digestion being stopped by the
addition of ImM PMSF in propan-l-ol. Solutions of either this
nicked LT or of untreated LT were then labelled with Nbf by
incubating with a near saturating solution of Nbf CI at pH8.5 a
described in section 2.13 (see also section 5.2.4.1). After this
treatment, a portion of the un-nicked, labelled toxin was then
treated with trypsin as described above. This gave three different
preparations: un-nicked, Nbf- labelled LT^ LT nicked before
labelling and LT nicked after labelling. When these samples were
analysed by 12% SDS-PAGE they showed three bands (two for the
un-nicked LT) visible under ultraviolet light and staining with
coomassie blue with the expected mobilities of subunits A, B, Ai or
A2. Measurement of the absorbance for protein at 280nm and for the
amino derivative of Nbf at 475nm suggested that about two moles of
Nbf had bound per mole of toxin in each case.
When solutions of the three Nbf-labelled toxins were treated
with NAD"" (section 2.13) there was no alteration in either the
fluorescence intensity or the wavelength of maximum intensity which
stayed at 533nf/u This was in contrast to the results obtained using
Nbf-labelled cholera toxin Ai chain for which a marked enhancement




These studies verify previous reports which suggest that although
LT and cholera toxin have remarkable physfiochemical similarities,
each possesses unique features. The purification procedure used
highlights some of these differences. Bio Gel agarose A5m is acting
here as a kind of affinity matrix for LT. This is not altogether
surprising since LT, like cholera toxin, interacts with Gmi
ganglioside of which galactose is a component. However LT differs
from cholera toxin which although retarded is not prevented from
elution on agarose (Finkelstein and Lospalluto, 1969). This
difference may reflect differences in the nature of the interaction
of the two toxins with host cell membrane receptors. The LT A
subunit has an unusually high content of charged residues: 24
arginine, 17 aspartate, 15 asparagine and 14 glutamate. It also has
remarkably high concentrations of tyrosine (21) and phenylalanine
(11) (Spicer and Noble, 1982) which may account for the strong
affinity for agarose (Clements and Finkelstein, 1979). Cholera
toxin is similar in having a high content of charged residues but is
richer in glutamate, glutamine, aspartate and glyc»n2/
residues than is LT.
The purification procedure uses a whole-cell lysate of LT as,
unlike cholera toxin which is mostly secreted by V.Cholerae, LT is
predominantly intracellular in E.coli and little is found extra-
cellularly. A variety of Gram negative bacteria including Vibrios
and Pseudomonas species secrete proteins through their cell
envelopes into the extracellular environment. Other Gram negative
bacteria including E.coli rarely exhibited this phenomonen and may
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lack the secretory apparatus to do so. Hirst et al., (1984)
described the synthesis of LT by both E.coli and V.Cholerae strains
engineered to express the plasmid encoded elt operon but not the ctx
operon. They demonstrated that while E.coli retained LT in a cell-
associated compartment, V.Cholerae secreted it into the extra¬
cellular milieu. Thus LT is exported to two different locations
depending on the organism in which it is synthesised, suggesting
that bacterial-physiologial factors as well as the structural
properties of LT are important in determining its location.
The LT purified from E.coli 2107E was in a completely un-nicked
form. The nicking of the A subunit may be relevant to toxin
secretion because cholera toxin has previously been shown to have
nicked A subunits when secreted from V.Cholerae (Lonnroth and
Holmgren, 1973) but un-nicked A subunits when cell-associated in
E.coli (Pearson and Mekalonos, 1982). However, Hirst et al., (1984)
show that nicking must be important in the secretory process because
both porcine and human LT were completely secreted from Vibrio
Cholerae without their A subunits being nicked. The V.Cholerae
protease that nicks cholera toxin has been proposed to be soluble
hemagglutinin/protease which can also nick LT in vitro (Finkelstein
et al., 1983). The V.Cholerae strain used by Hirst et al.,
TRH 7000, presumably produced insufficient hemagglutinin to nick the
LT. The relevance of LT's intracellular location and un-nicked form
to the relatively mild and short-lived diarrhoea generally elicited
by enterotoxigenic E.coli is unclear. Certain wild type V.Cholerae
strains secrete very little toxin but are still extremely virulent
in vivo. There appears to be ample proteolytic activity in the
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small bowel to activate LT. Indeed in the human or animal intestine
in vivo gut fluid factors may be mainly responsible for both
releasing LT from its periplasmic location and activating it by
proteolytic nicking.
The low level of activity of LT seen in section 4.2.3 seems most
likely due to inefficient or in appropriate nicking with trypsin as,
despite its name, the heat labile LT is a fairly stable protein.
Previous reports have shown that purified LT is equivalent to
cholera toxin in specific activity in several biological assays
which have been applied to both toxins (Clements and Finkelstein,
1979). The failure of LT to become photochemically labelled under
conditions which resulted in efficient labelling of cholera toxin
(Chapter Six) and the lack of change in the fluorescence of Nbf-LT
when titrated with concentrations of NAD"* which enhanced the
fluorescence of Nbf-cholera toxin could reflect either subtle
differences in the structures of the toxins or, more likely, could
highlight a basic loss of activity in this particular preparation of
LT.
Finally, it is worth speculating on the evolutionary origin of
LT and cholera toxin and their role in the biology and ecology of
their host bacteria. Man is the only host for V.Cholerae which
survives poorly in the colon and the external environment. The
toxin may confer survival advantage by increasing the numbers of
bacteria released into the environment. Passage in animals
reportedly favours hypertoxinogenic strains (Mekalonos et al.,
1983). E.coli is fairly ubiquitous and therefore its ability to
produce LT may be of little advantage. As the toxins are as highly
124
homologous and seem certain to share a common origin, it seems more
likely that E.coli received the toxin genes from V.cholerae rather
than vice versa.
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Chapter Five Binding of NAD" to cholera toxin
5.1 Introduction
In Chapter Three a K„ of 4mM for NAD"" was calculated for the NAD""
Glycohydrolase (NAD'ase) activity of cholera toxin. In the presence
of the low molecular weight substrate analogues A599 and 4406, the
apparent K™ rose even higher to around 40mM. This implies that the
binding affinity of the Ai subunit for NAD"" may also be \oW and may
be adversely affected by the binding of A599 or 4406.
The number of binding sites for NAD"" on the Ai chain has not been
previously estimated. Although it may be reasonable to assume that
the toxin has not evolved separate catalytic sites for the NAD'ase
and ADP-ribosylation activities, this has not been proven. Poly
(ADP-ribosyl) transferase enzymes isolated from the eukaryotic
nucleus have been shown to contain both an initial catalytic site
and one or more different acceptor sites (Bauer and Kun, 1984;
Kawaichi et al. , 1981). For any binding interaction, the
determination of stoichiometry, (the maximum number of moles of
ligand bound per mole of protein, n) and of the equilibrium
dissociation constant, Kd, can be done using a variety of
techniques. The mathematical description of a simple equilibrium of
protein, P, and ligand, A, is given by
P + A = PA
ir -1P)IA1 i"* "TpaT "
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If the number of moles of A bound per mole of P is defined as r then
concentration of A bound to P
r =
total concentration of all forms of P
[PA]
[P] + [PA]








In this case r<l and is the fractional saturation of sites. This
assumes that one mole of P can bind one mole of A.
Two basic types of experimental procedure have been used in
measurements of ligand binding by proteins; so-called separation and
non-separation methods. In the separation method the protein:ligand
system is physically separated from free ligand (or protein) at
equilibrium. This allows a direct measurement of bound ligand at
equilibrium to be made without disturbing the equilibrium.
Techniques include equilibrium dialysis and gel filtration. Since
free ligand, A, and fractional saturation, r, are measured
independently it should be possible to evaluate equilibria
accurately. However these techniques can be time consuming.
The non-separation method involves correlation of some measurable
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change accompanying binding with fractional saturation, r. The most
commonly used techniques are spectroscopic measurements of changes
in absorbance, fluorescence or optical rotary dispersion. These
techniques have the advantage of both speed and sensitivity and can
provide information on both Kd and the nature of the protein- ligand
complex. Under certain conditions when both the exact concentration
of protein is known and there is some independent way of relating
ligand fluorescence to concentration, an estimate of n can also be
obtained.
In this chapter a number of techniques, both separation and non-
separation, have been used in an attempt to study the binding of
cholera toxin and NAD"". These included equilibrium dialysis and
measurements of absorbance and fluorescence changes accompanying the
binding of NAD"1". A number of experimental problems, most arising
from the high concentrations of NAD"*" required to reach saturation,
were encountered and are described in the Results section.
Eventually an indirect method of evaluating binding based on the
relationship between substrate binding and the susceptibility of the
toxin's Aa chain to protease digestion was used in order to
calculate a Kd of 4mM for NAD"". The ability of various NAD""
derivatives to bind to the Aa chain in place of NAD"" was also
studied using this method and the results compared with the




Equilibrium dialysis was performed using a Dianom equilibrium
dialysis apparatus consisting of arrays of Teflon cells in a
rotating assembly. Each cell consisted of two half cells separated
by a membrane with ports in both sides for loading and unloading
samples. This apparatus allows a quick and reproducible estimate of
Kd and n (Weder et al., 1971). A number of preliminary experiments
were performed to characterise the system in terms of equilibrium
time, stability of ligand and protein etc. and these are described
below.
5.2.1.1 Dialysis time
The time taken to reach equilibrium under the experimental
conditions outlined in section 2.11 was determined by the time taken
for solutions of [4~3H] NAD"" (20nCi) containing 0.1 - lOmM
unlabelled NAD"" to equilibrate between two half cells of the
dialysis equipment. Samples were taken through ports from both
sides of the membrane over an incubation time of four hours at 37®C
and the radioactivity counted. Equilibrium was reached after 120
min.
5.2.1.2 Recovery of radioactivity
When [4~3H] NAD"" was dialysed against cholera toxin Ai chain
(0.1 mg/ml) comparison of the total amount of radioactivity added
with the amounts found in each half cell during dialysis showed that
more than 95% of the total radioactivity was recovered. The small
loss of radioactivity was most probably caused by the ligand binding
to the dialysis membrane.
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5.2.1.3 Stability of protein and ligand
To check that the cholera toxin used retained biological activity
after dialysis, samples of the Ai chain or cholera toxin were
dialysed against either O.lM borate, pH8.5 or TEAN buffer, pH7.5.
Following incubation at 37°C for up to four hours, 50yl samples were
removed from the protein-containing half cell and were assayed by
the ADP-ribosylation assay described in section 2.9. Samples were
also analysed on 12% SDS-PAGE in the presence of thiol to see
whether aggregation or degradation had occurred. In all cases the
dialysed samples retained 80 - 100% of their original activity and
their apparent molecular weight was unaffected. To determine the
integrity of the NAD"" after dialysis against cholera toxin, samples
were removed at the end of each experiment and were analysed by
tic as described in section 2.10. In all cases breakdown of NAD"" to
nicotinamide was below 5%. This indicates that unlike diphtheria
toxin which can completely hydrolyse a ten fold molar excess of NAD""
within two hours (Kandel et al.y 1974), the NAD"' Glycohydrolase
activity of cholera toxin should not complicate the dialysis
experiments.
5.2.1.4 Binding experiments
Preliminary experiments were attempted using lyM (0.1 mg/ml)
cholera toxin and 0.02 - 2mM NAD"" containing 20nCi [4~3H] NAD"". The
results failed to detect any significant binding of NAD"". With
results from kinetic experiments suggesting values of K„ for NAD"" of
4mM in the absence of acceptors, it seemed that much higher
concentrations of both NAD"" and protein would be required. If the
probability of binding, p, is defined as
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actual measurement of protein:ligand complex
p =
maximum possible concentration of protein:ligand complex
then for stoichiometric measurements p should ideally equal one.
Protein concentration should therefore be as high as possible so that
as much ligand as possible is bound but not so high as to cause
problems with protein solubility and the Gibbs Donnan effect
(van Holde, 1971) which can upset the equilibrium. Experiments were
repeated using 12yM (1 mg/ml) cholera toxin in TEAN buffer pH7.5
containing 5mM DTT and using 0.01 - 5.0 mM NAD"". The data were
first analysed using a computer programme based on the method of
Marquardt (1963) (Appendix A). The results are also presented
graphically as a plot of 1/r vs 1/A (fig. 5-1), a double reciprocal
plot of mol ligand bound per mol. protein versus free ligand
concentration (Hughes-Klotz plot). This plot was used in preference
to the more familiar Scatchard plot (Scatchard, 1949). Nimmo et
al., (1977) reviewed a number of methods of analysing data obtained
from experiments of similar design to those described here, and
concluded that the regression of 1/r on 1/A was the best because it
gave estimates that were accurate, precise and symmetrically
distributed. This regression is loosely equivalent to the
Lineweaver-Burk double-reciprocal plot of enzyme kinetics
(Lineweaver and Burk, 1934) which is not favoured by many workers
because of the unequal distribution of errors it produces (Price and
Dwek, 1979).
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fig. 5-1 Double reciprocal plot of ligand binding data
Cholera toxin (12uM) was dialysed against concentrations
of NAD* between 0.01 and 5.0mM.
Results were analysed by computer (Appendix A) and are
presented here as a plot of 1/r versus 1/A, where r is
calculated from b (bound ligand in mol l-1)
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Presumably their differing suitabilities arise because in enzyme
kinetics one of the variables (substrate concentration) is genuinely
liY^ependent in the statistical sense (i.e. fixed by the observer and
effectively free from error) whereas in equilibrium dialysis both of
the derived variables, r and A are subject to experimental error
which differs for each ligand concentration.
The binding parameters calculated from these data were
n = 1.0+0.8 and kd = 3.0±2.8mM. The error involved in these
calculations is considerable and makes it doubtful whether the
values, especially of Kd can be considered accurate. These errors
may be due in part to the high concentrations of NAD"'" being used
(which mean that the concentration of bound ligand accounts for a
very small difference between two large numbers). For example at
the lowest concentration of ligand, 0.1 mM NAD"", an experimental
error in estimating free ligand radioactivity of 1% could lead to
errors in r of about 4%. At the highest concentration of ligand
(5mM) the comparable value would be up to 20% error in the estimate
of r.
Binding of NAD"" to the Ai chain alone was also studied. Using
conditions as described for cholera toxin and with concentrations of
Aj. chain up to lOyM (0.2 mg/ml) no binding of ligand could be
detected. Increasing the concentration of NAD"" and of A! chain
proved difficult as at the concentrations of protein required (up to
2 mg/ml or 80yM) the Ax chain came out of solution after a few
minutes. Although 2.5M urea could effectively keep the Ai chain in
solution alternative methods were sought as the urea, being a
chaotropic agent, could have been disrupting the native conformation
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of the protein so as to interfere with the binding of its substrate.
Substitution of 0.1M borate, pH8.5 for TEAN buffer allowed the Ai
concentration to be increased to 2 mg/ml. However, when these
concentrations of Ai were used in binding experiments, the data
obtained showed errors of up to 25% in the quadruplet samples cpm
values. It appeared that during the course of the experiments (up
to two hours) the A! chain was gradually precipitating. Despite
numerous attempts, no results suitable for analysis were obtained
using the Ai chain.
5.2,2 Quenching of protein fluorescence by NAD""
For both diphtheria toxin fragment A (Kandel et a!., 1974) and an
active peptide derived from pseudomonas exotoxin A (Chung and
Collier, 1977b) the binding of NAD" causes a quenching of the
intrinsic fluorescence (excitation 285nm, emmission 333nm) of the
toxins. The intrinsic fluorescence of diphtheria toxin fragment A
was reduced by up to 60% while that of the exotoxin A peptide was
reduced by about 20%. In both cases the concentration of NAD" that
caused half maximal quenching was about 9yM, which correlated well
with the Km of 8yM for NAD" for their ADP-ribosylation activities.
The quenching is thought to be the result of a charge transfer
complex between the nicotinamide moiety of NAD" and a tryptophan
residue within each protein.
To determine whether a similar effect was evident for cholera
toxin or its A* chain alone, the intensity of fluorescence of
cholera toxin (lmg/ml, 12yM) or ^ chain (0.5mg/ml, 20yM) in either
TEAN buffer, pH7.5, phosphate buffer, pH6.5 or borate buffer, pH8.5
was measured in the presence of increasing concentrations of NAD" as
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described in section 2.13. As shown in fig. 5-2 at saturating
concentrations of NAD"1" (4mM and above) the fluorescence at 333nm
(excitation 285nm) of whole toxin, at pH7.5, was reduced to a level
of about 50% of its initial value. A similar effect was seen for
the Ai chain. Although this at first appeared to represent a direct
effect of NAD"" on the intrinsic fluorescence of cholera toxin, the
decrease in fluorescence could be explained fully by the increased
absorption of NAD"" at 285nm.
Changing the excitation wavelength to 290nm at which wavelength
the absorbance of NAD"" is significantly lower, was not enough to
prevent the absorption of NAD"" from reducing the effective intensity
of light reaching the sample as shown in table 5-1. This in turn












Table 5-1 The contribution of NAD"^ absorbance at 290nm to
the proportion of light transmitted to the
sample
The absorbance of a ImM solution of NAD"" at
290nm was taken to be 0.53
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NAD*" (mM)
fig. 5-2 Decrease in fluorescence intensity as a function of NAD"
concentration
The decrease in fluorescence intensity (ex290/em330) was
recorded when NAD" was added to cholera toxin, 12yM in
TEAN buffer, pH7.5 at 25*C.
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The absorbance of NAD"* was not a problem when diphtheria toxin and
exotoxin A were examined at this wavelength as the concentration of
NAD"*" required to reach saturation was a thousand fold lower. It is
impossible to say from these results whether or not NAD"1" causes a
change in the intrinsic fluorescence of cholera toxin as any effect
at this wavelength is effectively swamped by the absorbance of NAD"*".
5.2,3 Ultra violet difference spectra
When NAD"* binds to diphtheria toxin fragment A, it causes
alterations in the fragment's spectral properties. Difference
spectra revealed a red shift in the absorbance peaks at 281nm for
tyrosine and 294nm for tryptophan presumably due to transfer of these
residues into a more hydrophobic environment. There was also a new
absorbance band produced at 360nm. When plotted as a function of
NAD"* concentration the absorbance at 360nm lay on a theoretical
curve calculated from the binding of NAD"* with fragment A of 8pM
(Kandel et al., 1974).
The difference spectrum of the Ai chain generated by NAD"* was
recorded using pairs of matching tandem double quartz cuvettes (1cm
light path). NAD"* solution was added in microlitre quantities to a
15yM solution of the Ax chain in TEAN buffer at pH7.5 and to buffer
in the reference cuvette. An equal volume of buffer was added to
the protein reference cuvette. Difference spectra were recorded
using a Pye Unicam SP800 spectrophotometer. The temperature in the
water-jacketed cuvette chamber was kept at 25*C. Results are
presented in fig. 5-3 of the change in absorbance seen at 269nm. No
change in absorbance was seen at 360nm. The results are difficult
to interpret because of the strong absorbance of NAD"* itself at
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260nm. How much of the apparent quench was due to an actual change
in the Ax chain's spectral properties and how much due to
difficulties in matching the sample and reference cuvettes after the
addition of NAD* is not apparent.
fig. 5-3 Difference spectra of cholera toxin Ax chain generated by
NAD*
To cholera toxin Ax chain 15yM in TEAN buffer and to the
buffer in the reference cuvette NAD* was added in 300yM
increments. (a = no NAD*, b = 300yM, c = 600yM,
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5.2.4 Cholera toxin labelled with 7-chloro-4-nitrobenzofuran (Nbf)
As there was no measurable change in the intrinsic fluorescence
of cholera toxin following the binding of NAD"*", fluorescently
labelled toxin was used instead to try to detect some measurable
change following the binding of NAD"1". Portions of cholera toxin,
its Ai chain and E.coli heat labile toxin (LT, see Chapter Four and
in particular section 4.2.3) were labelled with the fluorescent
probe Nbf. Nbf reacts most readily with free sulphydryl groups and
has generally been used in this way. There are no free sulphydryl
groups in cholera toxin but at pH8.5 Nbf will also react with the
amino groups of lysine residues of which there are several in both
subunits of the toxin (Duffy et al., 1985; Lai, 1977).
5.2.4,1 Preparation of Nbf-labelled toxin and subunits
A solution of cholera toxin or its Ax chain alone was labelled
with Nbf by incubating with a near saturating solution at pH8.5 as
described in section 2.13. After exhaustive dialysis, the product
showed the properties expected of the Nbf derivative of a protein
with an absorbance maximum at 475nm and a fluorescence maximum at
about 530nm with the excitation maximum at 468nm. When the labelled
toxin was analysed by 12% SDS-PAGE it showed three bands (or one
band for labelled Ax chain) visible under ultra violet light and
staining with coomassie blue. These bands had the expected mobility
of subunits Ax, A2 and B.
A portion of the labelled toxin was separated into its
constituent subunits by gel filtration chromatography in 6.5M urea
at pH3.2 (section 2.3). Urea was removed from the solution by
dialysis as described. The B subunit was collected and shown to be
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pure on 12% SDS-PAGE. Measurement of the absorbance for protein at
280nm and for the amino derivative of Nbf at 475nm suggested that
about 2 moles of Nbf had bound per mole of cholera toxin, 2 moles
per mole of the A! chain and 1 mole per mole of the purified B5
pentamer. After labelling and separation, cholera toxin Ai chain
retained its biological activity in the ADP-ribosylation assay
described in section 2.9, while subunit B retained the ability to
bind ganglioside as judged by diffusion experiments described in
section 2.3.
5.2.4.2 Fluorescence of the Nbf-toxin and the effect of NAD"'
When a solution of Nbf-labelled toxin was treated with NAD" as
described in section 2.14 there was a marked increase in the
fluorescence intensity but no measurable change in the wavelength of
maximum intensity which stayed at 533nm. As shown in fig. 5-4, the
addition of 150yM NAD" resulted in an increase in fluorescence from
3.9 arbitfary units to 7.5 arbitrary units, an increase of over 50%.
The result of a quantitative titration of a solution of Nbf toxin
(15yM) in TEAN buffer, pH7.5 with NAD" is shown in fig. 5-5. The
effect was saturable, the fluorescence reaching a maximum after
160yM NAD" had been added. There was, however, a lag at the start
of the titration curve, with no enhancement of fluorescence evident
until 25yM NAD" had been added. Similar enhancement was seen when
Nbf-Ai chain was titrated with NAD". No change was seen in the
fluorescence of Nbf-B subunit on addition of NAD". The addition of
saturating concentrations of the arginine derivative A599 (see fig.
3-1) produced no change in the fluorescence of Nbf-labelled cholera
toxin, At chain or B subunit, either in the presence of absence of
490 530 570
wavelength (nm )
fig. 5-4 Fluorescence intensity of Nbf-toxin in the presence and
absence of NAIT
The toxin was approximately 10pM in TEAN buffer, pH7.5 at
25*C. The excitation wavelength was 468nm and the
excitation and emission slits were 15 nm and 5nm
respectively.
142
60 120 180 240
NAD+ ( >iM )
I
fig. 5-5 Fluorescence titration of Nbf-toxin
The toxin was approximately 15yM. Conditions are as in
fig. 5-4. The ordinate is the ratio of the fluorescence
intensity of the toxin solution to that of a solution of
Nbf-myoglobin of comparable initial fluorescence




In equilibrium dialysis, separation of bound and free ligand at
equilibrium allowed a direct measurement of free ligand, free
protein and protein:ligand complex. From these values a calculation
of r, the fractional saturation was made. Alternatively, an
indirect estimate of r can be made based on some measurable change
in either protein or ligand which is assumed to accompany protein:
ligand binding. The bound and free ligand do not then need to be
separated. Here the assumption made is that the enhancement of
fluorescence at 533nm can be correlated to r. More specifically,
the ratio of the fluorescence intensity of a solution of Nbf-toxin
to that of a solution of Nbf-toxin fully saturated with NAD" is
interpreted as correlating with fractional saturation. This assumes
that only the protein contributes towards the fluorescence and that
the ligand, NAD", neither absorbs nor fluoresces. Returning to
equation 2 in the introduction to this Chapter,
rearrangement gives
A plot of 1/r versus 1/[A] should give a straight line of slope Kd.










fig. 5-6 Double reciprocal plot of fluorescence titration results
The data presented in fig. 5-5 are plotted here as \!Af
(2Jf = the ratio of the fluorescence intensity of a
solution of Nbf-toxin to that of a solution of Nbf-toxin
fully saturated with NAD") versus 1/NAD".
A value of IC* = 40±4yM for NAD" was tentatively calculated
from this graph.
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where fmM is the maximum change in relative fluorescence intensity
when the system is saturated with NAD"*" and f is the change in
relative fluorescence intensity at a particular concentration of
NAD"1". A plot of 1/ f versus 1 /[A] for the data in fig. 5-5 is shown
in fig. 5-6. The estimated Ka value from the slope of this plot was
Kd = 40±4yM. This value was lower than might be expected bearing in
mind the millimolar for NAD"1" calculated in Chapter Three and the
millimolar estimate of Kd obtained using equilibrium dialysis. The
lag at the start of the titration curve in fig. 5-6 cannot be
explained by this model. In fact, although the curve indicates that
saturation with NAD"" occurs at around 200yM NAD"" the curve is not a
typical saturation curve at all, a point which argues against the
subsequent analysis of the data in this way. The assumptions made
concerning fluorescence enhancement and fractional saturation may be
incorrect and an estimate of Kd based on this data would then be
invalid. Whether or not the estimate of a micromolar Kd value is
correct, the results indicate at least that NAD"" is capable of
causing a change in conformation of cholera toxin or of its A! chain
alone, but not of its B subunit, and that the concentration of NAD""
Orve. WuncUfccl
necessary to bring about this change is approximately |fold lower
than the estimated value for NAD"*. Why such an effect should
occur at these NAD"" concentrations is not clear. The ability of
NAD"" to bind to the Ax chain may have allowed it to interact with
the Nbf probe in a way that is not directly proportional to the
amount of NAD"" bound. As already mentioned, NAD"" had no effect on
the fluorescence of Nbf-proteins to which it does not bind (such as
Nbf-B subunit and Nbf-myoglobin).
^ Vic cc^culcdieci m cV^apte< 3 ond Ihe **"»
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An alternative explanation for the Kd value could be that
potential experimental errors are too great to allow an accurate
measurement. Weber (1965) presented a mathematical analysis of
this problem based on the concept of probability of binding, p,
which is defined as:
actual concentration of [PA] complex
p =














The results of Weber's analysis relate error in Kd to the
probability of binding. Error in Kd is a minimum when p = 0.5
whereas it increases sharply in the range above 0.8 and below 0.2 .
A protein:ligand equilibrium can be accurately determined only when
the protein concentration is comparable in magnitude or smaller than
Kd according to this analysis. The protein concentration, at 15yM,
is below the estimated Kd value here so an accurate estimate should
be feasible.
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5.2.5 The relationship between the susceptibility of the A1 chain
to digestion and substrate binding.
The techniques used so far have either involved making direct
measurements of NAD"" concentration as in equilibrium dialysis or
have involved indirect estimates of binding based on spectroscopic
or fluorescence changes. In equilibrium dialysis, the errors
involved in measuring a tiny amount of bound NAD"" in the presence of
a large amount of unbound ligand led to a varied and inaccurate
estimate of K^. In intrinsic fluorescence and difference spectrum
measurements the absorbance at 260nm of the large concentrations of
NAD"" necessary to reach saturation swamped any changes in the
fluorescence or absorbance of toxin. The use of Nbf-labelled toxin
avoided the problem of NAD's strong absorbance but yielded a Kd
value (Ka = 40±15pM) which did not seem to agree with the
concentrations of NAD"" necessary for catalytic activity (see Chapter
Three) and was in other ways unsatisfactory. An alternative method
of calculating a Kd value was sought.
It was first noted by Karen Harper, a summer student working
with Dr. Simon van Heyningen in the Department of Biochemistry,
University of Edinburgh, that the Ai chain of cholera toxin produced
a clear and consistent pattern of bands when digested with trypsin
and analysed by 15% SDS-PAGE. Of most interest was the subsequent
finding that 50mM NAD"" could completely protect the Ai chain from
digestion (fig. 5-7). This was taken as evidence that the NAD"" was
inducing a conformational change in the Ai chain upon binding that
drastically altered its susceptibility to protease digestion. It
was pointed out by Dr. David Apps that a method based on the concept
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fig. 5-7 15% SDS—PAGE showing cholera toxin Ax chain treated with
5pg/ml trypsin in the presence of 0-4mM NAD"*"
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of using changes in the rate of tryptic digestion as a measure of
substrate binding had been used successfully by Jacobs and
Cunningham (1968) to calculate binding constants for the interaction
of creatine kinase with its substrates. Their method relied on an
indirect estimate of substrate binding measured by the ability of
each substrate to protect the protein from digestion. Jacobs and
Cunningham used a pH stat meter to measure the rate of digestion of
creatine kinase. Here the initial rate of digestion of cholera
toxin's Ax chain was measured by the appearance of digestion bands
on 15% SDS-PAGE using a densitometric scanner as described in
sections 2.16 and 2.7.3.
5.2.5.1 Protection of the Ax chain from proteolysis
Samples of the Ax chain in TEAN buffer pH7.5 containing a total of
25yg protein were incubated with trypsin for periods of up to an
hour. The reaction was stopped by the addition of ImM PMSF in
propan-l-ol and the digested protein was analysed by 15% SDS-PAGE.
A clear pattern of bands appeared ranging in molecular weight from
approximately 20,000 to 12,000. The appearance of the largest band
of molecular weight 20,000 was measured in each case. The
appearance of this band rather than the disappearance of the
original Ax band (molecular weight 22,000) was measured as its
appearance represented an easily measurable increase rather than a
small gradual decrease in a denser protein band as was the case for
the larger band. However, results from the disappearance of the
22,000 band or from an average of the appearance of the bands at
20,000, 16,000 and 14,000 gave essentially the same value for the
rate of digestion over 30 min.
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To determine the optimum conditions for digestion, samples of the
Ax chain were incubated with l-50yg/ml trypsin for times up to one
hour. The clearest pattern of digested bands was obtained using
5yg/ml trypsin with digestion continued for up to 30 min. Whole
cholera toxin was not used for these experiments as the pattern of
digestion bands became too complicated.
A time course for the digestion of the Ax chain by trypsin is
shown in fig. 5-8(a). Fig. 5-8(b) shows a densitometric scan of one
lane of this gel. When the appearance of the 20,000 band was
plotted as a function of time, a rapid initial burst of digestion
was seen followed by a much slower reaction which exhibited a
relatively constant rate for at least 20 min. (fig. 5-9). It is the
slope of the linear portion of this graph which has been used to
compare the susceptibility of the protein to tryptic digestion under
various conditions. The reason for the initial rapid burst of
digestion is not certain. It could be caused by a rapid digestion
of susceptible surface or denatured bonds followed by a slower but
relatively constant rate of digestion. Alternatively the linear
portion could represent a steady state as the 20,000 band is formed
and degraded. When digestion was allowed to proceed beyond 30 min.,
the 20,000 band gradually disappeared as it was digested to form
smaller peptides. Whatever the complex kinetic explanation behind
the buphasic digestion rate, the linear portion is clearly a
function of
7 and . is related to j the NAD"* concentration and was
measured in each case.
151
kD
C 2 5 15 30 undigested
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fig. 5-8(a) 15% SDS—PAGE showing the rate of digestion of the At
chain by trypsin.
Conditions were as outlined in the text
6 7 8 9 10 11
distance into gel (cm)
fie. 5-8(b) Desitometric analysis of a tryptic digest of the A»
chain (25ug/ml)
Trypsin was added to a concentration of 5yg/n;l and
digestion allowed to proceed for 30 ir.in at 37*C
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time (mins)
fig. 5-9 Rate of digestion of the At chain by trypsin
The rate of digestion was measured by the appearance of a
digestion band of molecular weight (approximately) 20,000
154
In experiments to determine the extent of substrate protection by
NAD"", concentrations of NAD"" of up to lOOmM were added to the Ai
chain and left to stand for 10 min at room temperature prior to
digestion. The presence of 50mM NAD^" was found to inhibit digestion
of the Ax chain completely for up to one hour at 37°C. NAD"" also
protected the Ax chain from digestion by chymotrypsin (5yg/ml) but
to a lesser extent, with some digested bands apparent after a few
minutes even with 50mM NAD"". The more complex pattern of bands seen
following digestion with chymotrypsin and the less easily
interpreted densitometric scan are shown in fig. 5-10.
When the Ax chain was digested with trypsin in the presence of
lOmM A603 (one of the arginine derivatives described in Chapter
Three and illustrated in fig. 3-1) there was essentially no
digestion over 30 min. (fig. 5-11). Digestion was inhibited by
concentrations of A603 down to 0.5mM (the lowest concentration
tested, but not necessarily the lowest concentration to cause an
effect). This substrate protection is interpreted to be caused by a
conformational change in the Ax chain brought about by the binding
of A603. This shows that the substrate analogue A603 can bind to the
toxin's Ax chain in the absence of NAD"". Analysis of the data
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fig. 5-10 Digestion of the A, chain with chymotrypsin
At chain (25yg) was digested with 5yg/ml chymotrypsin for
30 min. at 37"C as described. The photo shows the rate
of digestion by chymotrypsin in the presence of lOmM
NAD". The densitometric scan is of a sample of At chain
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fig. 5-11 Densito»etric analysis of the At chain (25)tg) digested
with 5yg/al trypsin in the presence or absence of 8nM
A603
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The implications of these results in terms of the kinetic mechanism
of the toxin are discussed in Chapter 3.
Control experiments using ovalbumin as a substrate in place of the
Ai chain indicated that neither NAD"*" nor A603 affected its digestion
by trypsin. In another control to ensure that neither NAD"*" nor A603
had a direct effect upon trypsin activity, digestion of the
artificial trypsin substrate BAEE (Ot benzoyl ^- arginine methyl
ester) was measured using a pH stat meter as described in Materials
and Methods. An identical rate of digestion was obtained in the
presence and absence of NAD"" and A603.
5.2.5.2 The relationship between digestion rate and NAD"" binding
When the rate of digestion of the Ax chain was measured at
concentrations of NAD"" from ImM - 20mM, the rate of digestion was
found to decrease in the presence of NAD"" (fig. 5-12). The results
are presented in fig. 5-13 as a reciprocal plot of the rate of
digestion as a function of NAD"" concentration. The assumptions made
for this treatment of the data are as follows.








Assume that only E is digested and not EL and assume v (velocity of
digestion) is given by
v = k[E]
Vmmj€ = k[ E]m<ut = k[Et] = velocity measurable when L = 0
[EL] = [Et] - [E]
v = k[Et] -JL - k[E] K
[L] [L]
K K
v = Vm« —- -VJ-
[L] [L]
multiply by [L] and divide by v to get:
[L] = - . Vm_ K-K
v
A graph of 1/v versus [L] is a straight line with intercepts -K and
1/Vmax and slope Vmm3t.K.
this assumes that when [L] =0, v = V (no ligand)
and when [L] = 00 v = 0 (100% inhibition of digestion)






5-12 Rate of digestion of the Ax chain in the presence of
concentrations of HAD"" from 0 - 20aM.
The rate was measured from the appearance of the
digestion band of approximate molecular weight 20,000
lbO
NAD+ (mM )
fig. 5-13 Secondary plot of HAD"" concentration versus the rate of
digestion of the kx chain
The rate of digestion was measured from the linear
portion of the digestion rates in fig. 5-12 i.e. between
5 min. and 30 min. The rapid initial burst of digestion
was not included. From this graph a Kd of 4.0t0.4mM was
calculated
161
5.2.5.3 Binding of NAD"" analogues
The ability of various NAD"" analogues and derivatives to protect
the At chain from digestion in place of NAD"*" was studied. Samples
of Ai (25yg) in TEAN pH7.5 were allowed to stand for 10 min. at room
temperature with either lOmM or 20mM additions of the following:
thio NAD"", deamino NAD"", nicotinamide, NMN, NADP. NADH, ADP-ribose,
ATP, ADP, AMP and adenine. The only molecules capable of
protecting the A! chain from digestion by trypsin to any extent were
thio NAD"" and acetyl pyridinetfAD at lOmM and above and deamino NAD"",
nicotinamide and NMN at 20mM. Protection was shown by a decrease in
the extent of digestion as measured by the appearance of the largest
digestion band of molecular weight approximately 20,000. NADH could
also protect at lOmM. This may be due to contamination of the NADH
with NAD"" as it was not seen when the experiment was repeated using
a new batch of NADH"". The results are analysed in table 5.2 and
compared to the results from competitive inhibition results









nicotinamide some protection N/D
NMN some protection >100mM
deamino-NAD"" some protection 58mM
NADH some protection -
NADP no protection N/V
ATP no protection -
ADP no protection -
AMP no protection -
adenine no protection >1000mM
Table 5-2 Protection of the Ax chain from digestion
The ability of any molecule to protect the chain from
digestion was judged from the extent of digestion of a
25yg/ml sample of the At chain after 30 min. with 5yg/ml
trypsin in the presence of 20mM of the sample molecule.
Those marked with a star could also protect the Ai chain
from digestion at concentrations of lOmM
N/V = no value obtained
- = not determined
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5.3 Discussion
Here the binding of NAD- and the arginine substrate analogue,
A603 (see fig. 3-1 for structure) to cholera toxin has been studied
using a variety of methods. The overwhelming conclusion from these
studies is that the millimolar concentrations of NAD- necessary to
reach saturation have made the apparently simple task of calculating
a dissociation constant for NAD- extremely complicated.
5.3.1 Equilibrium Dialysis
The first technique used was equilibrium dialysis. A possible
problem using this technique might have been the NAD- Glycohydrolase
activity of cholera toxin, in which NAD- is hydrolysed to
nicotinamide and ADP-ribose. Diphtheria toxin, another ADP-ribosyl
transferase, also exhibits NAD-'ase activity, which was found by
Kandel et al., (1974) to be sufficiently rapid to prevent the use
of equilibrium dialysis to measure binding of NAD- to diphtheria
toxin. The dynamic dialysis technique of Colowick and Womack (1969)
was used instead in this case. However, for cholera toxin, control
experiments suggested that the NAD'ase activity was negligible under
the conditions used. It has been suggested (Tait and van Heyningen,
1980) that some of the NAD'ase activity previously attributed to
cholera toxin may in fact have been due to contamination, and that
the toxin's intrinsic NAD'ase activity is of a much lower order of
magnitude than its ADP-ribosyl transferase activity.
Despite a preliminary estimate of K* = 3.0 ±2.8mM for NAD-, the
size of the error involved cast doubts on the likely accuracy of
this value. After numerous efforts, the measurements of bound and
free ligand continued to show errors of up to 25% between
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quadruplicate samples. Possible sources of this error are outlined
in section 5.2. The greatest cause of the error may be the
insolubility of both the toxin and especially of the isolated Aa
chain at the concentrations of protein used in the dialysis
experiments. It was virtually impossible to keep the toxin in
solution in the dialysis cells except at lower concentrations (i.e.
less than lmg/ml). At these lower concentrations the percentage of
NAD"" bound would only represent 0.02% of the total NAD"" present.
The binding of A599 or other arginine derivatives to the toxin was
not studied by equilibrium dialysis as radiolabeled derivatives
were not available. However it was previously reported that no
binding of the ADP-ribose acceptor analogue 125I-guanyl tyramine
could be detected by equilibrium dialysis under conditions which
would allow optimal enzyme activity for that substrate, i.e. 0.1M
phosphate buffer, 60mM mercaptoethanol pH7.0 (Mekalonos et al.,
1979a).
5.3.2 Intrinsic fluorescence and difference spectra
Measurements of changes in the intrinsic fluorescence or
absorbance of cholera toxin brought about by saturating
concentrations of NAD"" failed to produce any conclusive results.
Tryptophan fluoresces at 333nim (excitation 285nm). Shifrin (1964)
used the model compound indolyl ethyl-nicotinamide to show that the
fluorescence of the indolyl ring is entirely quenched by its
combination with nicotinamide. When diphtheria toxin and
P.aeruginosa exotoxin A were titrated with saturating concentrations
of NAD"" (Kandel et al., 1974; Chung and Collier, 1977a) there was a
marked quench in their intrinsic fluorescence. The interpretation
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made was that for both toxins a charge transfer complex had formed
between the nicotinamide moiety of NAD"" and a side chain of
tryptophan in each protein. However, both toxins have Kd values for
NAD"" in the region of 8.9yM. They therefore require a thousand fold
less NAD"" to reach saturation. As shown in table 5-2, when a
similar quenching of fluorescence was seen for cholera toxin Ai
chain, it could be explained fully by the absorbance of NAD"" at the
exciting wavelength. If a similar charge transfer complex to the
one described does occur between NAD"" and one of the two tryptophan
residues in the A! chain (Duffy et al., 1985), then it is swamped by
the NAD"" absorbance. In a similar way, the apparent difference
spectra in fig. 5-3 may simply be due to inaccurate addition of
NAD"", which absorbs with a maximum at 260nm. Tyrosine and
tryptophan have absorbance peaks at 281nm and 294nm respectively but
these are not evident in the absorbance spectrum. Consequently,
neither is any shift in their absorbance maxima, commonly seen when
either residue moves into a more hydrophobic (red shift) or
hydrophilic (blue shift) environment.
5.3.3 Nbf-labelled
Cholera toxin was labelled with the fluorescent probe Nbf, the
amino acid derivative of which has an excitation wavelength of 438nm
well outwith the absorbance of NAD"". Under the conditions used, the
Nbf probe is incorporated into lysine amino groups. Of the eight
lysines in the A subunit, six are within the A2 chain and only two
in the At. However SDS-PAGE analysis suggested that the A2 chain
was no more heavily labelled than the Ai. The A2 chain may be
buried between the Ai and the B5 ring (Yamamoto et al., 1985, Gill,
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1976a). In such a position, its lysine residues may have been
inaccessible to the Nbf probe. When the Nbf-labelled toxin or Ai
chain was treated with NAD"", there was a change in the fluorescence
spectrum of the Nbf group. This was not seen for Nbf-B subunit or
for a standard solution of Nbf-myoglobin. The addition of A599
produced no changes in the Nbf-probe. The graph in fig. 5-5 implies
that there is a concentration of NAD"" at which the enhancement of
fluorescence is saturated. In principle, it is possible to
calculate a binding constant from these data, if the lag is ignored,
as has been done in fig. 5-6 to give a Kd for NAD"" of 40±4yM.
However it is impossible to know precisely what the saturation
corresponds to. When similar experiments were performed using Nbf
toxin (labelled in the A subunit only) titrated with ganglioside Gmi
(van Heyningen, 1982b) the steep slope of the titration graph
obtained at low concentrations of Gmi was compatible with a
dissociation constant of around 10~^M. Here there is no such
initial slope. Instead, there is a portion of the graph in which no
change in the fluorescent probe is seen at all until in excess of
60yM NAD"" had been added. The shape of the graph argues against its
further use in the calculation of a value. All that can be said
with certainty is that the addition of NAD"" causes a change in the
environment of the Nbf probe, most likely a movement into a more
hydrophobic environment.
5.3.4 Digestion of the Ai chain with trypsin
Substrate protection from proteolysis has been reported for other
ADP-ribosylating toxins (Kandel et al., 1974; Tweten et al., 1985)
and for other unrelated proteins (Jacobs and Cunningham, 1968;
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Trayser and Colowick, 1961) and has been exploited successfully in
the calculation of binding constants.
Here it was found that saturating concentrations of both NAD"" and
the arginine derivative A603 could completely protect the Ax chain
from digestion with trypsin for up to 30 min. This implies that the
binding of NAD"" or of A603 to the Ax chain results in shielding of
susceptible bonds and/or leads to some major conformational change
in the protein. The protection elicited by the two substrates was
not additive. The value of 4.0+0.4mM calculated from a secondary
plot of digestion rates as a function of NAD"" concentration agrees
well with the for NAD"" for both the NAD'ase and ADP-ribosylation
reactions (Moss et al.y 1979b; Mekalonos et al., 1979). The ability
of various NAD"" analogues and derivatives to protect the Ax chain
from digestion (a tentative measure of binding affinity) also
correlated with the KA values reported in Chapter Three. The
properties of the NAD"" binding site seem consistent with the idea
that it is involved in the catalytic activity of the toxin. This
indirect and unusual technique has therefore allowed an estimate of
the dissociation constant for NAD"" based on the assumption that a
decline in the rate of digestion by trypsin is a function of
substrate binding.
The rate of digestion of the Ax chain by trypsin was biphasic
(see fig. 5-9). Similar biphasic kinetics were found when creatine
kinase was digested with trypsin and the reaction followed by the
release of H"" ions (Jacobs and Cunningham, 1968) suggesting that this
is not just an artefact of the SDS-PAGE method of following
digestion. The linear portion of the digestion rate was measured in
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each case and was found to change as a function of NAD""
concentration.
The ability of A603 to bind to the Ax chain in the absence of
NAD"' has implications with respect to the kinetic mechanism of the
toxin. As outlined in Chapter Three, a random order sequential
mechanism may exist for cholera toxin. This mechanism has also been
proposed for an avian erythrocyte transferase. Diphtheria toxin and
exotoxin A appear to have ordered sequential mechanisms with NAD"
binding first.
5.3.5 The nature of the binding site
What, if anything, does this say about the nature of the binding
site(s) for NAD" and A603? The binding of NAD" to the Ax chain is
of low affinity (Kavk«4mM). In fact this value is closer to the
of NAD" for dehydrogenases (typically 10~3 - 10-AM (Dalziel, 1975)),
in which case NAD" is used as a cofactor to which a hydride ion is
transferred, than it is to other ADP-ribosyl transferases. For
these NAD" is a substrate in which the bond between nicotinamide and
ribose is broken. Both prokaryotic (Moss et al., 1983; Gill, 1978)
and eukaryotic ADP-ribosyl transferases (Osborne et al., 1985;
Burtscher et al., 1986) have K* values for NAD" in the micromolar
range. There seems to be no obvious explanation for this unusually
low affinity, especially when contrasted to the normal cellular
concentration of NAD" of around 70-lOOyM (Gill, 1975).
The binding of NAD" to the toxin seems to involve recognition of
the whole NAD" molecule, with nicotinamide especially important.
Similar results were reported for diphtheria toxin and exotoxin A
and for dehydrogenases which interact with the whole NAD" molecule.
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There have been unsubstantiated reports from secondary structure
predictions that cholera toxin, diphtheria toxin and E.coli LT may
all have a 3oc3a sequence of secondary structure (Duffy and Lai,
1986; Yamamoto et al., 1984). This structure is proposed to
resemble the so-called "Rossman fold", an alternating a helix and
8-sheet structure which constitutes the NAD"* binding region of
lactate dehydrogenase (Rossman et al. , 1974) and other
dehydrogenases. However, direct evidence of the secondary structure
of exotoxin A derived from X-ray crystallography (Allured et al.,
1986) failed to detect any such structure. The most notable
structure feature of the active site domain was an extended cleft.
It seems unlikely then that diphtheria toxin contains a Rossman
fold-type structure. Exotoxin A and diphtheria toxin fragment A
have virtually identical specific activities, K™ values for NAD"* and
Ef-2, sensitivities to inhibition and sequential mechanisms (Chung
and Collier, 1977b). These results all suggest a high degree of
homology in the structures of the active sites on the two peptides.
It remains unproven then, that cholera toxin has a PaflCi structure as
part of its binding site.
The NAD'ase activity of cholera toxin implies that when NAD"* is
bound to the Ai chain, its nicotinamide-ribose linkage is accessible
to nucleophilic substitution by water. It seems probable,
therefore, that it might also be highly reactive with an
appropriately placed nucleophilic group on N. (or an analogue
thereof). A working model proposed by Tait and Nassau (1984) agrees
with this. On the basis of results using a number of artificial
arginine derivatives as substrates for ADP-ribosylation, the active
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site of the toxin was inferred to comprise a hydrophobic pocket
responsible for efficiently binding the substrate, with a
hydrophilic region associated with the site at which the ADP-
ribosylation reaction occurs. This model does not explain why the
binding of NAD"" should be of such low affinity. A segment of the Ai
chain, notable for its high concentration of hydrophobic residues
has been proposed to be a transmembrane segment involved in the
insertion of the A* chain into the plasma membrane (Yamamoto et al.,
1984). As previously noted (Chapter Three), covalently cross-linked
toxin can still activate adenylate cyclase and may only require to
penetrate the membrane to catalyse its reaction. Taken together
with the hydrophobic nature of the ADP-ribose acceptor (Tait and
Nassau, 1984; Mekalonos et al., 1979a; Gilman, 1984) the suggestion
is that the reaction occurs close to the plasma membrane. Perhaps
this has some unexplained bearing on the affinity for NAD"" in vivo.
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Chapter Six Photo affinity labelling of cholera toxin with NAD"
6.1 Introduction
The studies in the preceding chapters have provided some ideas
about the interaction of NAD"" with cholera toxin, namely the
possible kinetic mechanism and the affinity of binding. But they
have given no idea as to the location of the NAD"" binding site
within the toxin's Ai chain. Since cleavage of the disulphide bond
between the Ai and A2 chains is required for activity, and since
S-alkylated Ax retains its catalytic activity, the portion of the
molecule near the only cysteine residue in At at position 191 (but
not the SH group itself) has been suggested as a candidate for the
Ai chain's active site (Wodnor-Filipowicz and Lai, 1976; Xia et al.,
1984). Certainly there is a change in the conformation of the At
chain following reduction (de Wolf et al., 1985). However,
comparison of the amino acid sequence of cholera toxin's Ai chain
with that of the closely related E.coli LT Ai chain indicated that
the amino termimal amino acids showed the greatest homology with
long stretches of identical sequence and that there was greater
divergence towards the carboxyl terminus (Duffy et al., 1985;
Yamamoto et al., 1984; Spicer and Noble, 1982; Dykes et al., 1985).
The classical approach to acquiring information about the
residues at the active site of an enzyme has been the use of general
and specific reagents for chemical modification of active site
residues, commonly referred to as affinity labelling (Singer, 1967;
Shaw, 1970; Wold, 1977). Ideal labelling reagents should react not
only with nucleophiles but also with the less reactive but
ubiquitous hydrophobic regions, such as C-H bonds, of proteins.
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This high activity should be masked but capable of activation once
the label is in place at the active site.
Photogenerated affinity labels satisfy both these requirements.
This form of labelling usually requires the modification of the
natural ligand by the incorporation of a chemically inert but
photolabile group. Most of these labels are electrophilic species
as they have to compete between a nucleophile at the binding site
and the water in which the labelling reaction occurs. Irradiation
can give rise to two general classes of species, each of which is
produced by the homolytic cleavage of chemical bonds. The
absorption of ultraviolet or visible radiation may lead to
fragmentation either at a single bond, resulting in the formation of
two free radicals or a diradical, or at a double bond or nitrogen,
which results in a carbene or nitrene (Bayley and Knowles, 1977).
These highly reactive species can then go on to react in a number of
ways with adjacent residues, including addition to double bonds,
insertion into single bonds, hydrogen abstraction, etc. (for a more
detailed account see Bayley and Knowles, 1977 and Chowdry and
Westheimer, 1979).
The first photo affinity label to be used was p-nitro phenyl
diazo acetate, used in the identification of
N2 0
p-nitro phenyl diazo acetate
chymotrypsin's active site serine residue. Other diazo acyl
derivatives have been synthesised for trypsin (Hexter and
Westheimer, 1971) and subtilisin (Stefanovsky and Westheimer, 1973).
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p-Azidopheny1-acylbromide was used to study glyceraldehyde-3-
phosphate-dehydrogenase (Hixson and Hixson, 1975), while 8-azido
cyclic-AMP was successfully used in the study of cyclic-AMP binding
proteins (Hayley, 1975). A number of NAD"" analogues have been
synthesised including arylazido-0-alanine NAD"" and S-a^ido adenine
NAD"" which were successful substitutes for NAD"" (Chen and Guillory,
1977; Koberstein, 1976). However, previous attempts at synthesising
suitable photolabile NAD"" derivatives were not so successful.
Neither 3-diazo acetoxymethyl NAD^ (Browne et al., 1971) nor 3-azido
NAD"" (Hixson and Hixson, 1973) proved to be suitable when used to
label yeast alcohol dehydrogenase. They both had reduced affinities
for the enzyme, which binds NAD"" relatively loosely anyway (Kd = 5
x 10~AM). There was only a low level of incorporation of the label,
much of which may have been non-specific. These examples illustrate
the problems inherent in photolabelling of "loose" rceptor binding
complexes. In principle, if the dissociation constant is millimolar
or below, and binding of the analogue is competitive with the
natural ligand, specific labelling will be seen provided the
lifetime of the reactive species generated is short (10-5 sec or
less).
The problems of reduced affinities of some photolabile substrate
analogues can be avoided if the natural ligand itself is used as the
photolabel. In this way there is no uncertainty about whether the
label behaves in an identical way to the natural ligand. If the
natural ligand has a functional group or aromatic moiety then it may
make an excellent photolabel. Unsaturated keto steroids have been
used to identify hormone receptor proteins including glucocorticoid
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(Govindan and Gronomeyer, 1984) and progesterone receptors
(Birnbaumer et al., 1983) and also androgen-binding protein (Taylor
et al., 1980). Underivatised thyroid hormones make good labels of
thyroid hormone binding proteins (van der Walt et al., 1982).
Nucleotides and cyclic nucleotides make very efficient labels
(Antonoff et al., 1976). When ATP was used to photolabel the
apparent catalytic site on the heavy chain of myosin, up to 0.5
moles of ATP were incorporated per mole of protein (Manuta and Korn,
1981).
It was recently shown that irradiation of mixtures of diphtheria
toxin fragment A and [carbonyl_1*C] NAD* with ultraviolet light
induced efficient transfer of the radiolabel to position 148,
corresponding to glutamate in the unmodified protein (Carroll et
al., 1980; Carroll and Collier, 1984). The photoproduct (an
<X-amino-8-(6-nicotinamidyl) butyric acid residue) contained the
entire nicotinamide moiety of NAD* linked via its number 6 carbon to
the decarboxylated ^-methylene carbon of glutamate 148 (Carroll et
al., 1985). No portion of the ADP-ribose moiety had been
incorporated. When site directed mutants of diphtheria toxin
fragment A were manufactured, in which glutamate 148 was replaced by
aspartate, the ADP-ribosylation activity of fragment A was abolished
(Tweten et al., 1985). These results indicate that glutamate 148
must be at or near the catalytic centre of the toxin.
Here the photoaffinity labelling of cholera toxin's A* chain with
underivatised NAD* has been attempted using a modification of
Collier's method. The bulk of this work was performed in the
Department of Microbial Biochemistry, Glaxo Group Research, Ltd.,
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Greenford, Middlesex. Some of these experiments used large amounts
of cholera toxin and radiolabeled NAD"*, both of which are very
expensive. Because of this, limitations on the scale of some of the
studies were imposed by financial constraints.
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6.2 Results
6.2.1 Photo-induced incorporation of NAD"" into cholera toxin
PhotoaffInity labelling experiments were performed as follows.
Mixtures of cholera toxin, 60yM in TEAN buffer, pH7.5 and NAD"", ImM
- 16mM containing 25yCi (25nMoles) [4_3H] NAD"" in the presence of
20mM DTT, were allowed to stand for 10 min. at 4°C. Droplets of 100
- 150yl were then placed on a parafilm-coated micro-titre plate
floating in an ice bath. Experiments were performed at 4"C to
minimise breakdown of the NAD"" by the toxin's NAD'ase activity. The
droplets were irradiated at a distance of 5cm using a CAMAG lOOw
dual wavelength ultra violet lamp at 254nm. At the times indicated,
20yl aliquots were removed, and firstly treated by precipitating any
covalent protein-ligand formed on Whatman 3mm paper impregnated with
12% trichloroacetic acid (TCA), 0.1M phosphoric acid. However
there seemed to be some non-specific adsorption of NAD"" onto the
filter paper resulting in high background levels. These high
backgrounds were reduced using the following procedure. Aliquots
were removed as described, then diluted with 25yl 6M urea containing
2-5% BSA. The urea was found necessary to dissociate any non-
covalently complexed protein and ligand. Samples were then
precipitated with 12% TCA/phosphoric acid, centrifuged and the
pellets washed a further three times.
In preliminary experiments to determine the time-course of
incorporation, [4~3H] NAD"" was replaced in some experiments with
[adenine-2,8~3H] NAD"". Results, presented in fig. 6-1, show that
incorporation of both adenine- or nicotinamide-labelled NAD""
continued over 2 hours. When the experiment was repeated for up to
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4 hours, the rate of incorporation was seen to level off (fig. 6-2).
Varying the pH from 6.5 - 8.5 had no significant effect on the
overall level of incorporation. The effect of varying the NAD"
concentration is shown in fig. 6-3. When the NAD" concentration was
increased up to 16mM there was a small increase in both the rate and
extent of incorporation. A greater increase may have been prevented
by a concomittant increase in optical shielding caused by the
absorbance of NAD" at 260nm. As evident in figs. 6-1 - 6-3, the
level of incorporation of NAD"1" was around 0.05 - 0.20 moles per mole
of toxin.
The concentrations of reagent are important in the design of
photolabelling experiments. If absolute specificity is required
then a high protein concentration and a low ligand concentration
should provide this, at the expense of a higher extent of labelling.
The converse situation, with excess ligand (at a concentration
greater than the dissociation constant) over protein should increase
the extent of labelling. However, non-specific labelling (whereby
labelling occurs outside the binding site, also called 'pseudo
affinity labelling' (Ruoho et al., 1973)) can occur when high
concentrations of ligand are used. Non-specific labelling may
especially be a problem for loosely bound ligands, as is the case
here for NAD" and cholera toxin. The concentration of NAD" chosen
was therefore 5mM, (Kd = 4mM). The photolabelling was also
performed in the presence of scavengers, which are intended to






fig. 6-1 Photoinduced incorporation of NAD" as a function of ti*
Samples contained cholera toxin, 60yM in TEAN buffer.
pH7.5. 20mM DTT and 5mM NAD" containing either lOyCi
(36nM> [Ad-2,8-3H] NAD" or 25yCi (25nM) [nic-4"3H) NAD".
















fig. 6-2 Photoioduced incorporation of NAD" as a function of time
Samples contained cholera toxin, 60yM in TEAN buffer,
pH7.5, 20mM DTT and 5mM NAD" containing either 10.8nM
(30yCi) [Ad-2,8~3H] NAD" or 30nM (30yCi) [nic-4-3H] NAD".
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fig. 6-3 The effect of NAD" concentration on photoinduced
incorporation
Samples contained cholera toxin, 60yM in TEAN buffer,
pH7.5, 20mM DTT and 4-16mM NAD" containing 3.81 [nic-4-3H]
NAD". Samples were treated as described.
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binding site i.e. free in solution. The 'scavengers' used here were
DTT and Tris (Rudnick et al., 1975; Maasen and Moller, 1974). The
concentrations of Tris and DTT used did not absorb significantly at
the exciting wavelength. In general, non-specific binding is not
saturable (Browne et al., 1971; Katzenellenbogen et al., 1974;
Cooperman et al., 1975). The time course in fig. 5-2 therefore
implies that the incorporation here is a specific, if very slow
event.
When incorporation of radiolabeled NAD" was studied in the
presence of lOOmM unlabelled NAD" it was found that the level of
incorporation of radioactivity was reduced to the level of the
background controls (namely, mixtures of cholera toxin and NAD"
incubated under identical conditions as the samples but not exposed
to ultraviolet light, and irradiated controls containing everything
except cholera toxin). A similar inhibition of radioactive
incorporation was seen when irradiation was performed in the
presence of lOOmM nicotinamide or lOOmM APAD (acetyl pyridine
adenine dinucleotide, a competitive inhibitor of NAD"). This
indicates that the radiolabeled NAD" binds to the same site as
NAD", presumably the active site of the toxin.
6.2.2 Stability of protein and ligand
Prolonged photolysis can result in such undesirable effects as
slow non-specific labelling by photolysis products and destruction
or alteration of the binding site. Exposure of NAD" to short-wave
ultraviolet light will eventually lead to its degradation to leave
nicotinamide and ADP-ribose (Carter, 1950; Seraydarian et al.,
1954). Exposure of proteins to ultraviolet light of below 300nm may
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lead to damage, denaturation and/or protein-protein cross-linking
and aggregation (Jori and Spikes, 1978). In view of the long
exposure times of up to 2 hours, controls were performed to check
the stability of the protein and ligand over this time. Samples of
cholera toxin were irradiated in TEAN buffer, pH7.5, 20mM DTT for up
to 2 hours. The activity of the irradiated samples was then
compared with samples treated in an identical way but not exposed to
radiation. The irradiated samples retained 80 - 100% of their
activity. The integrity of the NAD"1" was checked as follows.
Mixtures of cholera toxin and NAD" were allowed to stand on ice,
without irradiation, for 2 hours. Samples containing NAD" but no
toxin were irradiated for up to 2 hours. Aliquots from both were
then analysed by tic as described in section 2.9. Breakdown of NAD"
into nicotinamide under these conditions was below 10%.
The lamp used for irradiation was of relatively low intensity, 8w,
when compared to the lkw mercury-xenon lamps commonly used for
photo-affinity labelling experiments using steroids (Gronomyere,
1985). This may account for the long time courses of incorporation
(incorporation of NAD" into diphtheria toxin was virtually complete
after 30 min. using a 15w lamp (Carroll and Collier, 1984) while
photoincorporation of the herbicide analogue N-4-azidobenzoyl-3,4-
dichloro aniline is half complete in 20 sec (Bayley and Knowles,
1977). Rapid photolysis may be more important in the case of
chemically unstable ligands and derivatives, which may undergo slow
irradiation-independent degradation. Compared to the photo affinity
label arylazido-(J-alanine NAD" for instance (Chen and Guillory,
1977), NAD" is relatively stable. The stability of both protein and
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ligand may even be increased on binding owing to screening effets
caused by the light absorption of both. Alternatively the
sensitivity of the ligand to irradiation may increoe&on binding to
protein.
6.2.3 Specificity of NAD" incorporation
To determine whether or not photo-induced incorporation of NAD""
was evident for any other proteins, irradiation of several proteins
with NAD"" was performed. These proteins included lactate
dehydrogenase (which binds NAD""), BSA, alkaline phosphatase and
trypsin. All of the proteins were irradiated at concentrations of
5mg/ml in TEAN buffer, pH7.5 with 20mM DTT, and 5mM NAD containing
[4_3H] NAD"". No incorporation of radioactivity was seen for any of
these proteins. In addition, a sample of the E.coli LT prepared in
Chapter Four was similarly treated. There was no incorporation of
radioactivity either with nicked or un-nicked toxin. This result
may not, however, be significant as the preparation of LT
consistently failed to show activity in a number of systems (see
Chapter Four).
6.2.4 Activity of photolabelled toxin
A standard method for determining whether labelling has occurred
is to check the activity of the enzyme after removal of unbound
ligand. If the enzyme's active site is blocked, it should no longer
be active (Katzenellenbogen et al., 1974). Samples of irradiated
toxin (lmg total) were therefore dialysed against TEAN buffer,
pH7.5, to remove excess unbound ligand and then applied to a 2.0ml
column of NAD"" agarose (Sigma) equilibrated in the same buffer. In
theory, labelled toxin should pass straight through the column
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unretarded. Unlabelled toxin should bind to the NAIP agarose, from
which it can be eluted with lOmM NAD"*. In practise, all of the
toxin applied to the column passed through unretarded. It appealed
at first that dialysis may have failed to remove all of the non-
covalently bound NAD"*. The dialysis was repeated, this time in the
presence of 2.5M urea. Again the toxin was applied to the column
but again it all passed through unretarded. It seems unlikely that
all of toxin had been covalently labelled with NAD"* (unlabelled NAD"*
was used which could not therefore be readily quantified following
TCA precipitation). In fact, when tested using the ADP-ribosylation
assay described in section 2.9, the toxin showed close to full
activity. Samples of non-irradiated toxin failed to bind to the
NAD"* agarose column either suggesting the problem to be caused by the
affinity agarose itself. Even if the NAD"* agarose column had
functioned as intended, it is unlikely that the amount of photo
labelled toxin formed under these conditions would have been
sufficient to allow an accurate estimate of its activity. The level
0-0£)-0*t«v>ol MAD+'/moHoy.iv\
of incorporation of NAD"* was typically A over 1 hour (from
fig. 6-1). The ADP-ribosylation assay used for determining activity
requires around lOOyg in total for an accurate estimate of activity.
Upwards of 5mg cholera toxin would have to be irradiated to provide
sufficient photolabelled toxin for an accurate activity estimate.
Financial constraints imposed by the expense of both toxin and
radiolabel did not permit this experiment to be repeated using these
concentrations of protein.
It is not always the case that a photoaffinity-labelled enzyme
will show a complete loss of activity (although it should be if an
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active site residue is involved). Because of the lack of chemical
specificity of many photoaffinity labelling reactions, the labelled
material may be composed of a mixture of closely related products,
some of which may retain partial biological activity. Likewise,
the presence of ligand may increase the sensitivity of some proteins
to photolytic inactivation (Cysyk and Prusoff, 1972) and may mediate
photooxidation or other photosensitized destructions (Jori, 1975;
Laustrait and Hasselman, 1975). In those cases the demonstration of
a loss of biological activity would not necessarily imply that
photoaffinity labelling of the active site had occurred.
6.2.5 Location of the photoincorporated NAD' within the toxin
It is the Ai chain of the toxin which binds NAD"* and which
contains the catalytic activity of the toxin. It was important to
show that it was in fact the Ai chain into which NAD"* had been
incorporated.
Samples of 50yM cholera toxin in TEAN, pH7.5, 20mM DTT and 5mM
NAD"* with either 16.7nM [4-3H] NAD"* or 16.7nV| [A-2,8-3H] NAD"* in a
total volume of lOOyl were irradiated for 2 hours. The samples were
subjected to 12% SDS-PAGE, stained, destained and soaked in New
England Nuclear "en3Hance" fluorographic enhancer before
autoradiography. After 14 days the autoradiograph was developed and
is shown in fig. 6-4. All of the radioactivity had migrated with
the Ai chain of apparent molecular weight 22,000. In addition to
confirming that the NAD"* was located in the Aj chain, this result
confirms the covalent nature of the labelling, i.e. the label is
retained despite electrophoresis in the presence of SDS and
extensive washing of the resulting gel with denaturing solvents.
Ib-T-nM Ib-f/AO'
lb -T<\H LA-l,VHtl KJAb* - bbj+G'
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Although the NAD"" was incorporated into TCA-precipitable material in
section 6.2.1 it could have been argued that some of the ligand had
merely become physically entrapped in the protein precipitate.
fig. 6-4 12% SDS-PAGE of radiolabelled toxin showing the
incorporation of radioactivity into the chain.
The autoradiographl was developed for 14 days. I Lanes (1)
and (3) show cholera toxin irradiated in the presence of
16.7yCi [nic-4~3H] NAD"", (2) and (4) were irradiated
with 56yCi [Ad-2,8~3H] NAD""ov-\c* coooacxoote. loLma. oIcxckoc c(
0€4





6.2.6 Isolation of a radiolabelled peptide from the Ax chain
A sample of irradiated toxin was chromatographed on a column of
Sephadex G75 in 5% formic acid. This treatment has previously been
shown to separate the toxin into its constituent subunits (Lai et
al., 1976). The five B subunits, which remained as an aggregate
under these conditions (they can be separated by boiling in dilute
SDS) were eluted first, closely followed by the Ax chain (as the
irradiation was performed in the presence of DTT, the disulphide
bridge linking the Ai and A2 chains will have been reduced). As
shown in fig. 6-5 all of the radioactivity migrated with the Aj.
chain. This again points to the covalent nature of the NAD-protein
linkage. Fractions containing radioactivity were pooled and freeze-
dried.
The freeze-dried Aa chain was then taken up in 3ml TEAN buffer,
pH7.5 and digested with trypsin (2%w/w) for 3 hours at room
temperature. The digested peptide was then applied directly to a
column of Sephadex G25 (2.2 x 90cm) equilibrated with 50mM ammonium




















fig. 6-5 Isolation of the radiolabelled kx chain
A total of 5mg cholera toxin was mixed with 5mM NAD
containing 175nM [4~3H] NAD~*in a total volume of 750yl
TEAN buffer, pH7.5 containing 20mM DTT. The mixture was
irradiated as described then dialysed extensively against
TEAN buffer pH7.5 until no more radioactivity was
recovered in the dialysate. Formic acid was added to a
final concentration of 5% and the sample was loaded onto a
column of Sephadex G75 (1cm x 110cm) pre-equilibrated in
5% formic acid. The column was run at 20ml/h and
fractions of 2.0ml were collected and assayed for
radioactivity and for absorbance at 280nm




















fig. 6-6 Column chromatography of tryptic peptides from
radiolabeled At chain
Digested radiolabeled Ai chain was applied to a column of
Sephadex G25 (2.2 x 90cm) and run at 10ml/h. Fractions of
2ml were collected and assayed for radioactivity and for
absorbance at 280nm
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This major peak of radiolabelled peptide was freeze-dried and taken
up in 50mM ammonium formate, pH3.0 before being applied to a column
of Dowex AG50W-X8 (1cm x 16cm) anion exchange resin equilibrated
in the same buffer. The column was washed with a stepwise pH
gradient of 50mM ammonium formate pH3.0 - pH5.0 then 50mM sodium
acetate pH5.1 - pH7.0 as described in fig. 6-7. One main peak of
radiolabelled peptide eluted at pH3.0 - 3.5. During one preparation
an additional peak of radioactivity eluted at pH6.0. Analysis of
this minor peak is described in section 6.2.7.
6.2.7 Spectral analysis of the photolabelled peptides
After the main radiolabelled peak described above had been freeze-
dried and taken up in water, its spectral properties between the
wavelengths 240 - 360nm were recorded. As shown in fig. 6-8 there
was a well-defined absorbance maximum at 260nm consistent with the
notion that an aromatic moiety of NAD"" was present. Reaction of the
sample with potassium cyanide as described in section 2.11 produced
a new absorbance peak at 340nm. When a solution of NAD"" of
comparable initial absorbance at 260nm was treated in the same way,
an identical peak of absorbance at 340nm was produced. Spectral
curves for the oxidised and cyanide addition product forms of NAD""
and various derivatives thereof have been published (Sigel et al .,
1959). When compared to the curves of NAD"", 3-acetyl pyridine
adenine dinuc leotide, 3-pyridine aldehydeNAD"", deaminoNAD"",
3-acetyl pyridine deamino NAD"", 3-pyridine aldehyde deaminoNAD"" and
thioNAD"", the absorbance maxima at 260nm and 340nm of the
radiolabelled sample cyanide complex and the shape of the spectral
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fig. 6-7 Ion exchange chromatography of tryptic peptides from
radiolabelled Ax chain
Fractions making up the main peak of radiolabelled peptide
in fig. 5-6 were pooled, freeze-dried and applied to a
column of Dowex AG50W-X8 in 50mM ammonium formate, pH3.0.
The column was washed with ammonium formate buffer of
increasing pH from 3.0 to 5.0 then with 50mM sodium
acetate from pH5.1 to 7.0. The column was run at lml/min.
and fractions of lml collected and assayed for
radioactivity and for absorbance at 280nmrTV»e u'ns






















fig. 6-8 Absorbance of the major radiolabelled peptide in the
presence and absence of potassium cyanide
Spectra were recorded using a Carey spectrophotometer as
described in materials and methods
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curve most closely resembled those of NMT itself. The cyanide peak
(340nm) of the sample was similar to that of NMN but the spectra
differed in other ways. NMN has a two-component peak of absorbance
at 274nm and 256nm which dissappears completely on reaction with
cyanide. This suggests that the NAD*" incorporated into the peptide
has not been converted into any of the above derivatives. Most of
these derivatives can be synthesised either enzymically, whereby
NAD'ase enzymes are used to catalyse the exchange of nicotinamide
for various derivatives or by chemical modification such as the
deamination of the adenine moiety. Presumably, photoexcitation of
the NAD"*" has not caused any of these modifications.
In contrast, the minor radio-labelled peak described in section
6.2.6 showed no reaction at all with potassium cyanide (fig. 6-9).
Its spectrum showed a peak with an absorbance maximum at 264nm and a
shoulder at 256nm. The absorbance maximum of nicotinamide is at
264nm, and the spectrum described is similar but not identical to
the spectrum of NMN which has a maximum at 266nm with shoulders at
274nm and 256nm. However, reaction of NMN with cyanide produces a
large absorbance maximum at 325nm (P.L. Biochemicals information
sheet 6, 1973). Cyanide forms an addition product with the pyridine
ring of N-substituted nicotinamides (Colowick and Womack, 1969).
The incorporated NAD*" or derivative in this sample has presumably
become linked to the toxin in such a way as to prevent the reaction
of cyanide with the nicotinamide ring, as at least part of the















fig. 6-9 Absorbance of the ainor radiolabelled peptide in the
presence and absence of potassiua cyanide
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present. Two distinct NAD"*"-toxin complexes have therefore been
isolated.
6.2.8 Amino acids analysis
Amino acid analysis was performed in an attempt to identify the
radiolabeled peptide by comparison with the known amino acid
sequence of the Aj chain. Initial attempts were made using an LKB
4400 analyser in the Department of Biochemistry, University of
Edinburgh with the help of Mr. Andy Cronshaw. This method employs
ion exchange chromatography followed by post-column derivatization
with ninhydrin in a low volume, high temperature reaction coil.
Upon reaction with ninhydrin, most amino acids produce a complex
which absorbs strongly at 570nm; however, the imino acid proline
forms a complex with different absorbance characteristics which can
be detected if a dual channel detector, with the second channel set
at 440nm, is used.
The peptide samples (both 'major' and 'minor' peaks mentioned
above) were hydrolysed in evacuated tubes with 6 M HC1 at llO'C for
22h. When hydrolysis was complete the tubes were opened and HC1
removed under vacuum. Samples were injected into the analyser in a
pH2.2 buffer (Davies and Thomas, 1973; Moore and Stein, 1963) and
separation of the protein hydrolysate achieved using a system of
three citrate buffers (Condon et al.y 1984). Chromatograms were
produced for both the major and minor peak samples. The
chromatograms show good resolution of all amino acids but with some
disturbance in the 570nm baseline in the basic region of the
chromatogram. The results for both samples suggest that both
"major" and "minor" peaks represent the same peptide. Both samples
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contain large amounts of glycine, the major peptide sample in
particular. As the ratio of glycine to other amino acids in this
sample does not correspond to any tryptic peptide within the Ax
chain (Duffy et al., 1985) it seems likely to be a contaminant.
Glycine, in common with serine and certain other polar amino acids
is the most common environmental contaminant in samples for amino
acid analysis, possibly from atmospheric dust (Cohen et al., 1986).
As shown in Table 6-1 which summarises the results, the ninhydrin
method detects lysine in the samples, but no arginine. A small peak
has been assigned to arginine in the original traces. However, the
arginine peak was incompletely resolved from the large ammonia peak
and occurred at a region of disturbed baseline. The automatic
integrator used with this analyser may have overestimated the
presence of arginine, likewise of histidine which also appears at a
region of disturbed baseline, caused by a change in buffer.
The major sample peak (none of the minor peak sample remained) was
analysed further using an alternative method of analysis. This was
kindly performed by Mr. Ian Davidson in the Department of
Biochemistry, University of Aberdeen. The method is based on a
gaseous acid hydrolysis of the sample followed by the formation of a
pheny1-thiocarbamyl (PTC) derivative of the amino acids by
derivatization with phenyl isothiocyanate (PITC) (Bidlingmeyeret
al., 1984; Koop et al., 1982). The derivatized amino acids are then
separated by reverse phase hplc, followed by ultraviolet detection
at 254nm. This method can detect as little as one picomole of each
amino acid under certain conditions and can provide extremely rapid
analysis. A chromatogram of the radiolabeled sample is shown in
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fig. 6-10 and the results summarised in table 6-1. Again, the
presence of lysine is indicated with this time a complete absence of
arginine. There is a large peak corresponding to glycine which
again may be elevated by atmospheric contamination. Two extremely
large peaks have not been assigned to any amino acid. They may
represent hydrolysis breakdown products of NAD"1" which would absorb
strongly around 260nm and would thus be visible in the 254nm trace.
Such NAD"' derivatives would be unlikely to react with ninhydrin and
would not be visible at 570nm.
The fact that both analysis methods suggest the presence of
lysine simplifies the search for the tryptic peptide as the At chain
contains only two lysine residues, at positions 4 and 17, close to
the amino-terminus. The sequence of the first 20 residues of the Ai
chain is shown below table 6-1. If the peptide contains lysine then
it must be either Asn-Asp-Asp'Lys or Pro*Pro-Asp-Glu*ile«lys. An
empirical formula calculated from the PTC results fits exactly with
the first peptide (if the glycine is ignored completely and the
unknown peaks are assumed to be NAD" derivatives). Asparagine and
aspartate cannot be distinguished following acid hydrolysis. An
empirical formula from the ninhydrin results does not fit so well
with the first peptide, but neither does it fit with the second
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fie. b-10 Amino acid analysis of the major radiolabeled peptide
The analysis used reverse phase hplc on a "vBONDAPAKTIt" C18
column and an acetate/acetonitrile gradient system. The
gradient was 100% to 0% acetate, 0% to 100% acetonitrile
over 12 min. at a flow rate of l.Oml/min. followed by an
8.0 min. wash with 100% acetate at flow rate 1.5ml/min.




table 6-1 Amino acid analysis of the major radiolabelled peptide:
results from both ninhydrin and PTC analyses
ninhydrin PTC
amino nMoles empirical nMoles empirical
acid detected formula detected formula






Gly 6.82 2 . 3.34 6










Lys 2.81 1 0.58 1
Arg
m one. -expervert! y Qlvj wcv= oj-pe>co.\e..
NH2 - ASN - ASP - ASP - LYS - LEU - TYR - ARG - ALA - ASP - SER -
1 1 345678910
ARG - PRO - PRO - ASP - GLU - ILE - LYS - GLN - SER - GLY
11 12 13 14 15 16 17 18 19 20
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peptide, even after allowance has been taken for the poor reaction
of proline with ninhydrin. As mentioned, polar amino acids such as
serine, threonine, glycine and alanine are the most common
contaminants in analyses of this sort. Contamination through
handling the tubes with the fingertips, from dust or from sample
buffers may have led to the low levels of some polar amino acids in
the ninhydrin trace.
6.2.9 Amino acid sequencing
The sample of radiolabeled peptide was then subjected to amino
acid sequencing which was kindly performed by Mr. Bryan Dunbar in
the Department of Biochemistry, University of Aberdeen. Sequencing
was done automatically with an Applied Biosystems gas phase
sequencer, operated as described in Materials and Methods. In the
gas phase machine, the sample is contained on the surface of a thin
disc of glass filter mounted inside a glass column. Polybrene, a
polymeric quaternary ammonium salt that adheres to both glass and
peptide is added to retain the sample. The Edman chemicals (Edman,
1956; Edman and Begg, 1967) are then added as vapours, e.g. in
argon. In this case polybrene (lmg) was added to the sintered glass
fibre sample disc and subjected to a three hour cycle of washes
before the sample of radiolabelled peptide (approximately 600nmol)
was introduced. The sequencer automatically converted thiazotinones
to thiohydantoin derivatives by reaction with trifluoroacetic acid,
and then delivered each sample into a Waters low volume insert vial.
The samples were dried in a Speedvac centrifuge for 15 min. at room
temperature. Acetate buffer, pH5.0 (15yl) and acetonitrile (15yl)
were then added at least 15 min. before hplc analysis.
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The phenyl thiohydantoin derivatives were identified by hplc on
Apex Cyano columns (0.4 x 25cm) with an acetate buffer pH5.0/
acetonitrile gradient system and a 254nm detector. Repetitive yields
were calculated by linear regression analysis of the yields at each
cycle, omitting PTH-Ser, PTH-Thr, PTH-ile and PTH-Scarboxymethyl Cys
all of which had low yields. When the results for an analysis of
radiolabeled peptide were examined and compared to a standard run,
no residues other than the internal standard (0.5nmol PTH nor-
leucine) were present in any of the first six cycles. The same
result was obtained when a larger volume of sample (25yl) was
injected). This indicates either that there is no peptide in the
sample (but this is not the case as shown by amino acid analysis) or
the amino-terminal residue is blocked from reacting with
phenylisothio cyanate. Certain conditions can hinder the reaction
of some amino acids with phenylisothio cyanate. If the peptide
contains a large number of aspartate residues, acid catalysed
cleavage can obscure amino acid components by causing a high
background. Residues linked to those with bulky side chains may be
incompletely cleaved suggesting that if the NAD" had become
incorporated anywhere near the amino terminus it could interfere
with cleavage. The presence of high concentrations of DTT in sample
buffers (there was 20mM DTT in the original buffer) can obscure hplc
peaks of aspartate (Hunkapiller and Hood, 1978; Hewick et al., 1981;
Wittman-Liebold, 1982). In conclusion then, no sequence could be
determined by this method for the radiolabeled peptide as the
N-terminal residue did not react with the Edman chemicals, either
the irradiation procedure had modified the peptide and/or the
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incorporation of 3H-NAD"" was interfering with the reaction.
6.2.10 Dansyl chloride end group analysis
This analysis was done in the Department of Biochemistry of the
Dick Vet School, Edinburgh.
Amino-terminal analysis was performed using dansyl chloride, with
chromatography of the dansyl derivatives on polyamide thin layers as
described in Materials and Methods. Approximately 10 nMoles of the
radiolabeled peptide was treated with dansyl chloride as described
and then hydrolysed in an evacuated-tube with 6M HC1 at 110°C for
20h. After this time the tubes were opened and HC1 removed under
vacuum over NaOH pellets. The hydrolysed sample was chromatographed
as described and visualised under ultraviolet light at 365nm. The
developed plate and its corresponding standard are shown in fig.
6-11. The only spots visible were those corresponding to Dns-NH3
and Dns-OH, with nothing which might represent a dansyl-end group
derivative. It was previously shown (Chapter Three) that the end
group of the Ai chain could be identified as asparagine by this
method, indicating that the end residue is not normally blocked from
reaction with dansyl chloride. A possible effect of irradiation and
photoaffinity labelling of the peptide could have been to cause some
alteration in the end residue to block its subsequent reaction with
dansyl chloride. The NAD"" could have become photoincorporated into
the amino-terminal asparagine itself. Photoincorporation has
previously been reported to hinder the Edman reaction (Lifter et al.,
1974). The insertion of a nitrene group into the (Xcarbon of
tyrosine 88 in myeloma protein 460 apparently hindered Edman




fig. 6-11 Thin layer chromatography of dansyl-amino acid
derivatives on polyamide sheets
The solvent system used is described in section 2.18
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may also prevent Edman degradation. The same authors report that
the conversion of an Ol-peptide bond between asparagine and glycine
into a 3-aspartyl linkage, presumably the result of irradiation,
left the peptide unreactive. Something similar may have occurred
here. On the other hand, the purification procedure itself could
have caused some unknown alteration in the peptide's structure.
No results concerning the nature of the peptide were obtained
using this method. The N-terminal residue of the peptide had once
again failed to react, this time with dansyl chloride.
6.2,11 Fast-atom-bombardment mss spectrometry
This work was kindly performed by Mr. Alan Taylor of the
Department of Chemistry, University of Edinburgh. Fast-atom-
bombardment (FAB) mass spectra were recorded using argon gas on a
MS50TC model spectrometer with Data General software models DG30 and
DS90. Calibration was with caesium iodide and a copper or stainless
steel tip was used for the FAB probe.
Portions of freeze-dried sample were dissolved in various solvents
listed in table 6-2 and applied to the tip of the FAB probe. In FAB
mass spectrometry the sample is exposed to an ionising beam which
gently fragments the sample. The fragments pass over a magnet which
deflects them to land at a position dependant upon their mass/charge
ratio.
A total of 84 scans were run using the solvents listed, of which
PEG 200 and tetraglyme yielded the best results. Thioglycerol at
first appeared to be suitable but a small solvent peak was later
found to be interfering with the main sample peak at 1147 (fig.
6-12). The other solvents used were found to contain no
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contaminating peaks in this area. A species corresponding to
molecular weight 1147 was found to be present to a varying degree in
all the scans. There were also signs of apparent double-charged
forms of this peptide at positions 530-560. These occur when the
species accepts more than one charge. As shown in fig. 6-12 the
largest of these peaks corresponded to mass charge 555.
These results show that the sample of radiolabeled peptide
contains a species of molecular weight 1147. This corresponds to
the molecular weight of the tetrapeptide asn-asp-asp'lys plus
[4-aH]NAD"*. It is not possible from these results to say to which
residue the NATT" is bound or what the chemistry of binding is. The
number of multiple-charged species and the relatively low level of
the 1147 species suggest that the sample has by this time suffered
some level of degradation and that its structure contains a number
of charged groups.
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table 6-2 Solvents used for FAB mass spectrometry
analysis of the radiolabeled peptide














fig. 6-12 Fast atom bombardment mass spectra of the radiolabelled
peptide sample
(a) The solvent used was thioglycerol. In this trace only the main
peaks are shown. The peak at 1147 cannot be resolved from a
solvent peak at the same position.
(b) The solvent was dibutyl phathaldehyde. The large peak at 555
and the smaller peaks at 539 and 569 may correspond to double-
charged species, the variation in position arising from the
loss of one or more fragments during the FAB process.
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6.3.1 Nature of the photo induced incorporation of NAD"
The results presented here show that irradiation of mixtures of
cholera toxin and NAD"" with short wave ultraviolet light leads to
the covalent cross-linking of NAD"" to a specific region of the
toxin's Ai chain. Incorporation was saturable with between 0.05 and
0.20 moles of NAD"" incorporated per mole of toxin. The protein-NAD""
linkage was stable in 12% TCA, 5% formic acid, 6M urea, 50mM tris-
HC1, 0.1% SDS, methanol and acetic acid. This strongly suggests
that the linkage is covalent. It was not susceptible to cleavage
with trypsin. The similarity in the incorporation of adenine or
nicotinamide radiolabeled NAD"" together with the spectrum obtained
on reaction of a purified radiolabeled peptide with potassium
cyanide both suggest that most, if not all of the NAD"" molecule had
been incorporated into the main peak of radiolabeled peptide. This
last point contrasts with results reported for diphtheria toxin
(Carroll and Collier, 1984; Carroll et al., 1985). Photoinduced
incorporation of NAD"" was much more efficient with nicotinamide-
labelled NAD" than it was with NAD" labelled in other portions of
the molecule and the photolabelled product was eventually identified
to be glutamate with the nicotinamide moiety of NAD" attached. The
ADP-ribose group was not present and had presumably been cleaved
either by the effects of irradiation or by the intrinsic NAD'ase
activity of diphtheria toxin. The apparent stability of adenine-
radiolabelled NAD" (at least in the main peptide) when attached to
cholera toxin could reflect a lower level of NAD'ase activity, a
lowered susceptibility to photoinduced cleavage of the nicotinamide-
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ribose bond, or it could indicate a difference in the nature of the
NAD"-toxin attachment.
6,3.2 Nature of the radiolabeled peptide
Gel filtration and ion exchange chromatography allowed the
isolation of a discrete peak of radiolabeled peptide. The apparent
level of incorporation of NAD"" for this peptide was approximately
0.7 moles NAD" per mole peptide. It is not possible to say from the
results whether one or more molecules of NAD" were incorporated or
whether the NAD" was linked to one particular residue within the
peptide. However, preliminary results using fast-atom-bombardment
mass spectrometry indicate the presence of a major species of
molecular weight 1147. This is very close to the molecular weight
of 1155 obtained by adding the weights of one NAD" and the tetra
peptide Asn»Asp *Asp•Lys. The nature of this apparently pure
radiolabeled peptide was investigated using a number of techniques.
Amino acid analysis allowed an estimate of the amount of peptide
present. As shown in table 6-1 the results obtained from a
ninhydrin ion-exchange system analyser and a phenyl thio carbamyl
(PTC) derivative hplc separation analyser were not identical.
However, they both indicate that the peptide, whatever it is, is
small. It contains almost exclusively polar amino acids such as
aspartate, glutamate, lysine with leucine and alanine
and a large amount of glycine. The PTC analysis which was five
times more sensitive than the ninhydrin trace suggested the presence
of even fewer components; aspartate, lysine and again a large amount
of glycine. If the glycine is presumed to be a contaminant, then
this analysis fits very well with one of the two lysine-containing
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tryptic peptides in the Ax chain corresponding to residues 1-4;
Asn-Asp'Asp-Lys. The ninhydrin analysis does not discount this
peptide as a possibility. It suggests the presence of aspartate and
lysine in an approximate 2:1 ratio. The other amino acids present
are all common environmental contaminants (Hunkapilla and Hood,
1978) although serine and threonine which are also reportedly two of
the most common contaminants are not present. If the tetra peptide
Asn*Asp-Asp*Lys is a possible candidate then there is no indication
to which residue(s) the NAD"1" label has become attached. Such a
small peptide might not have been expected to elute in the position
it did following gel filtration chromatography (fig. 6-6). However
the tryptic peptides loaded onto this column may have clumped
together and been poorly resolved. The electrophoretic mobility and
other physical properties important in the separation of such a
small peptide may have been changed by the covalent binding of the
ligand (Bayley and Knowles, 1977). A number of investigators have
observed that photolabelled proteins and peptides do not always
comigrate exactly with their unlabelled counterparts (Cooperman et
al., 1975; Girshovich et al., 1974; Hsiung et al., 1974).
Amino acid sequencing and end group analysis using dansyl chloride,
both techniques which might be expected to give more detailed
information, if not proof of the exact nature of this peptide, both
failed to provide any information concerning the nature of the amino
acids present as the radiolabeled peptide was apparently blocked
from reaction with the chemicals used. The lack of any reaction
with dansyl chloride does suggest that the peptide sample is pure as
free amino acids might be expected to react with the dansyl chloride
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themselves. Contamination of the samples with glycine as evident in
amino acid analysis, could have occurred at any stage in their
preparation for the analysis. The possibility of photoaffinity
labelling interfering with the Edman degradation was mentioned in
section 5.2.10.
- ■ "* . i
6.3.3 The minor radiolabeled peptide
Followng ion-exchange chromatography of one batch of radiolabeled
toxin (fig. 6-6), a "minor" peak of radiolabeled material was
eluted at higher pH (pH 6.0 - 6.5). This peak was only present once
out of a total of three radiolabelling experiments (all of which
produced an identical 'major' peak), and very little was available
for analysis. However amino acid analysis using the ninhydrin
method showed that the major and minor peptides had the same amino
acid composition. A difference was noted in their absorbance
spectra and in their ability to react with cyanide. The absorbance
spectrum of the minor peak resembled that of NMN in having a maximum
at 264nm with a shoulder at 256nm. Unlike NMN, there was no
reaction at all with cyanide although the nicotinamide ring
containing the tritium group must have been present. The elution of
the major and minor peaks at different pH values suggests that they
may have a different net charge, presumably caused by a difference
in the incorporation of the NAD*. This could highlight the
indiscriminate nature of the photolabelling procedure and a possible
randomness of incorporation (e.g. see Fleet et al., 1972; Fisher and
Press, 1974), or it could mean that the NAD* is attached in the same
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way but, in the case of the minor peptide, has become degraded or
altered following irradiation and purification.
6.3.4 The amino terminal peptide as a component of the active site
One interpretation of these results is that the [4~3H] NAD"^ has
become covalently linked to an unspecified amino acid within the
first four residues of cholera toxin's Ai chain (for the complete
amino acid sequence of the A subunit of cholera toxin, see Appendix
C). How does this result compare with what is known about the
structure of the At chain? The complete amino acid and nucleotide
sequences of both subunits of cholera toxin are known, and have been
compared to those of the highly homologous E.coli LT (see for
instance Dykes et al., 1985; Spicer and Noble, 1982; Lockman et al.,
1984). Certain regions of completely conserved nucleotide sequence
have been related to domains of the two proteins important for
activity. Ideas about the secondary structure of the Ai chain have
been based on predictions from analysis of the primary structure, as
no crystal suitable for detailed study of the structure have yet
been reported (see Sigler et al., 1 977 for preliminary
crystallographic results). Further ideas on the regions of the
toxin responsible for activity have come from activity studies with
proteolytic fragments (Matus et al., 1976; Lai et al., 1981) and
monoclonal antibodies directed at particular areas of the toxin
(Kurosky et al., 1982a). Results from these different approaches
can be summarised as follows: Yamamoto et al., (1984) showed that
the amino terminal residues of cholera toxin and of E.coli LT had
been very closely conserved, more so than the carboxyl-terminal
half of the toxins. In fact there were several regions of 100%
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homology including residues 3-17, 29 -54, 81- 102 and 110 - 130.




The top sequence is for E.coli LT (Yamamoto et al., 1984, although
several other authors suggest that residue 4 in LT may be arginine
(Dykes et al., 1985; Spicer and Noble, 1982). These regions have
most likely been conserved between the two proteins. It seems
unlikely that they would have been so strongly conserved if they
were not involved in some way in the toxin's activity. (There is
abrupt and complete divergence between the cholera toxin and E.coli
LT nucleotide sequences outside the structural genes (Lockman et
al., 1984)). A secondary structure prediction based on this
sequence (Yamamoto et al., 1984) suggests that residues 3 - 17,
being highly charged, may be close to the surface of the protein and
may form part of the active site. However, the fact that monoclonal
antibodies directed towards residues 95 - 140 of the Ai chain could
inhibit ADP-ribosylation (Kurasky et al., 1982a) suggests that this
region of the toxin may also be important for activity and may be
looped out on the surface of the protein (Duffy et al., 1985).
Additional evidence that this region may be important in the
catalytic activity of the toxin was suggested by the discovery of an
auto-ADP-ribosylation site at arginine 146 of the Ax chain (Lai et
al., 1983). Limited tryptic digestion of the Ax chain led to
reports of a modified core peptide of molecular weight 12,500
derived from residues 47 - 156 of the Ax chain, which apparently
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retained almost 50% of the catalytic activity of whole At chain (Lai
et al., 1981). This suggested that the central residues of the Ai
chain contained the catalytic site, but the finding that this core
peptide lost its activity following purification implied that an
active conformation had been lost during purification or that other
parts of the A! chain were also involved in the active site. In
fact the authors never showed that the activity they detected was a
property of the 12,500 peptide; rather, activity was present only in
a mixture of peptides formed by limited tryptic digestion of the Ai
chain. Just about any portion of the Ai chain could have been
involved.
There have even been tentative predictions, based on
primary sequence, that cholera toxin shares with diphtheria toxin a
fJafJa structure similar to that reported for lactate dehydrogenase
(Rossman et al., 1974). As mentioned in Chapter Five, direct
evidence from X-ray crystallographic studies of exotoxin A (Allured
et al., 1986) failed to detect any such structure and as diphtheria
toxin and exotoxin A are reportedly so similar (e.g. Chung and
Collier, 1977b; Carroll and Collier, 1984) it is unlikely that such
a region of structure exists in either diphtheria toxin or cholera
toxin. The evidence so far loosely implicates a central region of
the toxin as a likely location for the catalytic site but with
definite involvement from other parts of the toxin. As mentioned in
section 6.1, Xia et al., (1984) suggests that since cleavage of the
disulphide bond between Ai and A2 is required for activity, the
carboxyl terminal of the Ai chain close to the cysteine at 188 may
be involved in the active site. Reduction might expose this region
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to the substrates and a change in conformation in this area has been
noted following reduction (de Wolf et al., 1985). However, both
amino and carboxyl terminals are predicted to lie closely together
in the native protein (Duffy et al., 1985). The amino terminal of
the Ai chain in intact cholera toxin is hidden from monoclonal
antibodies against the A! chain (Kurosky et al., 1982a). Only after
dissociation of the A subunit with thiol and SDS (such as is used to
release the enzymic activity of the toxin) could antibodies be
raised against the amino terminus (Kurosky et al., 1982b).
Activation therefore appears to make the amino terminus more
accessible. This is consistent with the idea that the amino
terminal residues, while they may not constitute the whole of the Ai
chain's active site, may form a part of the catalytic site or at
least the binding site for NAD"*. In this way photoexcitation of the
NAD"* may have caused its incorporation into one of the four amino-
terminal residues. More precise sequence information of the
radiolabeled peptide purified here may answer this question more
fully.
6.3.5 Photoaffinity labelling as a tool for locating the active
site
Photoaffinity labelling is shown here to be a useful tool in
locating the active site of an enzyme. When diphtheria toxin was
labelled in a similar manner, the NAD"* became covalently linked to
residue 148, a glutamate within the active Ax fragment (Carroll and
Collier, 1984; Carroll et al., 1985). Subsequent analysis of site-
directed mutants showed that when this glutamate was replaced by an
aspartate (a residue of similar size and charge which was unlikely
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to have altered the protein's conformation), catalytic activity was
abolished. Photoaffintiy labelling had accurately identified a
residue within the toxin's active site which was crucial for
catalytic activity. This has implications for the suitable design
of vaccines, which could be prepared from biologically inactive, but
immunogenic forms of bacterial toxins such as cholera toxin. (The
currently used vaccine for cholera toxin is made from killed whole
organisms and is only 30% effective for 3-6 months).
However, it has not been proved here that the photolabelled
preparation of toxin lacks activity, which would be expected if the
active site were involved. While such a loss of activity would not
prove unequivocally that the active site was labelled (the
modification could have altered the protein's conformation for
instance), it would strongly suggest that this was the case. The
saturable nature of the incorporation and the specificity (only one
peptide was labelled) suggest that the NAD"* has become incorporated
into either the binding site or the active site itself. However,
care should be taken in interpreting results from this kind of
experiment. In general, photoaffinity labelling tends to be more
efficient when the ligand binds tightly to the protein, with non¬
specific binding more of a problem for ligands with Kd values above
lOOyM. But the rate of dissociation and the half-life of the photo-
activated form of the ligand are also important. If the half-life
is long (>10"5 sec) and the rate of dissociation is fast then the
photogenerated species may have time to diffuse some distance from
its site of photoactivation and to label distant residues. Even for
tightly bound complexes such as carbonic anhydrase and the
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photo-affinity label p-azidobenzene sulphonimide (KA = 10_6M)
photolysis leading to covalent labelling reportedly ocurred at sites
some distance from the active site (Hixson and Hixson, 1975). The
indiscriminate nature of the photolabelling process itself might be
expected to produce a range of chemically similar species. Photo-
labelling of cholera toxin's Ai chain has been reported before
(Wisnieski et al., 1979; Wisnieski and Bramhall, 1981). But in this
case the photoreactive probe was not directed towards the active
site. The probe 12-(4-azido-2-nitrophenoxy) stearoylglucosamine
[l^C] was used instead to show that the Ai chain of the toxin could
insert into membrane bilayers, where it became photolabelled. The
actual residue which had become labelled was not so important.
In conclusion then, while photoaffinity labelling has led to the
purification of a tryptic peptide of cholera toxin's A* chain
containing a covalently-linked NAD"" residue, care should be taken
not to over-interpret the results of what can be a fairly
indiscriminate technique. It is also worth noting that the
photolabelling procedure itself may lead to anomalous results when
the labelled protein is analysed using conventional methods of
separation and analysis.
6.4 Conclusions and future work
The overwhelming impression gained from these studies must be that
cholera toxin has a strikingly high K™ for its substrate NAD"", a
point reflected also in the calculated here to be of the order of
4mM. There are no other reports of ADP-ribosyl transferases with K*,
values of this order; diphtheria toxin, exotoxin A, pertussis toxin,
turkey erythrocyte transferase; they all have K„ (and K* values)
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between 5 and 25yM. There is little indication as to why the Km for
NAD"" should be quite so high in the case of cholera toxin. Findings
outlined in Chapters Three and Five (the variable nature of K„
values for both substrates and the ability of both NAD"" and an
analogue of the second substrate (N.) to bind to the toxin in the
absence of the other substrate) are consistent with a random order
rapid equilibrium kinetic mechanism proposed for cholera toxin by
Osborne et al., (1985), Certainly the phenomonen whereby the
presence of one substrate decreases the toxin's affinity for the
other substrate is an unusual one and has not been reported for
other bacterial toxins. This unusual mechanism might seem at first
to have some bearing on the high K™ value for NAD"". However, an
identical mechanism was proposed by the same authors for an avian
ADP-ribosyl transferase (arginine-specific like cholera toxin) which
had an estimated Km of 8yM for NAD^". The mechanism of action itself
cannot be the sole cause of this high Km value. In view of the
likely cellular concentration of NAD"" (around 70pM) an immediate
thought is that NAD"" itself cannot be the in vivo substrate, but
rather a closely related derivative of NAD"" may be the preferred
substrate. However, analysis of a number of derivatives and
analogues of NAD"", both as replacements for NAD"" in binding and
kinetic experiments showed NAD"" itself to be the best alternative.
Unless there is some unidentified derivative of NAD"" within
intestinal epithelial cells, this proposal does not seem likely.
Perhaps the answer lies in the site of action of the toxin's Ai
chain. There is a growing body of evidence that the Ax chain may
not only penetrate the membrane to allow entry into the cell but may
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catalyse Its ADP-ribosylation of N. either close to or partially
inserted into the plasma membrane. Van Heyningen, in demonstrating
the activation of adenylate cyclase (van Heyningen, 1977) by
covalentiy cross-linked toxin, provided evidence suggesting that the
A and B subunits of the toxin may not have to become fully
dissociated in vivo. Problems encountered in Chapter Three
involving the activity of isolated Ai (or rather the lack of it) did
suggest that when the Ai chain is kept on its own, it loses activity
perhaps as a consequence of its complete dissociation from the other
portions of the molecule. One theory might be that the Ai chain is
pushed through the membrane by some action of the rest of the toxin
elicited by binding to Gmi on the cell's surface (for instance a
large conformational change). It may penetrate the inner surface of
the membrane just far enough to catalyse the ADP-ribosylation of N.
with the help of the numerous cofactors so far identified. What
bearing this kind of mechanism might have on the availability of
NAD"*" is not clear. Certainly, reports that some membrane proteins
require a lipid environment for full activity (for instance N_
itself) imply that the hydrophobic nature of the membrane may
promote the formation of certain protein conformations or stabilise
others.
Exposure of mixtures of NAD"" and cholera toxin to ultraviolet
light resulted in Chapter Six in the covalent incorporation of the
NAD"" into a specific portion of the toxin's Ax chain. This portion
has been tentatively identified to be at the amino terminus of the
Ax chain, a portion which shows remarkably strong homology to the
related E.coli heat labile toxin. As the phenomonen of photoinduced
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incorporation has been reported for other toxins (diphtheria toxin
and exotoxin A), the technique may provide a way of comparing the
architecture of these enzyme's active sites. For instance the
active site of E.coli LT seems likely to be similar, if not
identical to that of cholera toxin as they are homologous and
catalyse the same reaction. But do cholera toxin and LT resemble
diphtheria toxin and exotoxin A? Functional domains responsible for
a particular property, such as substrate binding may be shared
between proteins, e.g. the Rossman fold domain of dehydrogenases.
Both diphtheria and cholera toxins have intrinsic NAD'ase activity
(the hydrolysis of NAD"). This suggests that they can bind NAD" in
such a way that its nicotinamide-ribose bond is exposed to
nucleophilic attack. This particular orientation of binding may be
enough to promote photoactivation of the NAD" in a certain way on
exposure to ultraviolet light of a particular wavelength. Similar
photoincorporation may well turn out to be a property of other ADP-
ribosyl transferases, both bacterial and eukaryotic.
Work for the future might be found in defining exactly the site of
photoincorporation of NAD" into cholera toxin and in using the
technique to compare the active sites of different transferases.
The role of cellular cofactors in the in vivo action of cholera
toxin provides much scope for study as does the entry process for
the Ai chain. Also, the use of cholera toxin and pertussis toxin as
tools in the study of G-proteins and their role in cellular-
transduction processes seems likely to prove invaluable in defining
more exactly the role of these processes in cellular signalling and
perhaps even in the events surrounding oncogenic transformation.
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APPENDIX A ANALYSIS OF RESULTS
a. Binding results
In equilibrium dialysis it is assumed that after equilibrium is
established then the activity (taken to be equal to concentration in
this case) of free ligand is equal on both sides of the membrane.
By measuring the concentration of ligand on both sides of the
membrane b (bound ligand in mol 1_1) and f (free ligand in mol 1_1)
can be calculated. The binding parameters of Kd and n can then be
calculated using a computer program based on the non-linear
expression of b and f using Marquardt's aligorithm (Marquardt, 1963)
or from the linear regression of 1/r on 1/f.
b. Kinetic data
Initial velocities for the enzyme catalysed release of
nicotinamide from NAD"' were calculated from linear progress curves
of the reaction rate (Cornish-Bowden, 1975). Michaelis constants,
maximum velocities and inhibition data were calculated using the
non-parametric method of Cornish-Bowden and Eisenthal (1978) fitted
by the method of Marquardt (1963).
Interactive programs were written in IMP and run on the ICL 2988




A! - the Ai chain of cholera toxin
Ap~ - CtmpicHWn <C£J'Iesttxrvce
ACTH - adrenal corticotrophic hormone
ADPR, ADP-ribose - adenosine diphosphoribose
APAD - acetyl pyridine adenine dinucleotide
A599 - [I2-(phenylmethylamino) dodecanyl] guanidine
BSA - bovine serum albumin
CT - cholera toxin
DNS - dansyl
DTT - dithiothf«itol
EF-2 - elongation factor 2




hplc - high pressure liquid chromatography
LT - E.coli heat labile toxin
NAD'ase - NAD*" glycohydrolase
Nbf-Cl - 4-chloro-7-nitrobenzofuran
Na - the inhibitory regulatory subunit of
adenylate cyclase
Niot - the a subunit of N±
N_ - the stimulatory regulatory subunit of
adenylate cyclase
N.,* - the a subunit of N.
N» - the 3 subunit of N» and/or N*
PITC - phenylisothiocyanate
PMSF - phenylmethylsulphonyl fluoride
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PTC - phenylthiocarbamyl
ROS - rod outer segments of the retina
SDS - sodium dodecyl sulphate
12% SDS-PAGE - 12% polyacrylamide gel electrophoresis in
presence of SDS
TEMED - N, N, N1, N1-tetra methylethylene diamine
tic - thin layer chromatography
thio-NAD"' - thionicotinamide adenine dinucleotide
4406 - [lO-(phenylmethylamino) decanyl] guanidine
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APPENDIX C THE PRIMARY STRUCTURE OF CHOLERA TOXIN A SUBUNIT
The disulphide bridge is shown and the point of cleavage
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